MEDTRONIC INC
DEF 14A, 1994-07-27
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: LOUISIANA PACIFIC CORP, 8-K, 1994-07-27
Next: MEDTRONIC INC, 10-K, 1994-07-27




                           SCHEDULE 14A INFORMATION 

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 
1934 

FILED BY THE REGISTRANT [ X ] 
FILED BY A PARTY OTHER THAN THE REGISTRANT [   ] 

CHECK THE APPROPRIATE BOX:   
[   ] PRELIMINARY PROXY STATEMENT 
[ X ] DEFINITIVE PROXY STATEMENT   
[   ] DEFINITIVE ADDITIONAL MATERIALS   
[   ] SOLICITING MATERIAL PURSUANT TO RULE 14A-11(C) OR RULE 14A-12 

                         MEDTRONIC, INC 
           . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
            (NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) 


                        CAROL E. MALKINSON
           . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

          (NAME OF PERSON(S) FILING PROXY STATEMENT) 

PAYMENT OF FILING FEE (CHECK THE 
APPROPRIATE BOX): 
[ X ] $125 PER EXCHANGE ACT RULES 0-11(C) (1)(II), 14A-6(I) 
      (1), OR 14A- 6(J) (2). 
[   ] $500 PER EACH PARTY TO THE CONTROVERSY PURSUANT TO EXCHANGE ACT RULE 
      14A-6(I) (3).   
[   ] FEE COMPUTED ON TABLE BELOW PER EXCHANGE ACT RULES 
      14A-6(I) (4) and 0-11. 
      1) Title of each class of securities to which transaction applies
 
           . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
      2) Aggregate number of securities to which transaction applies
 
           . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
      3) Per unit price or other underlying value of transaction computed 
         pursuant  to Exchange Act Rule 0-11: _/

           . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
      4) Proposed maximum aggregate value of transaction

           . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 

_/ Set forth the amount on which the filing fee is calculated and state how 
   it was determined. 

  [   ] Check box if any part of the fee is offset as provided by 
        Exchange Act Rule 0-11(a) (2) and identify the filing for 
        which the offsetting fee was paid previously. Identify the previous 
        filing by registration statement number, or the Form or Schedule and 
        the date of its filing. 

        1) Amount Previously Paid:

           . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
        2) Form, Schedule or Registration Statement No.:

           . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
        3) Filing Party:

           . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
        4) Date Filed:

           . . . . . . . . . . . . . . . . . . . . . . . . . . . . 



NOTICE OF 1994 
ANNUAL MEETING AND 
PROXY STATEMENT 
Medtronic, Inc. 
7000 Central Avenue N.E. 
Minneapolis, MN 55432 

 [LOGO]

7000 Central Avenue N.E. 
Minneapolis, Minnesota 55432 
Telephone: 612/574-4000 
                                July 28, 1994 


Dear Shareholder: 

You are cordially invited to join us for our Annual Meeting of Shareholders 
to be held this year on Wednesday, August 31, 1994, at 10:00 a.m. (CDT) at 
Medtronic's Corporate Center at its Rice Creek facility, 7000 Central Avenue 
N.E., Minneapolis (Fridley), Minnesota. 

The Notice of Annual Meeting of Shareholders and the Proxy Statement that 
follow describe the business to be conducted at the meeting. We will also 
report on matters of current interest to our shareholders. 

Whether you own a few or many shares of stock, it is important that your 
shares be represented. If you cannot personally attend, we encourage you to 
make certain that you are represented at the Meeting by signing the 
accompanying Proxy card and promptly returning it in the enclosed envelope. 

Sincerely, 

/s/ Winston R. Wallin
Winston R. Wallin 
Chairman of the Board 

/s/ William W. George
William W. George 
President and Chief Executive Officer 


                           NOTICE OF ANNUAL MEETING 
                               OF SHAREHOLDERS 
                          WEDNESDAY, AUGUST 31, 1994 

To Our Shareholders: 

The 1994 Annual Meeting of Shareholders of Medtronic, Inc. will be held 
Wednesday, August 31, 1994, at the Medtronic, Inc. Corporate Center at its 
Rice Creek facility, 7000 Central Avenue N.E., Minneapolis (Fridley), 
Minnesota, at 10:00 a.m. (CDT) for the following purposes: 

1. To elect five Class II directors for three-year terms. 

2. To act upon a proposal to approve the Company's 1994 Stock Award Plan. 

3. To act upon a proposal to approve the Company's Management Incentive Plan. 

4. To approve appointment of Price Waterhouse as the Company's independent 
auditors. 

5. To take action on any other business that may properly be considered at 
the Meeting or any adjournment thereof. 

These items are more fully described in the following pages of the Proxy 
Statement. 

Shareholders of record at the close of business on July 8, 1994 will be 
entitled to vote at the Meeting and any adjournments of the Meeting. 

By Order of the Board of Directors, 

/s/ Ronald E. Lund 
Ronald E. Lund 
Secretary 


Approximate Date of Mailing 
Proxy Material: July 28, 1994 


                           YOUR VOTE IS IMPORTANT. 
                 PLEASE DATE AND SIGN THE ENCLOSED PROXY CARD 
               AND RETURN IT PROMPTLY IN THE ENCLOSED ENVELOPE. 
MEDTRONIC, INC. 
7000 CENTRAL AVENUE N.E. 
MINNEAPOLIS, MINNESOTA 55432 
                               PROXY STATEMENT 
                        ANNUAL MEETING OF SHAREHOLDERS 
                               AUGUST 31, 1994 

The Board of Directors of Medtronic, Inc. ("Medtronic" or the "Company") is 
soliciting the accompanying proxy for the Annual Meeting of Shareholders of 
Medtronic to be held on August 31, 1994. 

A proxy card is enclosed. In order to register your vote, complete, date and 
sign the proxy card and return it in the envelope supplied. 

When stock is registered in the name of more than one person, each such 
person should sign the proxy. If the shareholder is a corporation, the proxy 
should be signed in its corporate name by an executive or other authorized 
officer. If signed as attorney, executor, administrator, trustee, guardian, 
custodian or in any other representative capacity, the signer's full title 
should be given. 

Shareholders are entitled to one vote for each share of Medtronic Common 
Stock, $.10 par value, they hold of record as of the close of business on 
July 8, 1994. On that date, 57,559,109 shares of Medtronic Common Stock were 
outstanding. A quorum (a majority of the outstanding shares) must be 
represented at the Meeting in person or by proxy to transact business. 

Shares represented by a properly executed proxy received by Medtronic prior 
to the Meeting and not revoked will be voted in accordance with the 
instructions of the shareholder or, if no instructions are indicated, in 
accordance with the recommendations of the Board of Directors. A proxy may be 
revoked at any time before it is exercised by written revocation to the 
Corporate Secretary of Medtronic or by filing with the Corporate Secretary a 
new written proxy. 

                            ELECTION OF DIRECTORS 

DIRECTORS AND NOMINEES 
The Board of Directors is divided into three classes. The members of each 
class are elected to serve three-year terms with the terms of office of each 
class ending in successive years. William W. George, Bernadine P. Healy, 
M.D., Richard L. Schall, Gordon M. Sprenger and Richard A. Swalin, Ph.D. are 
the nominees for election to the Board as Class II directors to serve until 
the 1997 annual meeting and until their successors are elected and qualified. 
All of the nominees are currently directors and were elected to the Board of 
Directors by the shareholders, except for Bernadine P. Healy, M.D., who was 
elected by the Board on July 15, 1993. 

All of the nominees have indicated a willingness to serve if elected. 
However, if any nominee becomes unable to serve before the election, the 
shares represented by the proxy cards may be voted for a substitute 
designated by the Board, unless an instruction to the contrary is indicated 
on the proxy card. 

THE BOARD RECOMMENDS A VOTE FOR ELECTING THE NOMINEES. 
   
                        DIRECTOR NOMINEES -- CLASS II 
                              (TERM ENDING 1997) 

<TABLE>
<S>                                     <C>
                                        Medtronic's President and Chief Executive Officer since 
                                        May 1991; President and Chief Operating Officer from 
                                        March 1989 to April 1991. President, Honeywell Space and 
                                        Aviation Systems (products for commercial and military 
                                        aviation markets and space and satellite applications), 
                                        from December 1987 to March 1989; President, Honeywell 
[photo]                                 Industrial Automation and Control, from May 1987 to 
WILLIAM W. GEORGE, age 51               December 1987 and Executive Vice President of that 
DIRECTOR SINCE 1989                     business from January 1983 to May 1987. Also a director 
Class II Director                       of Dayton Hudson Corporation, Valspar Corporation, The 
Term expires 1994                       Toro Company and HealthSpan Health Systems Corporation; 
                                        a trustee of Abbott-Northwestern Hospital; and a 
                                        director of the Health Industry Manufacturers 
                                        Association. 
                                        


                                        Physician affiliated with The Cleveland Clinic 
                                        Foundation (nonprofit medical research organization) 
                                        since July 1993; Director of the National Institutes of 
                                        Health from April 1991 to June 1993; Chairman of the 
[photo]                                 Research Institute of The Cleveland Clinic Foundation 
BERNADINE P. HEALY, M.D., age 49        from November 1985 to April 1991; President, the 
DIRECTOR SINCE 1993                     American Heart Association, National Center, from 1988 
(AND 1987-1991)                         to 1989; Deputy Director of Office of Science and 
Class II Director                       Technology Policy, Executive Office of the United States 
Term expires 1994                       President, from 1984 to 1985; Professor of Medicine, The 
                                        Johns Hopkins University School of Medicine, from 1977 
                                        to 1984; a trustee of Battelle Memorial Institute. 
                                        


                                        Consultant since February 1985; Vice Chairman of Dayton 
                                        Hudson Corporation (retailing) from December 1977 to 
[photo]                                 retirement in February 1985. Also a director of EcoLab 
RICHARD L. SCHALL, age 64               Inc., First Bank System, Inc., CTL Credit, Inc. and 
DIRECTOR SINCE 1971                     Space Center Company; a trustee of Santa Barbara City 
Class II Director                       College Foundation and a director of the Santa Barbara 
Term expires 1994                       Foundation Finance Committee. 
                                        


                                        Chief Executive Officer and a director of HealthSpan 
                                        Health Systems Corporation (health care delivery) since 
                                        September 1992; President and Chief Executive Officer of 
[photo]                                 LifeSpan, Inc. (health care delivery) from 1982 to 
GORDON M. SPRENGER, age 57              September 1992; Chief Executive Officer of 
DIRECTOR SINCE 1991                     Abbott-Northwestern Hospital from 1982 to September 
Class II Director                       1992; President of Abbott-Northwestern Hospital from 
Term expires 1994                       1982 to 1988. Member of Board of Regents, St. Olaf 
                                        College. 
                                        


                                        Professor of Materials Science and Technology Management 
                                        at The University of Arizona since August 1984; 
                                        consultant in technology management since November 1987; 
[photo]                                 President and Chief Executive Officer of Arizona 
RICHARD A. SWALIN, PH.D., age 65        Technology Development Corp. from February 1987 to 
DIRECTOR SINCE 1980                     November 1987; Dean of the College of Engineering and 
(AND 1973-1977)                         Mines at The University of Arizona from September 1984 
Class II Director                       to July 1987; Vice President of Research and Development 
Term expires 1994                       at Allied-Signal Corp. from 1977 to 1984. Also a 
                                        director of BMC Corp. 


                           BOARD MEMBERS CONTINUING IN OFFICE -- CLASS I 
                                           (TERM ENDING 1996) 



                                        Consultant since February 1994. Chairman of Rosemount 
                                        Inc. (measurement and control instruments) from 1986 
                                        until retirement in February 1994, and President and 
[photo]                                 Chief Executive Officer from July 1968 until retirement 
VERNON H. HEATH, age 65                 in October 1991. Also a director of Tennant Company and 
DIRECTOR SINCE 1983                     Supervalu Inc., a Life Director of Sister Kenny 
Class I Director                        Institute, a trustee of the University of Minnesota 
Term expires 1996                       Foundation and a director of the Courage Center. 
                                        


                                        Vice President and Chief Information Officer of 
                                        International Telecommunications Satellite Organization 
                                        (INTELSAT) (operates global satellite system for 
                                        domestic and international information services) since 
                                        July 1992; Vice President, High Technology Center, The 
                                        Boeing Company, October 1984 to June 1992; Deputy 
                                        Undersecretary of Defense for Research and Advanced 
                                        Technology, 1982 to 1984; Executive Director, Government 
[photo]                                 Systems Division, Control Data Corporation, 1980 to 
EDITH W. MARTIN, PH.D., age 49          1982; and Director, Computer Science and Technology 
DIRECTOR SINCE 1993                     Laboratory, Georgia Institute of Technology, 1976 to 
Class I Director                        1980. Also a director of Immunex Corporation and 
Term expires 1996                       Information Resources, Inc., a member of the Steering 
                                        Committee of the Scottish Collaborative Initiative on 
                                        Optoelectronic Sciences and the External Advisory 
                                        Committee of Mechanical and Electronic Engineering 
                                        Division of Los Alamos National Laboratory, and a fellow 
                                        of the Institute of Electrical and Electronic Engineers. 
                                        


                                        Vice Chairman of Medtronic since July 1988 and Executive 
                                        Vice President from September 1986 to July 1988; 
                                        Chairman and Chief Executive Officer of American 
                                        MedCenters, Inc. (HMO management) from July 1984 to 
[photo]                                 August 1986; President and Chairman of the Board of 
GLEN D. NELSON, M.D., age 57            Trustees of Park Nicollet Medical Center (medical 
DIRECTOR SINCE 1980                     services) from 1975 to 1986; Surgeon at Park Nicollet 
Class I Director                        Medical Center from 1969 to 1986. Also a director of 
Term expires 1996                       Northwestern National Life Insurance Company, The NWNL
                                        Companies, Inc., The St. Paul Companies, Inc., and 
                                        Carlson Holdings, Inc. 
                                        


                                        Chairman of the Board of Stericycle, Inc. (medical waste 
                                        treatment and recycling business) since 1990; President 
                                        and Chief Operating Officer of Abbott Laboratories 
[photo]                                 (health care products company) from January 1987 to 
JACK W. SCHULER age 53                  August 1989; a director of that company from April 1985 
DIRECTOR SINCE 1990                     to August 1989 and Executive Vice President from January 
Class I Director                        1985 to January 1987. Also a director of Somatogen, Inc. 
Term expires 1996                       and Chiron Corp. 
                                        

                                        Private venture capital investor since June 1978; 
                                        President and Chief Executive Officer of Omnetics 
                                        Connector Corporation (microminiature connectors) since 
                                        March 1991; President and Chief Executive Officer of 
[photo]                                 Unisource Corporation (general partner of real estate 
GERALD W. SIMONSON, age 64              limited partnerships and equity investments) since 
DIRECTOR SINCE 1962                     January 1980. Also a director of Unisource Corporation, 
Class I Director                        Northwest Teleproductions, Inc., The Chromaline 
Term expires 1996                       Corporation and Winthrop Resources Corporation, and 
                                        Chairman of the Board of Fairview Hospital and 
                                        Healthcare Services. 



                          BOARD MEMBERS CONTINUING IN OFFICE -- CLASS III 
                                           (TERM ENDING 1995) 



                                        Medtronic's Founder and consultant to the Company since 
                                        retirement in April 1989; Senior Chairman from January 
                                        1986 to May 1989, and Chairman of the Board of Directors 
                                        for more than five years before January 1986. Also a 
[photo]                                 director of Medical Graphics Corp. and North Hawaii 
EARL E. BAKKEN, age 70                  Community Hospital. Mr. Bakken Will Retire From The 
DIRECTOR SINCE 1957                     Board on August 31, 1994 in accordance with the Board's 
Class III Director                      mandatory retirement policy. He will continue his 
Retires August 1994                     contributions to the Company as Founder and Director 
                                        Emeritus. 
                                        


                                        Consultant since May 1992. Vice Chairman of General 
                                        Mills, Inc. (consumer foods and restaurants) from 
                                        January 1981 to May 1992 and Chief Financial and 
[photo]                                 Administrative Officer of such company from November 
F. CALEB BLODGETT, age 67               1985 to May 1992, when he retired. Also a director of 
DIRECTOR SINCE 1976                     Northwestern National Life Insurance Company, The NWNL 
Class III Director                      Companies, Inc. and HealthSpan Health Systems 
Term expires 1995                       Corporation, and a trustee of Abbott-Northwestern 
                                        Hospital and Beloit College. 



                                        Chairman and Professor of the Department of Medicine 
                                        since 1977 and J. S. Abercrombie Chair, Atherosclerosis 
[photo]                                 and Lipoprotein Research, since 1976 at Baylor College 
ANTONIO M. GOTTO, JR., M.D., age 58     of Medicine and Methodist Hospital. Director and 
DIRECTOR SINCE 1992                     principal investigator, Specialized Center of Research 
Class III Director                      in Arteriosclerosis, National Heart, Lung and Blood 
Term expires 1995                       Institute; and president, International Atherosclerosis 
                                        Society. 
                                        


                                        Professor, Graduate School of Business, University of 
                                        St. Thomas, St. Paul, Minnesota since June 1985; 
                                        Chairman, Minneapolis-St. Paul Metropolitan Airports 
                                        Commission, from February 1989 to January 1991; Chairman 
                                        of the Board of Directors and Chief Executive Officer of 
                                        Inter-Regional Financial Group, Inc. (holding company 
[photo]                                 for various financial enterprises) from 1976 to June 
THOMAS E. HOLLORAN, age 64              1985. Also a director of Flexsteel Industries, Inc., MTS 
DIRECTOR SINCE 1960                     Systems Corp., ADC Telecommunications Inc., National 
Class III Director                      City Bank of Minneapolis, National City Bancorporation 
Term expires 1995                       and Space Center Company; chairman and a director of 
                                        Malt-O-Meal Company and the Bush Foundation; and a 
                                        director of the Minnesota Center for Corporate 
                                        Responsibility. 



                                        Medtronic's Chairman of the Board since January 1986 and 
                                        Chief Executive Officer from June 1985 to April 1991; 
                                        President of the Company from June 1985 to March 1989; 
[photo]                                 Vice Chairman of The Pillsbury Company (international 
WINSTON R. WALLIN, age 68               food company) from March 1984 to June 1985; President 
DIRECTOR SINCE 1978                     and Chief Operating Officer of that company from 1977 to 
Class II Director                       1984. Also a director of Bemis Company, Inc., Supervalu, 
Term expires 1995                       Inc., and Cargill, Inc., and Chairman of the Board of 
                                        Trustees of Carlton College. 

</TABLE>

The affirmative vote of a majority of the shares of Common Stock present or 
represented and entitled to vote at the Meeting is necessary to elect each 
director nominee. For this purpose, a shareholder voting through a proxy who 
abstains with respect to the election of directors is considered to be 
present and entitled to vote on the election of directors at the Meeting, and 
is in effect a negative vote; but a shareholder (including a broker) who does 
not give authority to a proxy to vote, or withholds authority to vote, on the 
election of directors, shall not be considered present and entitled to vote 
on the election of directors. 

BOARD AND BOARD COMMITTEE MEETINGS 
During fiscal 1994, Medtronic's Board of Directors held a total of nine Board 
meetings. Each director attended 75% or more of the total meetings of the 
Board of Directors and Board committees on which the director served (held 
during the period he or she served as a director), except for Bernadine P. 
Healy, M.D. and Edith W. Martin, Ph.D. The standing committees of the Board 
of Directors include the Audit Committee, the Compensation Committee, the 
Finance Committee, the Nominating and Organization Committee and the 
Technology and Quality Committee. 

    AUDIT COMMITTEE. 
The Audit Committee held four meetings in fiscal 1994. Committee members 
are Blodgett, Heath, Holloran, Schall (Chair), Simonson, Swalin and 
Wallin. The committee reviews Medtronic's annual financial statements; 
makes recommendations regarding Medtronic's independent auditors and scope 
of auditor services; reviews the adequacy of accounting and audit 
policies, compliance assurance procedures and internal controls; reviews 
nonaudit services performed by auditors to maintain auditors' 
independence; and reports to the Board of Directors on disclosure adequacy 
and adherence to accounting principles. 

COMPENSATION COMMITTEE. 
The Compensation Committee held four meetings in fiscal 1994. Committee 
members are Blodgett, Holloran (Chair), Martin, Schall, Simonson and 
Swalin. The committee reviews compensation philosophy and major 
compensation and benefits programs for employees; administers certain 
stock and benefit plans; and reviews executive officers' and directors' 
compensation. 

FINANCE COMMITTEE. 
The Finance Committee held four meetings in fiscal 1994. Committee members 
are Blodgett (Chair), Heath, Holloran, Schall, Schuler, Simonson, Sprenger 
and Wallin. The committee reviews and makes recommendations regarding 
financial policies and performance objectives as developed by management, 
including review of Medtronic's annual and long-range operating plans; 
assists management in evaluation of major acquisitions and divestitures 
from a financial perspective; reviews changes in capital structure; and 
reviews banking relationships, insurance coverage on assets, tax 
strategies and financial performance and related matters pertaining to 
Medtronic's employee pension and profit sharing plans. 

NOMINATING AND ORGANIZATION COMMITTEE. 
The Nominating and Organization Committee held four meetings in fiscal 
1994. Committee members are Bakken, Blodgett, Gotto, Healy, Heath (Chair), 
Holloran, Martin, Schall, Schuler, Simonson, Sprenger, Swalin and Wallin. 
The committee evaluates qualifications and candidates for positions on the 
Board; recommends Board committee composition; evaluates the performance 
of the chief executive officer; and reviews major organization changes and 
senior management performance. 

The Nominating and Organization Committee will consider nominees for Board 
membership submitted by shareholders. Nominations by shareholders must be 
made pursuant to timely notice in writing to the Corporate Secretary at 
7000 Central Avenue N.E., Minneapolis, Minnesota 55432. Candidates for 
director should be persons with broad training and experience in their 
chosen fields and who have earned distinction in their activities. Notice 
by the shareholder to be timely must be received not less than 50 nor more 
than 90 days prior to the meeting or, if less than 60 days' disclosure of 
the meeting date is given, not later than the close of business on the 
10th day following the day on which notice of the meeting date is mailed 
or public disclosure of such date is made. The notice shall set forth 
certain information concerning such shareholder and the nominees, 
including their names and addresses, their principal occupation or 
employment, the capital stock of the Company which they beneficially own, 
such other information as would be required in a proxy statement 
soliciting proxies for the election of the nominees and the consent of 
each nominee to serve as a director if so elected. The chairman of the 
meeting may refuse to acknowledge the nomination of any person not made in 
compliance with the foregoing procedure. 

TECHNOLOGY AND QUALITY COMMITTEE. 
The Technology and Quality Committee held three meetings in fiscal 1994. 
Committee members are Bakken, Gotto, Healy, Heath, Martin, Schuler 
(Chair), Sprenger, Swalin and Wallin. The committee reviews policies, 
practices, processes and quality programs concerning technological and 
product research; reviews efforts and investments in developing new 
products and businesses; evaluates Medtronic's technological education and 
recognition programs; and reviews quality process matters with Medtronic's 
chief quality officer. 

DIRECTOR COMPENSATION 
Directors who are not employees of Medtronic receive an annual retainer of 
$19,000, $900 per Board meeting, $700 per Board committee meeting, and 
reimbursement for reasonable expenses of attending meetings. Each committee 
chair receives an annual retainer of $3,000 in addition to the committee 
meeting fee, and the Chairman of the Board receives an annual retainer of 
$36,000. 

The Company's restricted stock plan for non-employee directors allows these 
directors to elect to take part or all of their annual retainer in restricted 
stock. Restrictions on the stock lapse upon termination as a director due to 
death, disability, retirement, or a material change in full-time position or 
responsibilities, or upon the occurrence of a "change in control" of the 
Company as described under "Executive Compensation -- Employment and Change 
in Control Arrangements" below. The 1994 Stock Award Plan, which has been 
proposed for approval by the Company's shareholders at the Annual Meeting, 
contains provisions permitting directors to receive their retainer and 
chairmanship fees in restricted stock which are similar to those in the 
Company's current restricted stock plan for non-employee directors. If 
approved, the 1994 Stock Award Plan will replace the existing plan. See 
"Approval of the Company's 1994 Stock Award Plan -- Non-Employee Director 
Awards." 

Under the Company's nonqualified stock option plan, each non-employee 
director automatically receives an initial stock option grant for Common 
Stock on the date he or she becomes a director and an additional automatic 
annual stock option grant on the date of the Annual Meeting of Shareholders. 
The number of shares subject to the initial stock option is determined by 
dividing an amount, initially equal to $100,000 and increased each year after 
August 1988 proportionately with the increase in annual retainer (which 
increase is currently 52%), by the per share closing price of the Company's 
Common Stock on the New York Stock Exchange on the date of grant. The number 
of shares subject to the annual stock option grant is determined by a formula 
based on directors' fees. Each grant includes a related grant of limited 
stock appreciation rights which are exercisable upon a "change in control" of 
the Company, as described under "Executive Compensation -- Employment and 
Change in Control Arrangements" below. The stock options become fully 
exercisable one year after the date of grant, except that the option granted 
to a director upon being elected or appointed to the Board will not become 
exercisable until the director has also been elected to the Board by the 
shareholders. The proposed 1994 Stock Award Plan contains provisions for 
grants to non-employee directors similar to the current nonqualified stock 
option plan. In addition, the proposed plan provides that non-employee 
directors who were formerly employees of the Company will receive annual, but 
not initial, option grants. If approved, the 1994 Stock Award Plan will 
replace the existing nonqualified stock option plan. See "Approval of the 
Company's 1994 Stock Award Plan -- Non-Employee Director Awards." 

In fiscal 1994, each non-employee director received an annual grant of 597 
shares with an exercise price of $62.13 and options for 6,567 shares of the 
Company's Common Stock, and related limited stock appreciation rights 
("Limited Rights"), were granted to non-employee directors as a group at an 
average exercise price per share of $62.13. 

Under the Company's retirement plan for directors, each director will receive 
an annual benefit, equal to the director's annual retainer in effect when 
leaving the Board, following retirement or other cessation of service as a 
director of the Company. The annual benefit is payable for a period equal to 
the years of service as a director up to a maximum of twenty years. No credit 
is given for years of service as a director while an employee of the Company. 
Each non-employee director also has been provided with group term life 
insurance in $100,000 policy amount. 

As part of its overall program to promote charitable giving, the Company's 
Foundation matches gifts by directors to qualified educational institutions 
up to $4,000 per fiscal year. The Company has also established a charitable 
contribution plan for directors. Under the plan, a director who has served 
for at least five years may recommend one or more qualifying charitable 
organizations to the Compensation Committee of the Board. Upon the director's 
death, the Company will donate $1 million to the qualifying charitable 
organizations which have been approved by the Compensation Committee. 
Individual directors derive no financial benefit from this program since all 
charitable deductions accrue solely to the Company. 

Winston R. Wallin, Chairman of the Board of Directors of the Company and its 
former chief executive officer, was paid $100,000 for consulting services 
rendered to the Company under an agreement through December 1993. The 
consulting agreement was terminated in December 1993, and an annual retainer 
of $36,000 for the Chairman of the Board was adopted effective January 1994. 
Mr. Wallin's duties include meeting with government officials and 
administrators on health care policies and practices affecting Medtronic's 
business, and consulting with management on business and policy matters. Earl 
E. Bakken, Founder and a director of the Company, was paid $100,000 for 
consulting services rendered to the Company during fiscal 1994. Mr. Bakken's 
duties as a consultant include representing the Company at major medical 
conferences, maintaining relationships with key opinion leaders in the 
cardiovascular field, and conducting speaking engagements including employee 
meetings and new employee orientation. In addition to the services indicated, 
certain other non-cash compensation and benefits were made available to 
Messrs. Wallin and Bakken. Mr. Bakken will continue his duties as a 
consultant in the capacity of Founder and Director Emeritus after his 
retirement from the Board in August 1994 (see "Election of Directors," 
above). He will receive $100,000 annually for these services, plus support 
services, reimbursement for expenses and certain non-cash benefits. This 
arrangement will be renewable annually by the Company. 

                SHAREHOLDINGS OF CERTAIN OWNERS AND MANAGEMENT 

    CERTAIN BENEFICIAL OWNERS. 
    To the best of Medtronic's knowledge, no shareholder beneficially owned 
    more than 5% of Medtronic's Common Stock as of July 8, 1994. 

    MANAGEMENT SHAREHOLDINGS. 
    The following table shows the number of shares of Medtronic Common Stock 
    beneficially owned by Medtronic's directors, executive officers identified 
    in the Summary Compensation Table below and all directors and executive 
    officers as a group as of July 8, 1994. 

<TABLE>
<CAPTION>
                                          AMOUNT AND NATURE OF 
 NAME OF BENEFICIAL OWNER              BENEFICIAL OWNERSHIP(1)(2) 
- - -------------------------              -------------------------
 <S>                                  <C>
 Earl E. Bakken                          824,536(3) 
 F. Caleb Blodgett                        21,645 
 Arthur D. Collins, Jr.                   48,328 
 William W. George                       182,482(4) 
 Antonio M. Gotto, Jr., M.D.               2,915 
 Bobby I. Griffin                         54,221 
 Bernadine P. Healy, M.D.                  1,597 
 Vernon H. Heath                          12,295(5) 
 Thomas E. Holloran                       22,645 
 Edith W. Martin, Ph.D.                    2,210 
 Glen D. Nelson, M.D.                    117,293 
 Robert L. Ryan                            2,703 
 Richard L. Schall                        34,753 
 Jack W. Schuler                           5,979 
 Gerald W. Simonson                        8,895 
 Gordon M. Sprenger                        3,503 
 Richard A. Swalin, Ph.D.                  9,175 
 Winston R. Wallin                       189,884(6) 
 Directors and executive officers      1,675,936 
   as a group (23 persons)(2) 

</TABLE>
- - --------------
(1) Except for E.E. Bakken, who beneficially owns 1.4% of the shares 
outstanding, no director or executive officer beneficially owns more than 1% 
of the shares outstanding. Medtronic's directors and executive officers as a 
group beneficially own approximately 2.9% of the shares outstanding. 

(2) Includes the following shares not currently outstanding but deemed 
beneficially owned because of the right to acquire them pursuant to options 
exercisable within 60 days (on or before September 6, 1994) as follows: 6,645 
shares by each of V.H. Heath, T.E. Holloran, R.L. Schall, and R.A. Swalin; 
F.C. Blodgett, 1,525 shares; A.M. Gotto, 2,639 shares; B.P. Healy, 597 
shares; E.W. Martin, 2,210 shares; J.W. Schuler, 4,521 shares; G.W. Simonson, 
1,525 shares; G.M. Sprenger, 2,905 shares; W.R. Wallin, 49,004 shares; W.W. 
George, 125,892 shares; G.D. Nelson, 23,368 shares; A.D. Collins, 29,585 
shares; R.L. Ryan, 2,703 shares; B.I. Griffin, 4,255 shares; and all 
directors and executive officers as a group, 318,554 shares. 

(3) E.E. Bakken holds sole voting and investment power over 464,728 shares, 
sole voting power only over 356,308 shares. He disclaims beneficial ownership 
as to an additional 3,500 shares owned by an irrevocable trust over which he 
has no voting or investment power but is entitled to receive a fixed 
percentage of the assets. 

(4) W.W. George disclaims beneficial ownership of 4,043 shares included in 
the above table, which are held by the George Family Foundation, a charitable 
trust of which he is one of the trustees. 

(5) V.H. Heath disclaims beneficial ownership of 500 shares included in the 
above table, which are held by the Heath Foundation, a charitable trust of 
which he is the trustee. 

(6) W.R. Wallin disclaims beneficial ownership of 814 shares included in the 
above table, which are held by The Wallin Foundation, a charitable trust of 
which he is one of the trustees. 

Section 16(a) of the Securities Exchange Act of 1934 requires the Company's 
directors and executive officers to file reports of ownership and changes in 
ownership of the Company's Common Stock with the Securities and Exchange 
Commission and the New York Stock Exchange, and the Company is required to 
identify any of those individuals who failed to file such reports on a timely 
basis. To the best of the Company's knowledge, based upon a review of such 
reports furnished to the Company and written representations that no other 
reports were required, there were no late filings by the Company's directors 
or executive officers in fiscal 1994. 

                   REPORT OF THE COMPENSATION COMMITTEE ON 
                      FISCAL 1994 EXECUTIVE COMPENSATION 

The Compensation Committee (the "Committee") of the Board of Directors is 
responsible for establishing compensation policy and administering the 
compensation programs of the Company's executive officers. The Committee is 
comprised of six independent outside directors. The Committee meets at least 
three times a year to review executive compensation policies, design of 
compensation programs and individual salaries and awards for the executive 
officers. The purpose of this report is to inform shareholders of the 
Company's compensation policies for executive officers and the rationale for 
the compensation paid to executive officers in fiscal 1994. 

COMPENSATION PHILOSOPHY 
The Company's compensation program is designed to motivate and reward 
executives responsible for attaining the financial and strategic objectives 
essential for the Company's long-term success and continued growth in 
shareholder value. The compensation program has been designed to provide a 
competitive level of total compensation and offers incentive and equity 
ownership opportunities directly linked to the Company's performance and 
shareholder return. The Committee believes it is in the best interests of the 
shareholders to reward executives when the Company's performance objectives 
are achieved and to provide significantly less compensation when these 
objectives are not met. Therefore, a significant portion of executive 
compensation is comprised of "at risk" performance- and stock-based 
incentives. 

Key objectives of the compensation program are to: 

* Provide a strong, direct link between the Company's short- and long-term 
financial and strategic goals and executive compensation. 

* Motivate executives to achieve corporate business unit and geographic 
operating goals through an emphasis on performance-based compensation. 

* Align the interests of executives with those of the Company's shareholders 
by providing a significant portion of compensation in Company Common Stock. 

* Provide competitive total compensation in order to attract and retain high 
caliber key executives critical to the long-term success of the Company. 

To maintain a competitive level of total executive compensation, the 
Committee annually evaluates the compensation packages of certain competitor 
companies. This group consists of competitors of the Company that derive at 
least 25% of their revenues from medical devices or equipment. This analysis 
provides the Committee with competitive data on the mix of compensation 
elements, the balance of short- and long-term incentives, and overall 
compensation levels. Differences in company size are adjusted through 
statistical analysis. Most of the surveyed companies are included in the 
industry group presented in the performance graph on page 13 of this Proxy 
Statement. The Committee also uses annual cross-industry compensation data 
from a survey of more than 300 U.S. manufacturing companies, including many 
Fortune 500 companies and industry competitors. The Committee's goal is to 
position the target total compensation for executive officers at the median 
of the marketplace and the actual total compensation in excess of the median 
when the Company outperforms the target performance goals. In fiscal 1994, 
the actual total compensation of executive officers and of the chief 
executive officer was judged by the Committee to generally be above the 
median of the above-described peer and cross-industry groups due to strong 
corporate operating performance and stock appreciation. 

EXECUTIVE OFFICER COMPENSATION PROGRAM 
The key components of the Company's executive officer compensation program 
are base salary, annual incentives and long-term incentives. These elements 
are described below. In determining compensation, the Committee considers all 
elements of an executive's compensation package. 

    BASE SALARY. 
The Committee annually reviews the base salaries of executive officers. In 
determining appropriate salary levels, the Committee considers individual 
performance, level of responsibility, scope and complexity of the 
position, and salary levels for comparable positions at the peer and 
cross-industry companies referenced above. In addition to the above, in 
determining the base salary for the chief executive officer, the Committee 
also considers corporate operating performance, strategic planning and 
succession planning for senior management. Factors considered in 
determining base salary are not assigned pre-determined relative weights. 

Although the Company's operating performance exceeded targeted levels for 
fiscal 1994, the Company is aggressively managing costs. To demonstrate 
commitment to cost management, the executive officers named in the Summary 
Compensation Table below, including Mr. George, did not receive base 
salary increases during fiscal 1994, except for the promotional increase 
for Mr. Collins. Any increase in their total compensation during this 
period occurred only through "at risk" performance- and stock-based 
compensation. 

ANNUAL INCENTIVE AWARDS. 
The purpose of the Company's annual incentive program is to provide a 
direct financial incentive in the form of an annual cash bonus to 
executive officers and key managers who achieve corporate operating, 
business unit and geographic performance goals established under the 
Company's annual operating plan. 

Beginning in fiscal 1995, executive officers are eligible for target 
awards under the annual incentive program ranging from 50% to 65% of base 
salary, with 65% in the case of the chief executive officer. The size of 
the target award is determined by the executive officer's position and 
competitive data for similar positions at the peer and cross-industry 
companies referenced above. The Company sets aggressive performance goals 
and, in keeping with the strong performance-based philosophy, the 
resulting awards decrease or increase substantially if actual Company 
performance fails to meet or exceeds targeted levels. The awards can range 
from 0% to 150% of the target amounts. For fiscal 1994, corporate 
operating performance was assessed against a target measure of corporate 
profit before taxes and after-tax return on net assets, with these 
measures given respective weights of 60% and 40%. Business unit and 
geographic financial performance were assessed against target measures of 
earnings before interest and taxes, return on net assets, revenue, 
distribution expense and/or inventory turnover, with these measures 
assigned respective weights that vary for each participant. In fiscal 
1994, all executive officers received annual incentive compensation 
because their respective performance levels were met or exceeded. 

Mr. George's annual incentive compensation is based solely on the 
corporate operating performance of the Company. For fiscal 1994, Mr. 
George received an award of 112.6% of the target level because actual 
corporate profit before taxes and after-tax return on net assets (weighted 
at 60% and 40%, respectively) exceeded the performance targets. 

LONG-TERM INCENTIVE PLANS. 
Long-term incentives are provided to executive officers primarily through 
the Company's performance share and stock option programs. 

The primary purpose of the performance share program is to offer incentive 
to executive officers to achieve the long-term performance goals of the 
Company. These targets are based primarily on the Company's long-term 
financial goals, with consideration given to an historic analysis of 
Company and peer group companies' performance. The target award for each 
executive officer is also approved by the Committee based on the scope and 
complexity of the position and competitive compensation data. 

The program provides the possibility of earning a payout in Company Common 
Stock and cash at the end of a three-year performance cycle. As with 
short-term incentive compensation, a threshold level of performance is 
required before payout occurs. At the end of each three-year cycle, the 
award earned can range from 0% to 180% of the initial performance share 
units awarded. Performance targets are consistent with the Company's 
long-term financial goals and were measured in fiscal 1994 based on 
three-year cumulative earnings per share and three-year average return on 
net assets, with these two measures given equal weight in determining 
performance level. The value of the award is determined by the average 
price of the Company's Common Stock for the last 20 trading days of the 
performance cycle. At least half of the award must be paid in the 
Company's stock, with the other half paid in cash or Company Common Stock 
at the discretion of the Committee. The plan is thus aligned with both 
financial results and shareholder value, as the percentage payout varies 
with financial performance, and the value of the performance share units 
varies with the stock price. 

For the three-year cycle ended in fiscal 1994, the Company achieved 
cumulative earnings per share and average return on net assets 
significantly in excess of performance targets. Consequently, the payout 
for this cycle for all executive officers, including Mr. George, was 180% 
of the target award. 

The Company's stock option program provides compensation opportunities 
that directly link the interests of management and shareholders, and aid 
in retaining key executive officers. Executive officers are eligible for 
annual grants of stock options. Guideline levels of options are prepared 
based on competitive data from the peer and cross-industry companies 
referenced above. Individual awards are based on the individual's 
responsibilities and performance, ability to impact financial performance 
and future potential. These factors are not assigned pre-determined 
relative weights. All individual stock option grants for executive 
officers are reviewed and approved by the Committee. Executive officers 
receive gains from exercised stock options only to the extent that the 
fair market value of the stock has increased since the date of option 
grant. 

In fiscal 1994, Mr. George was granted an annual stock option to purchase 
up to 9,717 shares of the Company's common stock at an average exercise 
price of $75.125 per share. In addition, Mr. George was granted an option 
to purchase up to 22,432 shares at an exercise price of $68.875 in 
exchange for terminating an existing nonqualified retirement benefit of 
$100,000 per year for life. This retirement benefit had replaced benefits 
foregone by Mr. George upon leaving his previous employer in order to join 
Medtronic. See "Employment and Change in Control Arrangements." The 
exchange of a guaranteed benefit for stock options is consistent with the 
Company's emphasis on linking pay with performance and stock-based 
compensation, and benefits the Company by eliminating an accrued 
nonqualified benefit expense. 

The Committee occasionally grants restricted stock with a fixed 
restriction period to ensure retention of key executive officers or as 
part of compensation provided to a new executive officer to replace 
compensation foregone by the officer when leaving another company to join 
Medtronic. During fiscal 1994, one executive officer was granted 195 
shares of restricted stock in connection with his induction into the 
Bakken Society, the Company's honorary technology society, in recognition 
of his significant technological contributions to the Company. 

TOTAL COMPENSATION OF CHIEF EXECUTIVE OFFICER. Mr. George's total 
compensation for fiscal 1994 was designed so that a significant portion of 
pay was linked to Company performance. Of his total compensation, 71% was 
derived from variable annual and long-term incentive elements. This "at 
risk" portion of compensation was heavily weighted with long-term 
incentives (approximately 52% of Mr. George's total compensation was 
derived from stock option and performance share programs). The emphasis on 
"at risk" and long-term incentives is intended to align Mr. George's 
compensation with the achievement of long-term growth and performance by 
the Company. 

DEDUCTIBILITY CAP ON EXECUTIVE COMPENSATION 
Effective January 1, 1994, the Internal Revenue Code will generally deny the 
deduction for compensation in excess of $1 million paid to executive officers 
named in the Proxy Statement, subject to an exception for "performance-based" 
compensation. Performance-based compensation, as defined in the tax law, is 
not subject to this limitation on deductibility provided that certain 
shareholder approval and other requirements are met. The Committee has 
determined that it will make every effort, consistent with sound executive 
compensation principles, to ensure that all amounts paid to the executive 
officers named in the Proxy Statement are deductible by the Company. 
Accordingly, the Committee has elected to seek shareholder approval of the 
1994 Stock Award Plan and the Management Incentive Plan (see pages 19 through 
31). The Committee expects that all performance- based compensation paid 
under these plans will qualify for deductibility under the new tax law. 

CONCLUSION 
The executive officer compensation program administered by the Committee 
provides incentive to attain strong financial performance and an alignment 
with shareholder interests. The Committee believes that the Company's 
compensation program focuses the efforts of the Company's executive officers 
on the continued achievement of growth and profitability for the benefit of 
the Company's shareholders. 

COMPENSATION COMMITTEE: 

Thomas E. Holloran, Chair 
F. Caleb Blodgett 
Edith W. Martin, Ph.D. 
Richard L. Schall 
Gerald W. Simonson 
Richard A. Swalin, Ph.D. 

                     SHAREHOLDER RETURN PERFORMANCE GRAPH 

The graph and table below compare the cumulative total shareholder return on 
the Company's Common Stock for the last five fiscal years with the cumulative 
total return on the S&P 500 Index and the S&P Medical Products and Supplies 
Index over the same period. The graph and table assume the investment of $100 
in each of the Company's Common Stock, the S&P 500 Index and the S&P Medical 
Products and Supplies Index on May 1, 1989 and that all dividends were 
reinvested. 

       COMPARISON OF FIVE-YEAR CUMULATIVE TOTAL RETURN AMONG MEDTRONIC, 
         S&P 500, AND S&P MEDICAL PRODUCTS & SUPPLIES INDUSTRY INDEX 

                            [graph]

<TABLE>
<CAPTION>
             April 30  April 30  April 30  April 30  April 30  April 30
               1989       1990     1991      1992      1993      1994 
 <S>         <C>       <C>       <C>       <C>        <C>       <C>
 MEDTRONIC   $100.00   $136.13   $239.71   $284.19    $285.62   $331.85 
 S&P 500      100.00    110.44    129.84    148.09     161.73    170.35 
 S&P MP&S     100.00    109.17    176.37    194.90     155.47    145.80 
</TABLE>

                          
                            EXECUTIVE COMPENSATION 

The following table sets forth the cash and non-cash compensation for each of 
the last three fiscal years ended April 30, 1994 awarded to or earned by the 
Chief Executive Officer and each of the other four most highly compensated 
executive officers of the Company. 



                           SUMMARY COMPENSATION TABLE 

<TABLE>
<CAPTION>
                                              ANNUAL COMPENSATION
                                       -----------------------------------
                                                                    
                                                              OTHER ANNUAL 
 NAME AND PRINCIPAL           FISCAL     SALARY       BONUS   COMPENSATION 
 POSITION                      YEAR        ($)         ($)        ($)(1) 
- - ---------------------        ------    --------     --------  -----------
 <S>                         <C>       <C>          <C>       <C>
 William W. George            1994    $479,991     $324,282          -- 
 President and Chief          1993     479,991      338,394          -- 
 Executive Officer            1992     435,050      277,475     * 
 

 Glen D. Nelson, M.D.         1994     369,996      208,308     $21,111 
 Vice Chairman                1993     369,996      217,373      21,746 
                              1992     330,000      175,395     * 
 

 Arthur D. Collins Jr.        1994     335,833      164,699       1,461 
 Chief Operating Officer      1993     316,458      185,919          -- 
                              1992          --           --     * 
 

 Robert L. Ryan               1994     300,000      135,120          -- 
 Senior Vice President and    1993      62,884(9)        --          -- 
 Chief Financial Officer      1992          --           --     * 
 

 Bobby I. Griffin             1994     271,575      110,585       2,973 
 Executive Vice President     1993     271,575      131,225       2,949 
 And President, Pacing        1992     255,000      125,358     * 


                                            LONG-TERM COMPENSATION 
                                          -----------------------------
                                          AWARDS                PAYOUTS 
                                ---------------------------    ---------  
                                RESTRICTED       SECURITIES 
                                   STOCK         UNDERLYING      LTIP        ALL OTHER 
 NAME AND PRINCIPAL               AWARDS       OPTIONS/SARS   PAYOUTS(5)  COMPENSATION(6) 
 POSITION                          ($)(2)            (#)           ($)           ($) 
- - --------------------          -----------      ------------   ----------  --------------  
 <S>                          <C>              <C>            <C>          <C>
 William W. George                   --       32,149(3)      $490,677     $55,085 
 President and Chief                 --        7,398          504,587      57,263 
 Executive Officer                   --        8,739          592,418      * 
 

 Glen D. Nelson, M.D.                --        6,988          334,990      32,754 
 Vice Chairman                       --        5,306          432,557      24,139 
                                     --        6,387          501,339      * 


 Arthur D. Collins Jr.               --        3,993               --     129,734(7) 
 Chief Operating Officer       $866,200       31,575(4)            --     161,887(7) 
                                     --              --            --      * 
 

 Robert L. Ryan                      --        6,639               --      94,599(8) 
 Senior Vice President and           --        7,507               --      50,000(10) 
 Chief Financial Officer             --              --            --      * 


 Bobby I. Griffin                12,480        3,993          230,014      26,372 
 Executive Vice President            --        2,806          301,234      28,495 
 And President, Pacing               --        3,160          332,165      * 

</TABLE>

- - ----------------

 (1) Amounts payable by the Company in above-market interest under deferred 
compensation plan. 

 (2) Mr. Collins received 12,200 shares of restricted stock when he joined 
the Company to replace restricted stock he forfeited upon termination from 
his previous employer. Half of these shares vested one year after the date of 
grant. At April 30, 1994, Mr. Collins held a total of 6,100 shares of 
restricted stock having a market value of $459,025. These shares subsequently 
vested on May 12, 1994, at which time Mr. Collins no longer held any 
restricted stock. On June 23, 1993, Mr. Griffin received a restricted stock 
award for 195 shares in connection with his induction into the Company's 
honorary technology society. The shares had a market value of $14,674 at 
April 30, 1994, and vested 100% on June 22, 1994, at which time Mr. Griffin 
no longer held any restricted stock. Dividend equivalents were paid on the 
restricted stock held by Messrs. Collins and Griffin. As of April 30, 1994, 
Messrs. George, Nelson, and Ryan held no restricted stock. 

 (3) Includes stock option to purchase up to 22,432 shares of Common Stock in 
exchange for terminating existing nonqualified retirement benefit of $100,000 
per year for life. See "Employment and Change in Control Arrangements." 

 (4) Includes stock option to purchase up to 28,922 shares of Common Stock 
granted as part of Mr. Collins' employment arrangement, a significant amount 
of which was a replacement for stock options forfeited upon termination from 
his previous employer. 

 (5) Includes the value of both cash and stock earned in fiscal 1994 under 
the Company's long-term incentive plan described in "Other Long-Term 
Incentive Awards" below. The stock for the fiscal 1994 payment was valued at 
$74.03 per share, the average fair market value for the last 20 trading days 
in April 1994. 

 (6) Amounts in this column for fiscal 1994 include the following: the 
Company contributed $6,351 under the employee stock ownership plan for each 
of the named executive officers for fiscal 1994 except for Mr. Ryan, for whom 
the Company contributed $2,019; the Company contributed $6,053, $1,121, 
$6,053, $2,019 and $6,053 to Messrs. George, Nelson, Collins, Ryan and 
Griffin, respectively, to match employee contributions under the 401(k) 
supplemental retirement plan; and the Company contributed $42,681, $25,281, 
$17,330, $1,010 and $13,968 to Messrs. George, Nelson, Collins, Ryan and 
Griffin, respectively, under the nonqualified supplemental benefit plan. 

 (7) Includes $100,000 employment award for each of fiscal 1993 and 1994 in 
connection with his initial hiring. In addition, fiscal 1993 includes $61,887 
in relocation expenses. 

 (8) Includes $89,550 in relocation expenses. 

 (9) Mr. Ryan joined the Company in April 1993. 

(10) Includes an employment award of $50,000 in connection with his initial 
hiring. 

* In accordance with transitional provisions of the Securities and Exchange 
Commission's revised rules for executive compensation disclosure, amounts of 
Other Annual Compensation and All Other Compensation are not included for 
fiscal 1992. 

OPTION/SAR GRANTS IN LAST FISCAL YEAR 
The following table sets forth for each of the named executives the stock 
options and stock appreciation rights granted by the Company in fiscal 1994 
and the potential value of these stock options and stock appreciation rights 
determined pursuant to Securities and Exchange Commission requirements. 

<TABLE>
<CAPTION>
                                                                            POTENTIAL REALIZABLE VALUE AT 
                                                                               ASSUMED ANNUAL RATES OF 
                                                                               STOCK PRICE APPRECIATION 
                              INDIVIDUAL GRANTS(1)                                 FOR OPTION TERM 
                     -------------------------------------                 ------------------------------
                       NUMBER OF 
                      SECURITIES     % OF TOTAL 
                      UNDERLYING    OPTIONS/SARS   EXERCISE 
                     OPTIONS/SARS    GRANTED TO     OR BASE 
                        GRANTED     EMPLOYEES IN     PRICE    EXPIRATION     0%       5%           10% 
 NAME                     (#)        FISCAL YEAR    ($/SH)       DATE       ($)     ($)(3)        ($)(3)
- - ------------        -------------  -------------- --------   -----------   ----  ---------    ---------- 
 <S>                <C>            <C>            <C>        <C>           <C>    <C>         <C>
 W.W. George           22,432(2)   4.2%           $68.88       5/5/03      $0     $971,645    $2,462,338 
                        9,717      1.8             75.13     11/22/03       0      459,087     1,163,415 
 G.D. Nelson,           6,988      1.3             75.13     11/22/03       0      330,153       836,673 
 M.D. 
 A.D. Collins,          3,993       .8             75.13     11/22/03       0      188,652       478,081 
 Jr. 
 R.L. Ryan              3,311       .6             68.88       5/5/03       0      143,416       363,445 
                        3,328       .6             75.13     11/22/03       0      157,234       398,461 
 B.I. Griffin           3,993       .8             75.13     11/22/03       0      188,652       478,081 

</TABLE>
- - ----------------
(1) All stock options granted to the named executive officers have an 
exercise price equal to the fair market value on the date of grant, vest 
annually in 25% increments (except as provided in Note 2 below) and have 
limited stock appreciation rights attached to them which become immediately 
exercisable in the event of a change in control. See "Employment and Change 
in Control Arrangements" below. 

(2) Mr. George was granted an option to purchase up to 22,432 shares of the 
Company's Common Stock in exchange for terminating an existing nonqualified 
retirement benefit of $100,000 per year for life. The option will become 100% 
exercisable when Mr. George reaches age 58 on September 14, 2000. See 
"Employment and Change in Control Arrangements" below. 

(3) The hypothetical potential appreciation shown in these columns reflects 
the required calculations at annual rates of 5% and 10% set by the Securities 
and Exchange Commission, and therefore is not intended to represent either 
historical appreciation or anticipated future appreciation of the Company's 
Common Stock price. 

AGGREGATED OPTION/SAR EXERCISES IN LAST FISCAL YEAR 
AND FISCAL YEAR-END OPTION/SAR VALUES 
The following table sets forth for each of the named executive officers the 
value realized from stock options exercised during fiscal 1994 and the number 
and value of exercisable and unexercisable stock options and stock 
appreciation rights held at April 30, 1994. 
<TABLE>
<CAPTION>
                                                    NUMBER OF 
                                                    SECURITIES 
                                                    UNDERLYING              VALUE OF 
                                                   UNEXERCISED             UNEXERCISED 
                                                   OPTIONS/SARS           IN-THE-MONEY 
                                                    AT FISCAL            OPTIONS/SARS AT 
                                                   YEAR-END (#)       FISCAL YEAR-END ($)(1)
                                                -----------------       ---------------------- 
                        SHARES         VALUE 
                       ACQUIRED      REALIZED     EXERCISABLE/           EXERCISABLE/ 
 NAME                 ON EXERCISE       ($)      UNEXERCISABLE           UNEXERCISABLE
- - ------------        -------------  ----------   -----------------     ----------------- 
 <S>                <C>            <C>          <C>                   <C>
 W.W. George              0        $        0   125,892/44,644        $6,268,136/22,932 
 G.D. Nelson,        54,400         3,438,509    23,368/16,465           759,818/76,326 
 M.D. 
 A.D. Collins,            0                 0    15,124/20,444            61,459/61,958 
 Jr. 
 R.L. Ryan                0                 0     1,876/12,270                 0/21,524 
 B.I. Griffin             0                 0      4,255/8,824           109,901/38,052 
</TABLE>

(1) Value of unexercised in-the-money options is determined by multiplying 
the difference between the exercise price per share and $75.25, the closing 
price per share on April 29, 1994, by the number of shares subject to such 
options. 

OTHER LONG-TERM INCENTIVE AWARDS 
The following table sets forth the number of performance share units granted 
to each of the named executives in fiscal 1994 under the Company's 
performance share plans and the performance-based award formula under such 
plans. 

          LONG-TERM INCENTIVE PLANS -- AWARDS IN LAST FISCAL YEAR(1) 

<TABLE>
<CAPTION>
                                                         ESTIMATED FUTURE PAYOUTS 
                                                          UNDER NON-STOCK PRICE 
                                                               BASED-PLANS 
                     NUMBER OF     PERFORMANCE OR   ---------------------------------      
                   SHARES, UNITS    OTHER PERIOD 
                      OR OTHER          UNTIL 
                       RIGHTS        MATURATION     THRESHOLD     TARGET      MAXIMUM 
 NAME                   (#)           OR PAYOUT        ($)         ($)          ($) 
- - ------------        ---------       --------------   ----------  ---------    ---------
 <S>                <C>             <C>              <C>         <C>          <C>
 W.W. George        3,825(2)        5/1/93-4/30/96   $62,061     $310,303     $558,546 
                    3,580(3)        5/1/94-4/30/97    58,086      290,428      522,770 
 

 G.D. Nelson, M.D.  2,654(2)        5/1/93-4/30/96    43,061      215,306      387,550 
                    2,492(3)        5/1/94-4/30/97    40,433      202,164      363,894 


 A.D. Collins, Jr.  2,072(2)        5/1/93-4/30/96    33,618      168,091      302,564 
                    2,336(3)        5/1/94-4/30/97    37,902      189,508      341,114 


 R.L. Ryan          1,913(2)        5/1/93-4/30/96    31,038      155,192      279,346 
                    1,710(3)        5/1/94-4/30/97    27,745      138,724      249,703 


 B.I. Griffin       1,731(2)        5/1/93-4/30/96    28,085      140,427      252,769 
                    1,614(3)        5/1/94-4/30/97    26,187      130,936      235,684 

</TABLE>
- - ------------------
(1) Payout of awards is based on achieving specified levels of designated 
performance objectives during a three-year performance cycle. Payout can 
range from 0% to 180% of units granted, with 20% and 180% as the threshold 
and maximum payouts, respectively. Payout of 100% of the units granted 
represents the target payout. Awards are payable at least 50% in Common 
Stock, with the remainder paid in cash or Common Stock at the discretion of 
the Compensation Committee. The value in dollars is determined when the award 
is earned based on the average fair market value per share for the last 20 
trading days of the performance cycle. For illustrative purposes, the value 
of estimated future payouts was determined using the closing price of the 
Common Stock on July 8, 1994 ($81.125 per share). See "Report of the 
Compensation Committee on Fiscal 1994 Executive Compensation -- Long-Term 
Incentive Plans" above. 

(2) These awards were granted under the 1979 Restricted Stock and Performance 
Share Award Plan. 

(3) These awards were granted under the new 1994 Stock Award Plan prior to 
fiscal year-end on April 29, 1994 to meet the then applicable deductibility 
requirement of Section 162(m) of the Internal Revenue Code. The awards are 
contingent on shareholder approval of such plan at the 1994 Annual Meeting. 

PENSION PLAN 
The Company's pension plan is a defined benefit plan covering most U. S. 
employees and generally provides 40% of the average of the highest five 
consecutive years of compensation (including certain incentive compensation) 
in the final ten years of service, offset by a Social Security allowance as 
published each year by the Internal Revenue Service. The table below 
illustrates the annual benefits payable to participants who retire at age 65 
with the indicated years of service with Medtronic and with the indicated 
five-year highest average annual compensation. The benefits have been 
calculated on a 50% joint and survivor annuity basis, before reduction for 
any amounts that may be available from Medtronic's former Retirement Account 
Plan, and include amounts that are provided under the nonqualified 
supplemental benefit plan. The compensation considered in determining the 
pensions payable to the below-named executive officers is the compensation 
shown in the "Salary" and "Bonus" columns of the Summary Compensation Table 
on page 14. 

<TABLE>
<CAPTION>

    FIVE-YEAR 
     AVERAGE                 YEARS OF SERVICE WITH THE COMPANY 
      ANNUAL       ----------------------------------------------------
  COMPENSATION(1)     15         20         25         30          35 
- - -----------------  -------   --------   --------   --------   ---------
 <S>              <C>        <C>        <C>        <C>         <C>
 $  200,000       $ 34,472   $ 45,966   $ 57,452   $ 68,945    $ 73,455 
    400,000         70,552     94,075    117,583    141,105     150,125 
    600,000        106,632    142,183    177,714    213,265     226,795 
    800,000        142,712    190,293    237,844    285,425     303,465 
  1,000,000        178,792    238,402    297,975    357,585     380,135 
  1,200,000        214,872    286,511    358,106    429,745     456,805 

</TABLE>
- - ---------------
(1) Calculated by considering a participant's compensation levels during the 
ten-year period immediately preceding retirement. The credited years of 
service (rounded to the nearest whole year) for the executive officers named 
in the Summary Compensation Table were as follows at April 30, 1994: W.W. 
George, 5 years; G.D. Nelson, 8 years; A.D. Collins, Jr., 2 years; R.L. Ryan, 
1 year; and B.I. Griffin, 21 years. 

Certain limitations on the amount of benefits under tax qualified plans, such 
as the Company's 401(k) supplemental retirement plan, employee stock 
ownership plan and retirement plan, were imposed by the Employee Retirement 
Income Security Act of 1974 ("ERISA") and Tax Reform Act of 1986 ("TRA"). The 
Company's nonqualified supplemental benefit plan provides for the payment of 
amounts to officers who may be affected by those limitations so that, in 
general, total benefits will be equal to the level of benefits which would 
have been payable under the named plans but for the ERISA and TRA 
limitations. The amounts shown in the pension plan table above include the 
additional retirement benefits provided under the nonqualified supplemental 
benefit plan. 

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION 
In fiscal 1994, the members of the Compensation Committee were Holloran 
(Chair), Blodgett, Martin, Schall, Simonson and Swalin. Mr. Holloran served 
in various capacities as an officer of the Company from 1961 to 1975, 
including serving as president of the Company from January 1974 to December 
1975. Under Section 162(m) of the Code, Mr. Holloran is considered an outside 
director until the date of the 1995 Annual Meeting of Shareholders. 

EMPLOYMENT AND CHANGE IN CONTROL ARRANGEMENTS 

    CHANGE IN CONTROL ARRANGEMENTS. 
    The executive officers of the Company, including those named in the 
    Summary Compensation Table, have change in control agreements (the 
    "Agreements") with the Company. The Agreements are operative only upon the 
    occurrence of a "change in control," which includes substantially those 
    events described below. Absent a "change in control," the Agreements do 
    not require the Company to retain the executives or to pay them any 
    specified level of compensation or benefits. 

    Each Agreement provides that for three years after a "change in control" 
    there will be no adverse change in the executive's salary, bonus, 
    opportunity, benefits or location of employment. If during this three-year 
    period the executive's employment is terminated by the Company other than 
    for cause, or if the executive terminates his employment for good reason 
    (as defined in the Agreements, and including compensation reductions, 
    demotions, relocation and excess travel), or voluntarily during the 30-day 
    period following the first anniversary of the "change in control," the 
    executive is entitled to receive an accrued salary and annual incentive 
    payment through the date of termination and, except in the event of death 
    or disability, a lump sum severance payment ("Lump Sum Payment") equal to 
    three times (two times in the event of termination by the executive in the 
    aforementioned 30-day period) the sum of his base salary and annual bonus 
    (and certain insurance and other welfare plan benefits). Further, an 
    additional payment ("gross-up") is required in an amount such that after 
    the payment of all taxes, income and excise, the executive will be in the 
    same after-tax position as if no excise tax under the Internal Revenue 
    Code had been imposed. 

    Generally, and subject to certain exceptions, a "change in control" is 
    deemed to have occurred if: (a) a majority of Medtronic's Board of 
    Directors becomes comprised of persons other than persons for whose 
    election proxies have been solicited by the Board, or who are then serving 
    as directors appointed by the Board to fill vacancies caused by death or 
    resignation (but not removal) of a director or to fill newly created 
    directorships; (b) another party becomes the beneficial owner of at least 
    30% of Medtronic's outstanding voting stock; or (c) Medtronic's 
    shareholders approve a definitive agreement or plan to merge or 
    consolidate Medtronic with another party (other than certain limited types 
    of mergers), exchange shares of voting stock of Medtronic for shares of 
    another corporation pursuant to a statutory exchange, sell or otherwise 
    dispose of all or substantially all of Medtronic's assets, or liquidate or 
    dissolve Medtronic. 

    If a "change in control" of the Company occurred mid-fiscal 1995 (November 
    1, 1994) and resulted in the involuntary termination of the named 
    executives at such time or the termination by such executives for good 
    reason, the Lump Sum Payment to be made under such Agreements to those 
    executive officers named in the Summary Compensation Table above would be 
    approximately as follows: W.W. George, $2,623,500; G.D. Nelson, 
    $1,968,000; A.D. Collins, Jr., $1,844,640; R.L. Ryan, $1,424,250; and B.I. 
    Griffin, $1,350,000. Such amounts are exclusive of the additional gross-up 
    payment required under each of the Agreements as a result of excise taxes 
    on a portion of those amounts. 

    In addition, events substantially identical to those described above also 
    constitute a "change in control" under certain of the Company's 
    compensation plans. The effects of a change in control under these plans 
    with respect to the compensation of each of the executive officers named 
    in the Summary Compensation Table are described below. 

    If a "change in control" of the Company occurs, awards under the Company's 
    management incentive plan will accelerate and, subject to certain 
    limitations set forth in the plan, each participant will be entitled to a 
    final award based on certain assumptions as to target performance and 
    salary. If a "change in control" of the Company occurred mid-fiscal 1995 
    (November 1, 1994), the awards under this plan to be paid to those 
    executive officers named in the Summary Compensation Table above would be 
    approximately as follows: W.W. George, $344,500; G.D. Nelson, $246,000; 
    A.D. Collins, Jr., $230,580; R.L. Ryan, $158,250; and B.I. Griffin, 
    $150,000. 

    The Company's restricted stock and performance share plans and agreements 
    thereunder provide that in the event of a "change in control" of the 
    Company, all restrictions under outstanding restricted stock awards shall 
    immediately lapse and the restricted stock period with respect to all such 
    shares shall be deemed to have expired, and performance share awards shall 
    vest immediately in a pro rata amount based on the portion of the 
    performance period elapsed prior to the "change in control" and certain 
    assumptions as to the anticipated performance which would have been 
    achieved during the applicable performance period. If a "change in 
    control" of the Company occurred mid-fiscal 1995 (November 1, 1994) and 
    further assuming for this purpose a market price for the Company's Common 
    Stock at such time of $81.125 (the July 8, 1994 New York Stock Exchange 
    closing price), the awards to be paid to those executive officers named in 
    the Summary Compensation Table above would be approximately as follows for 
    the performance share awards: W.W. George, $715,130; G.D. Nelson, 
    $496,285; A.D. Collins, Jr., $392,761; R.L. Ryan, $147,274 and B.I. 
    Griffin, $323,632. None of the named executive officers has outstanding 
    restricted stock awards. 

    The Company's stock option plans and agreements thereunder provide for or 
    permit acceleration of each option's exercisability upon the occurrence of 
    certain events (such as certain tender offers or exchange offers for the 
    Company's stock, certain changes in control of the Company, a merger or 
    consolidation of the Company with another entity, or a sale of 
    substantially all of the Company's assets or certain plans therefor) or at 
    the discretion of the Board of Directors. 

    Limited stock appreciation rights ("Limited Rights") granted under one of 
    the stock option plans are exercisable, with certain limitations, at any 
    time within the thirty-day period following a "change in control" of 
    Medtronic. Upon exercise of Limited Rights, the holder is entitled to 
    receive an amount in cash for each share with respect to which the Limited 
    Rights are exercised equal to the difference between the option exercise 
    price per share of stock covered by the underlying option and the fair 
    market value per share as of the date of exercise. If Limited Rights are 
    exercised, the underlying option will no longer be exercisable to the 
    extent of the number of shares with respect to which the Limited Rights 
    were exercised. 

    If a "change in control" occurs, subject to certain limitations, 
    Medtronic's contributions to the employee stock ownership plan for that 
    year will equal the greater of Medtronic's target percentage contribution 
    (presently 2.7% of aggregate covered employee compensation) or if a 
    "change in control" occurs after the first quarter of a plan year, the 
    percentage contribution Medtronic would have made upon completion of the 
    plan year based on performance as most recently projected by Medtronic 
    prior to the "change in control" and disregarding the effects of the 
    "change in control." 

    If a "change in control" occurs during a plan year, subject to certain 
    limitations, Medtronic's matching contribution to the 401(k) supplemental 
    retirement plan shall equal the greater of Medtronic's target percentage 
    matching contribution (presently 67.3% of the first 6% of a participant's 
    contribution), or if the "change in control" occurs after the first 
    quarter of a plan year, the percentage contribution Medtronic would have 
    made upon completion of the plan year based on performance as most 
    recently projected by Medtronic prior to the "change in control" and 
    disregarding the effects of the "change in control." 

    OTHER EMPLOYMENT ARRANGEMENTS. 
    When he joined the Company, Mr. George entered into an agreement that 
    provided, upon his retirement at any time after reaching age 58 in the 
    year 2000, an additional nonqualified retirement benefit of $100,000 per 
    year in the form of a single life annuity benefit. This retirement benefit 
    had replaced benefits foregone by Mr. George upon leaving his previous 
    employer to join Medtronic. Mr. George agreed to terminate this 
    arrangement in exchange for a stock option granted in May 1993. Under this 
    grant, Mr. George received an option to purchase up to 22,432 shares of 
    Common Stock at an exercise price of $68.875, which was the fair market 
    value on the date of grant. The option vests 100% when Mr. George reaches 
    age 58 and is exercisable for approximately three years thereafter. 

    Mr. Collins has a severance arrangement which provides that he will 
    receive an amount equal to his annual base salary and target annual 
    incentive award then in effect, plus a one-year continuation of benefits, 
    if he leaves the Company within the first 36 months of his employment for 
    any reason other than gross and willful neglect of duties. 

    Under the Company's postretirement survivor benefit plan, designated 
    beneficiaries or the estate of each Medtronic elected or appointed officer 
    who retires with the Company (as defined in the Company's tax-qualified 
    employee retirement plans) shall be entitled to receive following the 
    officer's death a lump sum payment equal to the annual salary of such 
    officer in effect at the date of retirement. 

APPROVAL OF THE COMPANY'S 1994 STOCK AWARD PLAN 

INTRODUCTION 

The Company's Board of Directors, upon the recommendation of the Compensation 
Committee of the Board, authorized the adoption of the Medtronic, Inc. 1994 
Stock Award Plan (the "Plan") effective as of April 29, 1994, subject to the 
approval of the Plan by the shareholders at the 1994 Annual Meeting of 
Shareholders. A copy of the Plan is included as Appendix A to this Proxy 
Statement, and this discussion is qualified in its entirety by reference to 
the full text of the Plan. 

The Compensation Committee and the Board of Directors believe that 
stock-based compensation programs are a key element in achieving the 
Company's continued financial and operational success. The Company's 
compensation programs have been designed to motivate executives and other key 
employees to work as a team to achieve the corporate goal of maximizing 
shareholder return. The Plan proposed by the Board of Directors is also 
designed to compensate executives for the creation of shareholder value 
consistent with the philosophy the Compensation Committee set out in its 
report elsewhere in this Proxy Statement. The Board of Directors sees this 
proposal as a means of further aligning the goals of the Company's management 
team with those of the shareholders. 

The Plan is intended to replace the Company's existing stock-based plans and 
to make administration of awards more efficient by bringing them under a 
single plan. Upon approval of the Plan by the shareholders, no further grants 
or awards will be made under the Company's 1979 Restricted Stock and 
Performance Share Award Plan, 1979 Nonqualified Stock Option Plan, 1989 
Phantom Stock Award Plan or 1991 Restricted Stock Plan for Non-Employee 
Directors. However, all grants and awards made under such plans prior to such 
shareholder approval will continue in accordance with the terms of such 
plans. 

As discussed in the report of the Compensation Committee elsewhere in this 
Proxy Statement, the Plan has been designed to meet the new requirements of 
Section 162(m) of the Internal Revenue Code of 1986, as amended (the "Code"), 
regarding deductibility of executive compensation. The basic features of the 
Plan are summarized below. 

PURPOSE 
The purpose of the Plan is to motivate key personnel, including Non-Employee 
Directors (as hereinafter defined), to produce a superior return to the 
shareholders of the Company by offering such individuals an opportunity to 
realize stock appreciation, by facilitating stock ownership, and by rewarding 
them for achieving a high level of corporate performance. The Plan is also 
intended to facilitate recruiting and retaining key personnel of outstanding 
ability. 

ADMINISTRATION 
The Plan will be administered by a committee (the "Committee") of three or 
more directors who are "disinterested persons" within the meaning of Rule 
16b-3 ("Exchange Act Rule 16b-3") under the Securities Exchange Act of 1934 
(the "Exchange Act"). The Company currently expects that the Compensation 
Committee of the Board of Directors will be the Committee that administers 
the Plan, all of whose members are both "disinterested directors" for 
purposes of Exchange Act Rule 16b-3 and "outside directors" for purposes of 
Section 162(m) of the Code. The Committee will have the exclusive power to 
make awards under the Plan and to determine when and to whom awards will be 
granted, and the form, amount and other terms and conditions of each award, 
subject to the provisions of the Plan, except that the granting, terms, 
conditions and eligibility requirements of awards granted under the Plan to 
Board members who are not employees of the Company or its affiliates 
("Non-Employee Directors") are governed solely by provisions of the Plan 
relating to Non-Employee Directors (see "Non-Employee Director Awards" 
below), and the Committee will have no discretion with respect to any terms, 
conditions or eligibility requirements of such awards. Except with respect to 
awards to Non-Employee Directors, the Committee will have the authority to 
interpret the Plan and any award or agreement made under the Plan, to 
establish, amend, waive and rescind any rules and regulations relating to the 
administration of the Plan, to determine the terms and provisions of any 
agreements entered into under the Plan (not inconsistent with the Plan), and 
to make all other determinations necessary or advisable for the 
administration of the Plan. The Committee may delegate its responsibilities 
under the Plan to persons who are not "disinterested persons" within the 
meaning of Exchange Act Rule 16b-3 for purposes of determining and 
administering awards solely to employees who are not then subject to the 
reporting requirements of Section 16 of the Exchange Act. 

ELIGIBILITY AND NUMBER OF SHARES 
All employees of the Company and its affiliates will be eligible to receive 
awards under the Plan at the discretion of the Committee. Awards other than 
incentive stock options (see "Types of Awards" below) also may be awarded by 
the Committee to individuals who are not employees but who provide services 
to the Company or its affiliates in the capacity of an independent 
contractor. Non-Employee Directors are eligible for certain awards under the 
Plan (see "Non-Employee Director Awards" below). The Company and its 
affiliates currently have approximately 8,709 full-time employees, and there 
are currently 13 Non-Employee Directors. 

The total number of shares of Company Common Stock available for distribution 
under the Plan is 2,800,000 (subject to adjustment for future stock splits, 
stock dividends and similar changes in the capitalization of the Company). No 
participant may receive any combination of options and stock appreciation 
rights relating to more than 500,000 shares in the aggregate over a five-year 
period under the Plan (which amount includes up to 350,000 shares pursuant to 
awards and up to 150,000 shares received under the Plan in lieu of cash 
compensation under the Company's annual incentive plan). No participant may 
receive performance shares relating to more than 85,000 shares pursuant to 
awards over a five-year period under the Plan. No more than 35% of all shares 
subject to the Plan may be granted in the aggregate pursuant to restricted 
stock, performance share and other stock-based awards (see "Types of Awards" 
below). 

The Plan provides that all awards are to be evidenced by written agreements 
containing the terms and conditions of the awards. Such agreements will be 
entered into by the recipients of the awards and the Company on or after the 
time the awards are granted and are subject to amendment, including 
unilateral amendment by the Company (with the approval of the Committee), 
unless such amendments are deemed by the Committee to be materially adverse 
to the recipient and are not required as a matter of law. Any shares of 
Company Common Stock subject to awards under the Plan which are not used 
because the terms and conditions of the awards are not met may again be used 
for an award under the Plan, unless such shares are related to stock 
appreciation rights which have been exercised or were shares of restricted 
stock which were granted with dividend or voting rights during the 
restriction period. 

TYPES OF AWARDS 
The types of awards that may be granted under the Plan include incentive and 
nonqualified stock options, stock appreciation rights, restricted stock, 
performance shares and other stock-based awards (awards based on stock other 
than options, stock appreciation rights, restricted stock or performance 
shares). Except for awards to Non-Employee Directors in lieu of certain 
directors' fees (see "Non-Employee Director Awards" below), and subject to 
certain restrictions applicable to incentive stock options, awards will be 
exercisable by the recipients at such times as are determined by the 
Committee, but in no event may the term of an award be longer than ten years 
after the date of grant. 

In addition to the general characteristics of all of the awards described in 
this Proxy Statement, the basic characteristics of awards that may be granted 
under the Plan are as follows: 

    INCENTIVE AND NONQUALIFIED STOCK OPTIONS. 
    Both incentive and nonqualified stock options may be granted to recipients 
    at such exercise prices as the Committee may determine but not less than 
    100% of their fair market value (as defined in the Plan) as of the date 
    the option is granted. Stock options may be granted and exercised at such 
    times as the Committee may determine, except that, unless applicable 
    federal tax laws are modified, (a) no incentive stock options may be 
    granted more than ten years after the effective date of the Plan, (b) an 
    incentive stock option shall not be exercisable more than ten years after 
    the date of grant and (c) the aggregate fair market value of the shares of 
    Company Common Stock with respect to which incentive stock options may 
    first become exercisable in any calendar year for any employee may not 
    exceed $100,000 under this Plan or any other plan of the Company. 
    Additional restrictions apply to an incentive stock option granted to an 
    individual who beneficially owns 10% or more of the combined voting power 
    of all classes of stock of the Company. 

    The purchase price payable upon exercise of options may be paid in cash, 
    or by reducing the number of shares delivered to the participant or by 
    delivering stock already owned by the participant (where the fair market 
    value of the shares withheld or delivered on the date of exercise is equal 
    to the option price of the stock being purchased), or in a combination of 
    cash and such stock, unless otherwise provided in the related agreement. 
    The participants may simultaneously exercise options and sell the stock 
    purchased upon such exercise pursuant to brokerage or similar 
    relationships and use the sale proceeds to pay the purchase price. 

    STOCK APPRECIATION RIGHTS AND PERFORMANCE SHARES. 
    The value of a stock appreciation right granted to a recipient is 
    determined by the appreciation in Company Common Stock, subject to any 
    limitations upon the amount or percentage of total appreciation that the 
    Committee may determine at the time the right is granted. The recipient 
    receives all or a portion of the amount by which the fair market value of 
    a specified number of shares, as of the date the stock appreciation right 
    is exercised, exceeds a price specified by the Committee at the time the 
    right is granted. The price specified by the Committee must be at least 
    100% of the fair market value of the specified number of shares of Company 
    Common Stock to which the right relates determined as of the date the 
    stock appreciation right is granted. A stock appreciation right may be 
    granted in connection with a previously or contemporaneously granted 
    option, or independent of any option. No stock appreciation right may be 
    exercised less than six months from the date it is granted unless the 
    recipient dies or becomes disabled. 

    Performance shares entitle the recipient to payment in amounts determined 
    by the Committee based upon the achievement of specified performance 
    targets during a specified term. With respect to recipients who are 
    "covered employees" under Section 162(m) of the Code, such performance 
    targets will consist of one or any combination of two or more of revenue, 
    revenue per employee, earnings before income tax (profit before taxes), 
    earnings before interest and income tax, net earnings (profit after 
    taxes), earnings per employee, tangible, controllable or total asset 
    turnover, earnings per share, operating income, total shareholder return, 
    market share, return on equity, before- or after-tax return on net assets, 
    distribution expense, inventory turnover or economic value added and any 
    such targets may relate to one or any combination of two or more of 
    corporate, group, unit, division, affiliate or individual performance. The 
    value in dollars is determined when the award is earned based on the 
    average fair market value per share for the last 20 trading days of the 
    performance cycle. 

    Payments with respect to stock appreciation rights and performance shares 
    may be paid in cash, shares of Company Common Stock or a combination of 
    cash and shares as determined by the Committee, provided that at least 25% 
    of the value of vested performance shares must be distributed in the form 
    of stock (or such higher percentage paid in stock as the Committee may 
    determine from time to time, which amount is currently 50%). Recipients 
    may defer any such cash payments under the Company's deferral plan if they 
    are eligible to participate in that plan. 

    RESTRICTED STOCK AND OTHER STOCK-BASED AWARDS. 
    Company Common Stock granted to recipients may contain such restrictions 
    as the Committee may determine, including provisions requiring forfeiture 
    and imposing restrictions upon stock transfer. Awards of restricted stock 
    may, in the discretion of the Committee, provide the participant with 
    dividends and voting rights prior to vesting. No award of restricted stock 
    may vest earlier than one year from the date of grant, except in the 
    circumstances provided in the applicable agreement. The Committee may also 
    from time to time grant awards of unrestricted stock or other stock-based 
    awards such as awards denominated in stock units, securities convertible 
    into stock and phantom securities. 

TRANSFERABILITY 
During the lifetime of a participant to whom an award is granted, only such 
participant (or such participant's legal representative or, if so provided in 
the applicable agreement in the case of a nonqualified stock option, a 
permitted transferee as hereafter described) may exercise an option or stock 
appreciation right or receive payment with respect to performance shares or 
any other award. No award of restricted stock (prior to the expiration of the 
restrictions), options, stock appreciation rights, performance shares or 
other award (other than an award of stock without restrictions) may be sold, 
assigned, transferred, exchanged, or otherwise encumbered, and any attempt to 
do so will be of no effect, except that an agreement may provide that (a) an 
award may be transferable to a successor in the event of a participant's 
death and (b) a nonqualified stock option may be transferable to any member 
of a participant's "immediate family" (as such term is defined in Rule 
16a-1(e) under the Exchange Act) or to a trust whose beneficiaries are 
members of such participant's "immediate family" or partnerships in which 
such family members are the only partners, provided that the participant 
receives no consideration for the transfer and such transferred nonqualified 
stock option will continue to be subject to the same terms and conditions as 
were applicable to such option immediately prior to its transfer. 

ACCELERATION OF AWARDS, LAPSE OF RESTRICTIONS, FORFEITURE 
The Committee may accelerate vesting requirements, performance periods and 
the expiration of the applicable term or restrictions, and adjust performance 
targets and payments, upon such terms and conditions as are set forth in the 
participant's agreement, or otherwise in the Committee's discretion, which 
may include, without limitation, acceleration resulting from a "change in 
control" or a "fundamental change" (as those terms are defined in the Plan), 
or the participant's death, disability, retirement or termination of 
employment. 

In the event of certain occurrences, which may include a recipient's 
competition with, unauthorized disclosure of confidential information of, or 
violation of the applicable business ethics policies or business policies of 
the Company, any payment of cash, delivery of stock or a combination thereof 
paid to the recipient within six months prior to the termination of 
employment of the recipient (or their economic value) may be subject to 
forfeiture at the Committee's discretion. 

DURATION, ADJUSTMENTS, MODIFICATIONS, TERMINATION 
The Plan will remain in effect until all stock subject to it is distributed 
or all awards have expired or lapsed, whichever is later to occur, or the 
Plan is terminated as described below. 

In the event of a "fundamental change", recapitalizations, stock dividends, 
stock splits or other relevant changes, the Committee has the discretion to 
adjust the number of shares available for awards or the number of shares and 
amount of cash subject to outstanding awards, the option exercise price of 
outstanding options, and outstanding awards of performance shares and 
payments with regard thereto. Adjustments in performance targets and payments 
on performance shares are also permitted upon the occurrence of such other 
events as may be specified in the related agreements, which may include a 
"change of control", stock dividend, stock split or other relevant changes. 

The Plan also gives the Board the right to amend, modify, terminate or 
suspend the Plan, except that amendments to the Plan are subject to 
shareholder approval if needed to comply with Exchange Act Rule 16b-3, the 
incentive stock option provisions of the Code, their successor provisions, or 
any other applicable law or regulation. Shareholder approval would also be 
required to change the terms, conditions or eligibility requirements of 
awards granted to Non-Employee Directors as described below under 
"Non-Employee Director Awards," and in no event may the provisions of the 
Plan as they relate to such awards be amended more than once every six 
months, other than to comply with changes in the Code. 

Under the Plan, the Committee may cancel outstanding options and stock 
appreciation rights generally in exchange for cash payments to the recipients 
in the event of a "fundamental change" (defined as certain dissolutions, 
liquidations, mergers, consolidations, statutory share exchanges or other 
similar events involving the Company). 

NON-EMPLOYEE DIRECTOR AWARDS 

    OPTION GRANTS. 
    Each Non-Employee Director first elected or appointed to the Board on or 
    after the date of the 1994 Annual Meeting of Shareholders of the Company 
    will automatically, without any Committee action, be granted a one-time 
    nonqualified stock option to purchase that number of shares of Company 
    Common Stock determined by dividing (a) an amount equal to $152,000 plus a 
    percentage increase in such $152,000 amount which is equal to the 
    percentage increase from the $19,000 annual director retainer in effect at 
    the time of the 1994 Annual Meeting to the annual director retainer in 
    effect at the date such director first becomes a director by (b) the fair 
    market value of a share of Company Common Stock on the date of grant. An 
    employee of the Company or an affiliate who terminates such employment and 
    thereafter becomes a Non-Employee Director is not entitled to receive this 
    initial option grant, but will be entitled to receive the annual option 
    grants described in the next paragraph. 

    Each year on the date of the annual meeting of shareholders, each 
    Non-Employee Director who is a director of the Company immediately 
    following such annual meeting will automatically, without any Committee 
    action, be granted a nonqualified stock option to purchase that number of 
    shares of Company Common Stock equal to the sum of (a) the annual director 
    retainer in effect when the grant is made, (b) the aggregate meeting fees 
    in effect when the grant is made for the total number of regular Board 
    meetings held in the previous fiscal year and the median number of regular 
    Board Committee meetings directors were scheduled to attend during the 
    previous fiscal year, and (c) one annual committee chairmanship fee in 
    effect when the grant is made, divided by the fair market value of a share 
    of Company Common Stock on the date of the grant. 

    The purchase price of each share subject to a nonqualified stock option 
    granted to Non-Employee Directors will be the fair market value of a share 
    as of the date of grant. Such options will vest and become exercisable in 
    full one year after grant, except that a Non-Employee Director initially 
    appointed by the Board will not be entitled to exercise such an option 
    unless such director is first elected to the Board by the shareholders of 
    the Company. Notwithstanding the foregoing, vesting of an option granted 
    to a Non-Employee Director who has been elected by the shareholders will 
    accelerate and the option will become immediately exercisable in full upon 
    the occurrence of a "change in control" or in the event that the 
    Non-Employee Director ceases to serve as a director of the Company due to 
    death, disability or retirement under the policies of the Company then in 
    effect. Such options will expire at the earlier of (a) the ten-year 
    anniversary date of the option's grant, or (b) the five-year anniversary 
    date of the earlier of (i) termination as a director due to such death, 
    disability or retirement or (ii) the date the Non-Employee Director 
    otherwise ceases to be a director of the Company, provided that an option 
    granted to a Non-Employee Director initially appointed by the Board will 
    expire on the date such director ceases to be a director of the Company 
    unless such director was elected by the shareholders after the date of 
    such grant. A Non-Employee Director may exercise a nonqualified stock 
    option using any of the payment forms described under "Types of Awards -- 
    Incentive and Nonqualified Stock Options" above. 

    In conjunction with the grant of any nonqualified stock option, the 
    Non-Employee Director receiving such grant will also simultaneously be 
    granted a limited stock appreciation right ("Limited Rights") with respect 
    to all of the shares covered by the related option, which Limited Rights 
    will become exercisable only after a "change in control" as defined in the 
    Plan. No Limited Right may be exercised within a period of six months 
    after the date of its grant. If Limited Rights are exercised, the related 
    option will no longer be exercisable to the extent of the number of shares 
    with respect to which the Limited Rights were exercised. Upon the exercise 
    or termination of a related option, Limited Rights granted with respect 
    thereto will terminate to the extent of the number of shares as to which 
    the related option was exercised or terminated. 

    Nonqualified stock options granted to Non-Employee Directors are subject 
    to transferability restrictions similar to those described under 
    "Transferability" above, except that the possibility of transfers to a 
    Non-Employee Director's "immediate family," trusts whose beneficiaries are 
    members of such director's "immediate family" or partnerships in which 
    such family members are the only partners will be permitted only in the 
    event of certain changes to Exchange Act Rule 16b-3, or when such director 
    is no longer subject to the reporting requirements of Section 16 of the 
    Exchange Act. In the event of a Non-Employee Director's death, an 
    unexpired nonqualified stock option granted to such director will be 
    transferable to the beneficiary designated by such director or, if no 
    beneficiary has been designated, such director's legal representative will 
    succeed to the option, and it will be transferable by will or pursuant to 
    the laws of descent and distribution. 

    ISSUANCE OF RESTRICTED STOCK IN LIEU OF COMPENSATION. 
    Each Non-Employee Director may irrevocably elect, at least six months 
    prior to the date on which such restricted stock is issued, to receive all 
    or any portion of the annual director retainer and any applicable 
    committee chairmanship fee due in the form of restricted stock to be 
    issued as of the first day of the year for which such annual retainer is 
    payable (currently October 1), based on the fair market value of the 
    Company's Common Stock at the time of issuance. 

    Shares of such restricted stock may not be assigned, sold, pledged, 
    hypothecated or otherwise transferred or disposed of (including, without 
    limitation, transfer by gift or donation), until the restrictions have 
    lapsed. Such restrictions will lapse upon the first to occur of (a) death, 
    or resignation or removal of the Non-Employee Director from the Board as a 
    result of disability, (b) retirement of the Non-Employee Director from the 
    Board in accordance with the policies of the Company then in effect 
    providing for retirement of Non-Employee Directors, (c) acceptance by the 
    Board of the offer of the Non-Employee Director to resign from the Board 
    in accordance with the policies of the Company then in effect after a 
    material change in such Non-Employee Director's full-time position or 
    responsibilities, (d) termination of service as a director with the 
    consent of a majority of the members of the Board other than the 
    terminating Non-Employee Director, or (e) a "change in control" (as 
    defined in the Plan). During the restricted period, the Non-Employee 
    Director will be entitled to all voting, dividend and distribution rights 
    with respect to such shares. If the Non-Employee Director ceases to be a 
    director of the Company before the restrictions lapse, such restricted 
    stock will be forfeited and revert to the Company. 

FEDERAL TAX CONSIDERATIONS 
The Company has been advised by its counsel that awards made under the Plan 
generally will result in the following tax events for United States citizens 
under current United States federal income tax laws. 

    INCENTIVE STOCK OPTIONS. 
    A recipient will realize no taxable income, and the Company will not be 
    entitled to any related deduction, at the time an incentive stock option 
    is granted under the Plan. If certain statutory employment and holding 
    period conditions are satisfied before the recipient disposes of shares 
    acquired pursuant to the exercise of such an option, then no taxable 
    income will result upon the exercise of such option and the Company will 
    not be entitled to any deduction in connection with such exercise. Upon 
    disposition of the shares after expiration of the statutory holding 
    periods, any gain or loss realized by a recipient will be a capital gain 
    or loss. The Company will not be entitled to a deduction with respect to a 
    disposition of the shares by a recipient after the expiration of the 
    statutory holding periods. 

    Except in the event of death, if shares acquired by a recipient upon the 
    exercise of an incentive stock option are disposed of by such recipient 
    before the expiration of the statutory holding periods (a "disqualifying 
    disposition"), such recipient will be considered to have realized as 
    compensation, taxable as ordinary income in the year of disposition, an 
    amount, not exceeding the gain realized on such disposition, equal to the 
    difference between the exercise price and the fair market value of the 
    shares on the date of exercise of the option. The Company will be entitled 
    to a deduction at the same time and in the same amount as the recipient is 
    deemed to have realized ordinary income. Any gain realized on the 
    disposition in excess of the amount treated as compensation or any loss 
    realized on the disposition will constitute capital gain or loss, 
    respectively. If the recipient pays the option price with shares that were 
    originally acquired pursuant to the exercise of an incentive stock option 
    and the statutory holding periods for such shares have not been met, the 
    recipient will be treated as having made a disqualifying disposition of 
    such shares, and the tax consequences of such disqualifying disposition 
    will be as described above. 

    The foregoing discussion applies only for regular tax purposes. For 
    alternative minimum tax purposes an incentive stock option will be treated 
    as if it were a nonqualified stock option, the tax consequences of which 
    are discussed below. 

    NONQUALIFIED STOCK OPTIONS. 
    A recipient will realize no taxable income, and the Company will not be 
    entitled to any related deduction, at the time a nonqualified stock option 
    is granted under the Plan. At the time of exercise of a nonqualified stock 
    option, the recipient will realize ordinary income, and the Company will 
    be entitled to a deduction, equal to the excess of the fair market value 
    of the stock on the date of exercise over the option price. Upon 
    disposition of the shares, any additional gain or loss realized by the 
    recipient will be taxed as a capital gain or loss. 

    STOCK APPRECIATION RIGHTS AND PERFORMANCE SHARES. 
    Generally (a) the recipient will not realize income upon the grant of a 
    stock appreciation right or performance share award, (b) the recipient 
    will realize ordinary income, and the Company will be entitled to a 
    corresponding deduction, in the year cash, shares of common stock or a 
    combination of cash and shares are delivered to the recipient upon 
    exercise of a stock appreciation right or in payment of the performance 
    share award and (c) the amount of such ordinary income and deduction will 
    be the amount of cash received plus the fair market value of the shares of 
    common stock received on the date of issuance. The federal income tax 
    consequences of a disposition of unrestricted shares received by the 
    recipient upon exercise of a stock appreciation right or in payment of a 
    performance share award are the same as described below with respect to a 
    disposition of unrestricted shares. 

    RESTRICTED AND UNRESTRICTED STOCK. 
    Unless the recipient files an election to be taxed under Section 83(b) of 
    the Code, (a) the recipient will not realize income upon the grant of 
    restricted stock, (b) the recipient will realize ordinary income, and the 
    Company will be entitled to a corresponding deduction, when the 
    restrictions have been removed or expire, and (c) the amount of such 
    ordinary income and deduction will be the fair market value of the 
    restricted stock on the date the restrictions are removed or expire. If 
    the recipient files an election to be taxed under Section 83(b) of the 
    Code, the tax consequences to the recipient and the Company will be 
    determined as of the date of the grant of the restricted stock rather than 
    as of the date of the removal or expiration of the restrictions. 

    With respect to awards of unrestricted stock, (a) the recipient will 
    realize ordinary income and the Company will be entitled to a 
    corresponding deduction upon the grant of the unrestricted stock, and (b) 
    the amount of such ordinary income and deduction will be the fair market 
    value of such unrestricted stock on the date of grant. 

    When the recipient disposes of restricted or unrestricted stock, the 
    difference between the amount received upon such disposition and the fair 
    market value of such shares on the date the recipient realizes ordinary 
    income will be treated as a capital gain or loss. 

WITHHOLDING 
The Plan permits the Company to withhold from awards an amount sufficient to 
cover any required withholding taxes. In lieu of cash, a participant may 
elect to cover withholding obligations through a reduction in the number of 
shares to be delivered to such participant or by delivery of shares already 
owned by the participant. The use of stock to satisfy withholding obligations 
is subject to certain restrictions if the participant is subject to the 
reporting requirements of Section 16 of the Exchange Act. 

NEW PLAN BENEFITS 
The awards shown below were granted by the Compensation Committee in April 
and June 1994, subject to approval of the Plan by the shareholders at the 
1994 Annual Meeting of Shareholders. The tables also include information 
relating to the Non-Employee Director annual nonqualified stock option grants 
in August 1994. 

                       1994 PERFORMANCE SHARE AWARDS(1) 

<TABLE>
<CAPTION>
                                                        
                                                                          
                                                        PERFORMANCE       ESTIMATED FUTURE PAYOUTS UNDER
                                        NUMBER OF    OR OTHER PERIOD       NON-STOCK PRICE BASED-PLANS 
                                      SHARES, UNITS        UNTIL       ------------------------------------ 
                                         OR OTHER       MATURATION     THRESHOLD     TARGET       MAXIMUM 
 NAME AND POSITION                      RIGHTS (#)       OR PAYOUT        ($)          ($)          ($) 
- - ------------------------------       -------------   ---------------  ----------  -----------   -----------
 <S>                                 <C>             <C>              <C>         <C>           <C>
 W.W. George, President               3,580          5/1/94- 4/30/97  $ 58,086   $   290,428    $  522,770 
 and Chief Executive Officer 
 

 G.D. Nelson, M.D, Vice Chairman      2,492          5/1/94- 4/30/97    40,433       202,164       363,894 
 

 A.D. Collins, Jr., Chief             2,336          5/1/94- 4/30/97    37,902       189,508       341,114 
 Operating Officer 
 

 R.L. Ryan, Senior Vice               1,710          5/1/94- 4/30/97    27,745       138,724       249,703 
 President and Chief Financial Officer
 

 B.I. Griffin, Executive Vice         1,614          5/1/94- 4/30/97    26,187       130,936       235,684 
 President and President, Pacing 
 

 All Executive Officers as a         17,004          5/1/94- 4/30/97   275,890     1,379,450     2,483,009 
 Group 
 

 All Directors who are not              0               0                0           0             0 
 Executive Officers as a Group 
 

 All Non-Executive Officer            7,954          5/1/94- 4/30/97   129,054       645,268     1,161,483 
 Employees as a Group 

</TABLE>
- - -----------------
(1) Payout of awards is based on achieving specified levels of earnings per 
share and after-tax return on net assets during a three-year performance 
cycle. Payout can range from 0% to 180% of units granted, with 20% and 180% 
as the threshold and maximum payouts, respectively. Payout of 100% of the 
units granted represents the target payout. Awards will be payable at least 
50% in Common Stock, with the remainder paid in cash or Common Stock at the 
discretion of the Compensation Committee. The value in dollars is determined 
when the award is earned based on the average fair market value per share for 
the last 20 trading days of the performance cycle. For illustrative purposes, 
the value of estimated future payouts was determined using the closing price 
of the Common Stock on July 8, 1994 ($81.125 per share). 

     1994 STOCK OPTION AWARDS TO ALL EMPLOYEES AND NON-EMPLOYEE DIRECTORS 

<TABLE>
<CAPTION>
                                                                             POTENTIAL REALIZABLE VALUE AT 
                                                                                          ASSUMED 
                                                                             ANNUAL RATES OF STOCK PRICE 
                                                                             APPRECIATION FOR THE OPTION TERM 
                                                                            --------------------------------- 
                                    OPTIONS     EXERCISE PRICE   EXPIRATION  
 NAME AND POSITION                GRANTED (#)  ($/SH)               DATE      0%($)    5%($)(1)   10%($)(1)
- - --------------------------      ------------   ---------------  -----------  ------   ---------  ----------  
 <S>                            <C>            <C>              <C>          <C>      <C>        <C>
 All Executive Officers                0       $ 0                     0     0        $       0  $       0 
  as a Group 

 All Directors who are not         5,124(2)     81.125          8/31/04      0         261,422    662,494 
  Executive Officers as a 
  Group 

 All Non-Executive Officer         6,287        75.75           4/29/04      0         299,505    759,004 
  Employees as a Group 
                                   7,743        78.625          6/22/04      0         382,867    970,260 

</TABLE>
- - -----------------
(1) The hypothetical potential appreciation shown in these columns reflects 
the required calculations at annual rates of 5% and 10% set by the Securities 
and Exchange Commission, and therefore are not intended to represent either 
historical appreciation or anticipated future appreciation of the Company's 
Common Stock price. 

(2) Pursuant to the Plan, and subject to approval of the Plan by the 
shareholders at the 1994 Annual Meeting, Non-Employee Directors of the 
Company will receive the annual nonqualified option grant on August 31, 1994. 
The actual number of shares and potential realizable values will be based on 
the fair market value of such shares on that date, which will also be the 
exercise price of such options. For purposes of the table, the number of 
shares and potential realizable values were calculated based upon the closing 
price of the Company's Common Stock on July 8, 1994 ($81.125 per share). 

                         1994 RESTRICTED STOCK AWARDS 

<TABLE>
<CAPTION>
 NAME AND POSITION                                   NUMBER OF SHARES (#)     DOLLAR VALUE($)(1) 
- - ------------------                                   ---------------------    ------------------
 <S>                                                       <C>                   <C>
 All Executive Officers as a Group                              0               $         0 
 All Directors who are not Executive Officers as a            951                    77,150 
 Group(2) 
 All Non-Executive Officer Employees as a Group            36,490                 2,960,251 

</TABLE>
- - -----------------------
(1) Based upon the closing price of the Company's Common Stock on July 8, 
1994 ($81.125 per share). 

(2) The number of shares of restricted stock that will be granted in lieu of 
the annual director retainer and chairmanship fees, described above under 
"Non-Employee Director Awards -- Issuance of Restricted Stock in Lieu of 
Compensation," varies with each Non-Employee Director's election to 
participate. 

VOTING REQUIREMENTS; RECOMMENDATION 
The affirmative vote of the holders of a majority of the outstanding shares 
of Common Stock of the Company entitled to vote on this item and present in 
person or by proxy at the Annual Meeting is required for approval of the 
Plan. Proxies solicited by the Board of Directors will be voted for approval 
of the Plan, unless shareholders specify otherwise in their proxies. 

For this purpose, a shareholder voting through a proxy who abstains with 
respect to approval of the Plan is considered to be present and entitled to 
vote on the approval of the Plan at the Annual Meeting, and is in effect a 
negative vote, but a shareholder (including a broker) who does not give 
authority to a proxy to vote, or withholds authority to vote, on the approval 
of the Plan shall not be considered present and entitled to vote on the 
proposal. 

THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR APPROVAL OF THE 1994 
STOCK AWARD PLAN. 


APPROVAL OF THE COMPANY'S MANAGEMENT INCENTIVE PLAN 

INTRODUCTION 

The Company has had some form of annual incentive plan in place since 1977. 
In response to the new federal tax law described below, the Board of 
Directors, upon the recommendation of the Compensation Committee of the 
Board, amended the Company's current annual incentive plan, known as the 
Medtronic, Inc. Management Incentive Plan ("MIP"), effective as of April 29, 
1994, and determined that the MIP would be submitted for shareholder approval 
at the 1994 Annual Meeting of Shareholders so that compensation under the MIP 
will be deductible. A copy of the MIP is included as Appendix B to this Proxy 
Statement, and this discussion is qualified in its entirety by reference to 
the full text of the MIP. 

SECTION 162(M) OF THE CODE 
As a result of the enactment in 1993 of Section 162(m) of the Code ("Section 
162(m)"), effective for tax years beginning January 1, 1994 and thereafter, 
publicly held companies will be limited to an annual deduction for federal 
income tax purposes of $1,000,000 for compensation paid to each of the chief 
executive officer and the other four most highly compensated executive 
officers (who are collectively referred to herein as "Covered Employees") 
determined at the end of each year. However, "performance-based" compensation 
is excluded from this limitation on deductibility. Under Section 162(m) and 
proposed regulations thereunder, compensation is considered performance-based 
if it is payable only upon the attainment of one or more performance goals 
established by a compensation committee of the board of directors consisting 
of at least two outside directors, the material terms of the compensation and 
the performance goals are disclosed to and approved by shareholders before 
payment, and the compensation committee certifies that such performance goals 
have been satisfied. The Company's Compensation Committee (the "Committee") 
qualifies as a committee of outside directors under Section 162(m). 
Performance goals can be based on one or more business criteria that apply to 
an individual, a business unit or the company as a whole. The maximum amount 
that may be paid to Covered Employees or the formula used to calculate such 
amount must be approved by the Company's shareholders. In accordance with 
proposed regulations under Section 162(m), the Compensation Committee may not 
increase the amount of compensation payable if the performance goal is met 
but may reduce or eliminate compensation even if the performance goal is 
attained. In light of this legislation and in keeping with the Compensation 
Committee's philosophy of performance-based pay, the Board is submitting the 
MIP to shareholders for approval. 

PURPOSE 
The MIP is designed to motivate officers and other key employees to achieve 
the Company's operating goals by providing the opportunity for incentive 
compensation in addition to annual salaries. The MIP is also designed to 
promote the accomplishment of management's primary annual objectives as 
reflected in the Company's annual operating plan, in the various business 
unit annual operating plans and in the objectives established by management 
for employees, and to recognize the achievement of these objectives through 
the payment of incentive compensation. 

ADMINISTRATION 
The Committee will administer the MIP, and may establish such rules and 
regulations as it deems necessary to do so. The Committee may delegate 
certain of its administrative powers and responsibilities under the MIP to 
the Chief Executive Officer of the Company for employees other than Covered 
Employees. 

ELIGIBILITY 
Employees eligible to participate in the MIP include executive officers, 
heads of key staff functions, heads of operating business units and other 
major contributors to business unit or corporate results. For each year, the 
Committee will select those Covered Employees who are to be participants in 
the MIP. The Chief Executive Officer will select the other participants in 
the MIP each year from among the other eligible employees. 

For the Company's current fiscal year (which is also the current MIP plan 
year), 310 officers and other employees have been selected to participate in 
the MIP. 

AWARDS UNDER THE MIP 
At the beginning of each plan year (or at such other time as is consistent 
with the requirements of Section 162(m)), each participant in the MIP will be 
assigned to a specified Participation Category. The range of potential awards 
to participants under the MIP is stated for each Participation Category as 
percentages of each participant's salary (as defined in the MIP) and, if 
minimum performance objectives are met or exceeded, actual awards will fall 
within a scale ranging from designated minimum awards to designated target 
awards to designated maximum awards. The designated target award for each 
respective Participation Category is referred to as the "Target Award 
Percentage." 

Each participant will also be assigned to a specified performance category 
("Performance Category"), which will set forth the weighted combinations of 
performance factors to be considered in connection with the award. Such 
factors may be one or a combination of the performance of the participant 
individually, as part of a team or as a member of management ("Management" 
performance), the participant's division or other business unit ("Unit 
Financial" performance), and the Company as a whole ("Corporate Financial" 
performance). Performance Categories for Covered Employees will be based 
solely on one or any combination of two or more of the following factors: 
revenue, revenue per employee, earnings before income tax (profit before 
taxes), earnings before interest and income tax, net earnings (profit after 
taxes), earnings per employee, tangible, controllable or total asset 
turnover, earnings per share, operating income, total shareholder return, 
market share, return on equity, before- or after-tax return on net assets, 
distribution expense, inventory turnover or economic value added; and such 
factors may relate to one or any combination of two or more of corporate, 
group, unit, division, affiliate or individual performance. These factors 
will be treated as Corporate Financial, Unit Financial or Management 
objectives, as appropriate. 

At the beginning of each plan year (or at such other time as is consistent 
with the requirements of Section 162(m)), the Committee will establish the 
objectives by which performance during the plan year will be measured. Each 
objective will have a stated performance target. In the event that more than 
one objective is used, the multiple objectives, when established, will be 
appropriately weighted by percentage in accordance with their importance 
(with the aggregate weighted objectives totalling 100%). At the end of each 
plan year the degree of achievement of each objective will be expressed as a 
percentage of the performance target for each such objective. When one 
objective in any of the three performance areas is used, such percentage will 
constitute the "Corporate Financial Score", the "Unit Financial Score" or the 
"Management Score", as the case may be. When more than one objective is used, 
the percentage achievement of each objective's target must be multiplied by 
the percentage weight (out of 100%) assigned to each such specific objective, 
and the resulting percentages for the various objectives must then be added. 
Unit Financial objectives will be based on financial goals reflected in the 
respective business unit's operating plan, and Management objectives will 
relate to objectives in the business unit's annual operating plan and/or 
long-range plan. 

At the beginning of each plan year (or at such other time as is consistent 
with the requirements of Section 162(m)), the Committee will establish a 
minimum threshold level of Corporate Financial objectives which the Company 
must achieve for there to be any award made under the MIP. If this minimum 
threshold is not met, no awards will be paid to participants regardless of 
whether other objectives have been met. Similarly, the Committee (in the case 
of Covered Employees) and the Chief Executive Officer (for participants other 
than Covered Employees) may adopt a minimum threshold level of a business 
unit's most significant financial objective which the business unit must 
achieve for there to be any award based on such business unit's financial and 
management performance. If such minimum is established and is not met, no 
award will be paid for one or both of the Unit Financial and Management 
portions, as determined by the Committee (for Covered Employees) or the Chief 
Executive Officer (for other participants), under the Performance Category of 
each participant in the applicable business unit. 

Each participant's final award will be equal to the sum of the following: 

(a) the Corporate Financial portion of each participant's award will be the 
product of (i) the participant's salary for the plan year, (ii) the Target 
Award Percentage for the participant's applicable Participation Category, 
(iii) the Corporate Financial percentage under the participant's Performance 
Category and (iv) the Corporate Performance Score; 

(b) the Unit Financial portion of each participant's award will be the 
product of (i) the participant's salary for the plan year, (ii) the Target 
Award Percentage for the participant's applicable Participation Category, 
(iii) the Unit Financial percentage under the participant's Performance 
Category and (iv) the Unit Financial Score; and 

(c) the Management portion of each participant's award will be the product of 
(i) the participant's salary for the plan year, (ii) the Target Award 
Percentage for the participant's applicable Participation Category, (iii) the 
Management percentage under the participant's Performance Category and (iv) 
the individual's Management Score; 

provided, however, that the final award to any participant may not exceed the 
maximum award as a percentage of salary for such participant's Participation 
Category, and that no Covered Employee may receive an award in excess of $2 
million in any plan year. For purposes of the foregoing calculation, the 
salary of a Covered Employee will be such employee's annual salary in effect 
on the first day of the plan year. 

Final awards will be paid to each participant in cash within 90 days after 
the end of the plan year unless the participant is eligible to participate in 
and elects to defer some or all of the payment under the Company's deferral 
plan or elects to receive stock options under the 1994 Stock Award Plan in 
lieu of some or all of such cash, if and on such terms as are permitted by 
the Committee. 

TERMINATION OF EMPLOYMENT 
Following termination of employment during a plan year by reason of death, 
disability or normal or early retirement, a participant will be eligible to 
receive a pro rata award equal to the portion of the final award, otherwise 
determined in accordance with the MIP, represented by the percentage equal to 
the number of full months of employment during the plan year divided by 12. 
Following a termination of employment for any other reason, a participant's 
eligibility to receive an award for that plan year (not greater than the 
prorated amount described in the preceding sentence) will be determined 
solely at the discretion of the Chief Executive Officer or, in the case of a 
Covered Employee, solely at the discretion of the Committee. 

NONASSIGNABILITY OF BENEFITS 
No participant may assign, transfer or encumber any interest in the MIP or 
any payments thereunder. 

CHANGE IN CONTROL PROVISIONS 
The MIP contains provisions providing for acceleration of payment of awards 
during a plan year in which a "change in control" of the Company occurs (as 
that term is defined in the MIP). 

MODIFICATION, TERMINATION 
The Committee, in its sole discretion, may modify, suspend, terminate or 
reinstate the Plan, provided that prior approval of the Board of Directors is 
required (a) to render non-employees eligible to participate in the MIP or 
(b) to increase the maximum awards (expressed as a percentage of salary) for 
a Participation Category beyond the maximum award which has previously been 
approved by the Board for such Participation Category. 

FEDERAL TAX CONSEQUENCES 
Under the Code as presently in effect, a grant of an award under the MIP 
would have no federal income tax consequence. Cash payment of the award is 
taxable to a participant as ordinary income. Amounts taxable to employees 
under the MIP will be deductible by the Company as compensation. The Company 
will withhold from payments under the MIP amounts necessary to pay any 
required taxes. 

NEW PLAN BENEFITS 
The following table sets forth certain information regarding potential 
payments for fiscal 1995 pursuant to awards granted by the Compensation 
Committee on April 29, 1994, subject to shareholder approval of the MIP at 
the 1994 Annual Meeting. Such payments are based on salary levels at the 
beginning of the current plan year and the Participation Categories assigned 
to all participants. 

<TABLE>
<CAPTION>
                                                                  ESTIMATED PAYMENTS(1) 
                                                        --------------------------------------
 NAME AND POSITION                                        MINIMUM($)    TARGET($)    MAXIMUM($)
- - -------------------                                     ------------  -----------  ------------ 
 <S>                                                    <C>           <C>          <C>
 W.W. George, President and Chief Executive             $  172,252   $   344,504  $   516,757 
 Officer 
 G.D. Nelson, M.D, Vice Chairman                           122,987       245,973      368,960 
 A.D. Collins, Jr., Chief Operating Officer                115,294       230,588      345,882 
 R.L. Ryan, Senior Vice President and Chief                 79,125       158,250      237,374 
 Financial Officer 
 B.I. Griffin, Executive Vice President and                 74,683       149,366      224,049 
 President, Pacing 
 All executive officers as a group                         803,301     1,606,602    2,409,903 
 All directors who are not executive officers as                 0             0            0 
 a group 
 All non-executive officer employees as a group          3,051,341     6,102,681    9,154,022 

</TABLE>

(1) No payments will be made under the MIP for the current plan year unless a 
minimum threshold level of designated objectives is achieved. 

VOTING REQUIREMENTS; RECOMMENDATION 
The affirmative vote of the holders of a majority of the outstanding shares 
of Common Stock of the Company entitled to vote on this item and present in 
person or by proxy at the Annual Meeting is required for approval of the MIP. 
Proxies solicited by the Board of Directors will be voted for approval of the 
MIP, unless shareholders specify otherwise in their proxies. 

For this purpose, a shareholder voting through a proxy who abstains with 
respect to approval of the MIP is considered to be present and entitled to 
vote on the approval of the MIP at the Annual Meeting, and is in effect a 
negative vote, but a shareholder (including a broker) who does not give 
authority to a proxy to vote, or withholds authority to vote, on the approval 
of the MIP shall not be considered present and entitled to vote on the 
proposal. 

THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR APPROVAL OF THE MANAGEMENT 
INCENTIVE PLAN. 

                      APPROVAL OF SELECTION OF AUDITORS 

Upon recommendation of its Audit Committee, Medtronic's Board has selected 
Price Waterhouse, certified public accountants, as independent auditors for 
Medtronic for the fiscal year ending April 30, 1995. That firm has acted as 
independent auditors for Medtronic for more than 20 years, and the Board 
considers it highly qualified. Although it is not required to do so, the 
Board of Directors wishes to submit the selection of Price Waterhouse for 
shareholders' approval at the Annual Meeting. If the shareholders do not give 
approval, the Board will reconsider its selection. 

Representatives of Price Waterhouse will be present at the Annual Meeting, 
will have the opportunity to make a statement if they desire and will be 
available to respond to appropriate questions. 

THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR RATIFICATION OF THIS 
APPOINTMENT. 

                                   GENERAL 

The costs of soliciting proxies will be borne by Medtronic, including the 
reimbursement to record holders of their expenses in forwarding proxy 
materials to beneficial owners. Directors, officers and regular employees of 
Medtronic, without extra compensation, may solicit proxies personally or by 
mail, telephone, fax, telex, telegraph or special letter. 

Medtronic has retained Chemical Bank, a firm that provides professional proxy 
soliciting services, to aid in the solicitation of proxies for a fee of up to 
$6,500 and reimbursement for certain out-of-pocket expenses. 


Any shareholder proposals for the Company's 1995 Annual Meeting of 
Shareholders (anticipated date August 30, 1995) must be received by the 
Company by March 29, 1995 in order to be included in the Company's Proxy 
Statement. The proposals also must comply with all applicable statutes and 
regulations. 


Medtronic's 1994 Annual Shareholder Report, including financial statements, 
is being sent to shareholders of record on July 8, 1994, together with this 
Proxy Statement. MEDTRONIC WILL FURNISH TO SHAREHOLDERS WITHOUT CHARGE A COPY 
OF ITS ANNUAL REPORT ON FORM 10-K FOR THE FISCAL YEAR ENDED APRIL 30, 1994, 
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION, UPON RECEIPT OF WRITTEN 
REQUEST ADDRESSED TO: INVESTOR RELATIONS DEPARTMENT, MEDTRONIC, INC., 7000 
CENTRAL AVENUE N.E., MINNEAPOLIS, MINNESOTA 55432. 

The Board of Directors knows of no other matters to be presented at the 
Annual Meeting. If any other business properly comes before the Annual 
Meeting or any adjournment thereof, the proxies will vote on that business in 
accordance with their best judgment. 

By Order of the Board of Directors, 

/s/ Ronald E. Lund
Ronald E. Lund, Secretary 
                               
                                                                    APPENDIX A 

                            1994 STOCK AWARD PLAN 
                          (EFFECTIVE APRIL 29, 1994) 

1. PURPOSE. The purpose of this 1994 Stock Award Plan (the "Plan") is to 
motivate key personnel, including non-employee directors, to produce a 
superior return to the shareholders of Medtronic, Inc. (the "Company") and 
its Affiliates by offering such individuals an opportunity to realize Stock 
appreciation, by facilitating Stock ownership, and by rewarding them for 
achieving a high level of corporate performance. This Plan is also intended 
to facilitate recruiting and retaining key personnel of outstanding ability. 

2. DEFINITIONS. The capitalized terms used in this Plan have the meanings set 
forth below. 

(a) "Affiliate" means any corporation that is a "parent corporation" or 
"subsidiary corporation" of the Company, as those terms are defined in 
Sections 424(e) and (f) of the Code, or any successor provision, and, for 
purposes other than the grant of Incentive Stock Options, any joint venture 
in which the Company or any such "parent corporation" or "subsidiary 
corporation" owns an equity interest. 

(b) "Agreement" means a written contract entered into between the Company or 
an Affiliate and a Participant containing the terms and conditions of an 
Award in such form (not inconsistent with this Plan) as the Committee 
approves from time to time, together with all amendments thereof, which 
amendments may be unilaterally made by the Company (with the approval of the 
Committee) unless such amendments are deemed by the Committee to be 
materially adverse to the Participant and are not required as a matter of 
law. 


(c) "Annual Retainer" means the fixed annual fee of a Non-Employee Director 
in effect on the first day of the year for which such Annual Retainer is 
payable for services to be rendered as a Non-Employee Director of the 
Company. The Annual Retainer does not include meeting or chairmanship fees. 


(d) "Award" means a grant made under this Plan in the form of Options, Stock 
Appreciation Rights, Restricted Stock, Performance Shares or any Other 
Stock-Based Award. 

(e) "Board" means the Board of Directors of the Company. 

(f) "Change in Control" means: 

(i) 
acquisition by any individual, entity or group (within the meaning of Section 
13(d) (3) or 14(d) (2) of the Securities Exchange Act of 1934, as amended 
(the "Exchange Act")) of beneficial ownership (within the meaning of Rule 
13d-3 promulgated under the Exchange Act) of 30% or more of either (A) the 
then outstanding Shares of Stock (the "Outstanding Company Common Stock") or 
(B) the combined voting power of the then outstanding voting securities of 
the Company entitled to vote generally in the election of directors (the 
"Outstanding Company Voting Securities"); provided, however, that the 
following acquisitions shall not constitute a Change of Control: (A) any 
acquisition directly from the Company, (B) any acquisition by the Company or 
any Subsidiary, (C) any acquisition by any employee benefit plan (or related 
trust) sponsored or maintained by the Company or any Subsidiary or (D) any 
acquisition by any corporation with respect to which, following such 
acquisition, more than 55% of, respectively, the then outstanding shares of 
common stock of such corporation and the combined voting power of the then 
outstanding voting securities of such corporation entitled to vote generally 
in the election of directors is then beneficially owned, directly or 
indirectly, by all or substantially all of the individuals and entities who 
were the beneficial owners, respectively, of the Outstanding Company Common 
Stock and Outstanding Company Voting Securities immediately prior to such 
acquisition in substantially the same proportions as their ownership, 
immediately prior to such acquisition, of the Outstanding Company Common 
Stock and Outstanding Company Voting Securities, as the case may be; or 

(ii) 
individuals who, as of the effective date of this Plan provided in Section 
14(a) of this Plan, constitute the Board (the "Incumbent Board") cease for 
any reason to constitute at least a majority of the Board; provided, however, 
that any individual becoming a director subsequent to the date hereof whose 
election, or nomination for election by the Company's shareholders, was 
approved by a vote of at least a majority of the directors then comprising 
the Incumbent Board shall be considered as though such individual were a 
member of the Incumbent Board, but excluding, for this purpose, any such 
individual whose initial assumption of office occurs as a result of either an 
actual or threatened election contest (as such terms are used in Rule 14a-11 
of Regulation 14A promulgated under the Exchange Act) or other actual or 
threatened solicitation of proxies or consents; or 

(iii) 
approval by the shareholders of the Company of a reorganization, merger, 
consolidation or statutory exchange of Outstanding Company Voting Securities, 
in each case, with respect to which all or substantially all of the 
individuals and entities who were the beneficial owners, respectively, of the 
Outstanding Company Common Stock and Outstanding Company Voting Securities 
immediately prior to such reorganization, merger, consolidation or exchange 
do not, following such reorganization, merger, consolidation or exchange, 
beneficially own, directly or indirectly, more than 55% of, respectively, the 
then outstanding shares of common stock and the combined voting power of the 
then outstanding voting securities entitled to vote generally in the election 
of directors, as the case may be, of the corporation resulting from such 
reorganization, merger, consolidation or exchange in substantially the same 
proportions as their ownership, immediately prior to such reorganization, 
merger, consolidation or exchange of the Outstanding Company Common Stock and 
Outstanding Company Voting Securities, as the case may be; or 


(iv) 
approval by the shareholders of the Company of (A) a complete liquidation or 
dissolution of the Company or (B) the sale or other disposition of all or 
substantially all of the assets of the Company, other than to a corporation 
with respect to which, following such sale or other disposition, more than 
55% of, respectively, the then outstanding shares of common stock of such 
corporation and the combined voting power of the then outstanding voting 
securities of such corporation entitled to vote generally in the election of 
directors is then beneficially owned, directly or indirectly, by all or 
substantially all of the individuals and entities who were the beneficial 
owners, respectively, of the Outstanding Company Common Stock and Outstanding 
Company Voting Securities immediately prior to such sale or other disposition 
in substantially the same proportion as their ownership, immediately prior to 
such sale or other disposition, of the Outstanding Company Common Stock and 
Outstanding Company Voting Securities, as the case may be. 

Notwithstanding the foregoing provisions of this definition, a Change of 
Control shall not be deemed to occur with respect to a Participant if the 
acquisition of the 30% or greater interest referred to in subparagraph (i) of 
this definition is by a group, acting in concert, that includes the 
Participant or if at least 40% of the then outstanding common stock or 
combined voting power of the then outstanding voting securities (or voting 
equity interests) of the surviving corporation or of any corporation (or 
other entity) acquiring all or substantially all of the assets of the Company 
shall be beneficially owned, directly or indirectly, immediately after a 
reorganization, merger, consolidation, statutory share exchange or 
disposition of assets referred to in subparagraph (iii) or (iv) of this 
definition by a group, acting in concert, that includes that Participant. 

(g) 
"Code" means the Internal Revenue Code of 1986, as amended and in effect from 
time to time, or any successor statute. 

(h) 
 "Committee" means three or more Disinterested Persons designated by the Board
to administer this Plan under Section 3 hereof and constituted so as to 
permit this Plan to comply with Exchange Act Rule 16b-3. 

(i) 
"Company" means Medtronic, Inc., a Minnesota corporation, or any successor to 
all or substantially all of its businesses by merger, consolidation, purchase 
of assets or otherwise. 

(j) 
"Disability" means the disability of a Participant such that the Participant 
is (or in the case of a Non-Employee Director, would, if an employee, be) 
considered disabled under any retirement plan of the Company which is 
qualified under Section 401 of the Code, or, except as this term is used in 
Sections 12 and 13 hereof, as otherwise determined by the Committee. 

(k) 
"Disinterested Person" means a member of the Board who is considered a 
disinterested person within the meaning of Exchange Act Rule 16b-3. 

(l) 
"Employee" means any full-time or part-time employee (including an officer or 
director who is also an employee) of the Company or an Affiliate. Except with 
respect to grants of Incentive Stock Options, "Employee" shall also include 
other individuals and entities who are not "employees" of the Company or an 
Affiliate but who provide services to the Company or an Affiliate in the 
capacity of an independent contractor. References in this Plan to 
"employment" and related terms shall include the providing of services in any 
such capacity. 

(m) 
"Exchange Act" means the Securities Exchange Act of 1934, as amended; 
"Exchange Act Rule 16b-3" means Rule 16b-3 promulgated by the Securities and 
Exchange Commission under the Exchange Act as in effect with respect to the 
Company or any successor regulation. 

(n) 
"Fair Market Value" as of any date means, unless otherwise expressly provided 
in this Plan: 

(i) 
the closing sale price of a Share (A) on the composite tape for New York 
Stock Exchange ("NYSE") listed shares, or (B) if the Shares are not quoted on 
the NYSE composite tape, on the principal United States securities exchange 
registered under the Exchange Act on which the Shares are listed, or (C) if 
the Shares are not listed on any such exchange, on the National Association 
of Securities Dealers, Inc. Automated Quotation System National Market 
System, in any case on the date immediately preceding that date, or, if no 
sale of Shares shall have occurred on that date, on the next preceding day on 
which a sale of Shares occurred, or 

(ii) 
if clause (i) is not applicable, what the Committee determines in good faith 
to be 100% of the fair market value of a Share on that date. 

However, if the applicable securities exchange or system has closed for the 
day at the time the event occurs that triggers a determination of Fair Market 
Value, all references in this paragraph to the "date immediately preceding 
that date" shall be deemed to be references to "that date." In the case of an 
Incentive Stock Option, if such determination of Fair Market Value is not 
consistent with the then current regulations of the Secretary of the 
Treasury, Fair Market Value shall be determined in accordance with said 
regulations. The determination of Fair Market Value shall be subject to 
adjustment as provided in Section 14(f) hereof. 

(o) 
"Fundamental Change" means a dissolution or liquidation of the Company, a 
sale of substantially all of the assets of the Company, a merger or 
consolidation of the Company with or into any other corporation, regardless 
of whether the Company is the surviving corporation, or a statutory share 
exchange involving capital stock of the Company. 

(p) 
"Incentive Stock Option" means any Option designated as such and granted in 
accordance with the requirements of Section 422 of the Code or any successor 
to such section. 

(q) 
"Non-Employee Director" means a member of the Board who is not an employee of 
the Company or any Affiliate. 

(r) 
"Non-Qualified Stock Option" means an Option other than an Incentive Stock 
Option. 

(s) 
"Other Stock-Based Award" means an Award of Stock or an Award based on Stock 
other than Options, Stock Appreciation Rights, Restricted Stock or 
Performance Shares. 

(t) 
"Option" means a right to purchase Stock, including both Non-Qualified Stock 
Options and Incentive Stock Options. 

(u) 
"Participant" means an Employee or a Non-Employee Director to whom an Award 
is made. 

(v) 
"Performance Period" means the period of time as specified in an Agreement 
over which Performance Shares are to be earned. 

(w) 
"Performance Shares" means a contingent award of a specified number of 
Performance Shares, with each Performance Share equivalent to one Share, a 
variable percentage of which may vest depending upon the extent of 
achievement of specified performance objectives during the applicable 
Performance Period. 

(x) 
"Plan" means this 1994 Stock Award Plan, as amended and in effect from time 
to time. 

(y) 
"Restricted Stock" means Stock granted under Section 10 or 13 hereof so long 
as such Stock remains subject to one or more restrictions. 

(z) 
"Retirement" means retirement of an Employee as defined under any retirement 
plan of the Company which is qualified under Section 401 of the Code (which 
currently provides for retirement on or after age 55, provided the Employee 
has been employed by the Company and/or one or more Affiliates for at least 
ten years, or retirement on or after age 62), or as otherwise determined by 
the Committee. 

(aa) 
"Share" means a share of Stock. 

(bb) 
"Stock" means the common stock, $.10 par value per share (as such par value 
may be adjusted from time to time), of the Company. 

(cc) 
"Stock Appreciation Right" means a right, the value of which is determined 
relative to appreciation in value of Shares pursuant to an Award granted 
under Section 8 hereof. 

(dd) 
"Subsidiary" means a "subsidiary corporation," as that term is defined in 
Section 424(f) of the Code, or any successor provision. 

(ee) 
"Successor" with respect to a Participant means the legal representative of 
an incompetent Participant and, if the Participant is deceased, the legal 
representative of the estate of the Participant or the person or persons who 
may, by bequest or inheritance, or under the terms of an Award or of forms 
submitted by the Participant to the Committee under Section 14(i) hereof, 
acquire the right to exercise an Option or Stock Appreciation Right or 
receive cash and/or Shares issuable in satisfaction of an Award in the event 
of a Participant's death. 

(ff) 
"Term" means the period during which an Option or Stock Appreciation Right 
may be exercised or the period during which the restrictions placed on 
Restricted Stock or any other Award are in effect. 

Except when otherwise indicated by the context, reference to the masculine 
gender shall include, when used, the feminine gender and any term used in the 
singular shall also include the plural. 

3. ADMINISTRATION. 

(a) 
AUTHORITY OF COMMITTEE. The Committee shall administer this Plan. The 
Committee shall have exclusive power to make Awards and to determine when and 
to whom Awards will be granted, and the form, amount and other terms and 
conditions of each Award, subject to the provisions of this Plan. The 
Committee may determine whether, to what extent and under what circumstances 
Awards may be settled, paid or exercised in cash, Shares or other Awards or 
other property, or cancelled, forfeited or suspended. The Committee shall 
have the authority to interpret this Plan and any Award or Agreement made 
under this Plan, to establish, amend, waive and rescind any rules and 
regulations relating to the administration of this Plan, to determine the 
terms and provisions of any Agreements entered into hereunder (not 
inconsistent with this Plan), and to make all other determinations necessary 
or advisable for the administration of this Plan. The Committee may correct 
any defect, supply any omission or reconcile any inconsistency in this Plan 
or in any Award in the manner and to the extent it shall deem desirable. The 
determinations of the Committee in the administration of this Plan, as 
described herein, shall be final, binding and conclusive. 

(b) 
DELEGATION OF AUTHORITY. The Committee may delegate all or any part of its 
authority under this Plan to persons who are not Disinterested Persons for 
purposes of determining and administering Awards solely to Employees who are 
not then subject to the reporting requirements of Section 16 of the Exchange 
Act. 

(c) 
AWARDS TO NON-EMPLOYEE DIRECTORS. Notwithstanding any contrary provisions of 
this Plan, the granting, terms, conditions and eligibility requirements of 
Awards granted to Non-Employee Directors under Sections 12 and 13 of this 
Plan are governed solely by the provisions of this Plan pertaining thereto, 
and the Committee shall have no discretion with respect to the granting of 
such Awards or to alter or amend any terms, conditions or eligibility 
requirements of such Awards to Non-Employee Directors. 

(d) 
RULE 16B-3 COMPLIANCE. It is the intent that this Plan and all Awards granted 
pursuant to it shall be administered by the Committee so as to permit this 
Plan and Awards to comply with Exchange Act Rule 16b-3. If any provision of 
this Plan or of any Award would otherwise frustrate or conflict with the 
intent expressed in this Section 3(d), that provision to the extent possible 
shall be interpreted and deemed amended in the manner determined by the 
Committee so as to avoid such conflict. To the extent of any remaining 
irreconcilable conflict with such intent, the provision shall be deemed void 
as applicable to Participants who are then subject to the reporting 
requirements of Section 16 of the Exchange Act to the extent permitted by law 
and in the manner deemed advisable by the Committee. 

(e) 
INDEMNIFICATION. To the full extent permitted by law, each member and former 
member of the Committee and each person to whom the Committee delegates or 
has delegated authority under this Plan shall be entitled to indemnification 
by the Company against and from any loss, liability, judgment, damage, cost 
and reasonable expense incurred by such member, former member or other person 
by reason of any action taken, failure to act or determination made in good 
faith under or with respect to this Plan. 

4. SHARES AVAILABLE; MAXIMUM PAYOUTS. 

(a) 
SHARES AVAILABLE. The number of Shares available for distribution under this 
Plan is 2,800,000 (subject to adjustment under Section 14(f) hereof). 

(b) 
SHARES AGAIN AVAILABLE.  Any Shares subject to the terms and conditions of an 
Award under this Plan which are not used because the terms and conditions of 
the Award are not met may again be used for an Award under this Plan. 
However, Shares with respect to which a Stock Appreciation Right has been 
exercised, whether paid in cash and/or in Shares, and Shares of Restricted 
Stock which have been granted with dividend or voting rights during the Term 
of the Restricted Stock may not again be awarded under this Plan. 

(c) 
UNEXERCISED AWARDS. Any unexercised or undistributed portion of any 
terminated, expired, exchanged, or forfeited Award or any Award settled in 
cash in lieu of Shares (except as provided in Section 4(b) hereof) shall be 
available for further Awards. 

(d) 
NO FRACTIONAL SHARES. No fractional Shares may be issued under this Plan; 
fractional Shares will be rounded to the nearest whole Share. 


(e) 
MAXIMUM PAYOUTS. No more than 35% of all Shares subject to this Plan may be 
granted in the aggregate pursuant to Restricted Stock, Performance Share and 
Other Stock-Based Awards. 

5. ELIGIBILITY. Awards may be granted under this Plan to any Employee at the 
discretion of the Committee. Non-Employee Directors are eligible for certain 
Awards under this Plan, as provided in Sections 12 and 13 hereof and subject 
to the restrictions in Section 3(c) hereof. 

6. GENERAL TERMS OF AWARDS. 

(a) 
AWARDS. Awards under this Plan may consist of Options (either Incentive Stock 
Options or Non-Qualified Stock Options), Stock Appreciation Rights, 
Performance Shares, Restricted Stock and Other Stock-Based Awards. Awards of 
Restricted Stock may, in the discretion of the Committee, provide the 
Participant with dividends or dividend equivalents and voting rights prior to 
vesting (whether vesting is based on a period of time or based on attainment 
of specified performance conditions). 

(b) 
AMOUNT OF AWARDS. Each Agreement shall set forth the number of Shares of 
Restricted Stock, Stock or Performance Shares subject to such Agreement, or 
the number of Shares to which the Option applies or with respect to which 
payment upon the exercise of the Stock Appreciation Right is to be 
determined, as the case may be, together with such other terms and conditions 
applicable to the Award (not inconsistent with this Plan) as determined by 
the Committee in its sole discretion. 

(c) 
TERM. Each Agreement, other than those relating solely to Awards of Stock 
without restrictions, shall set forth the Term of the Award and any 
applicable Performance Period for Performance Shares, as the case may be, but 
in no event shall the Term of an Award (other than Awards granted in lieu of 
cash compensation pursuant to Section 13 hereof or the Company's Management 
Incentive Plan as amended from time to time) or the Performance Period be 
longer than ten years after the date of grant. An Agreement with a 
Participant may permit acceleration of vesting requirements and of the 
expiration of the applicable Term upon such terms and conditions as shall be 
set forth in the Agreement, which may, but need not, include, without 
limitation, acceleration resulting from the occurrence of a Change in 
Control, a Fundamental Change, or the Participant's death, Disability or 
Retirement. Acceleration of the Performance Period of Performance Shares 
shall be subject to Section 9(b) hereof. 

(d) 
AGREEMENTS.  Each Award under this Plan shall be evidenced by an Agreement 
setting forth the terms and conditions, as determined by the Committee, which 
shall apply to such Award, in addition to the terms and conditions specified 
in this Plan. 

(e) 
TRANSFERABILITY.  During the lifetime of a Participant to whom an Award is 
granted, only such Participant (or such Participant's legal representative 
or, if so provided in the applicable Agreement in the case of a Non-Qualified 
Stock Option, a permitted transferee as hereafter described) may exercise an 
Option or Stock Appreciation Right or receive payment with respect to 
Performance Shares or any other Award. No Award of Restricted Stock (prior to 
the expiration of the restrictions), Options, Stock Appreciation Rights, 
Performance Shares or other Award (other than an award of Stock without 
restrictions) may be sold, assigned, transferred, exchanged, or otherwise 
encumbered, and any attempt to do so shall be of no effect. Notwithstanding 
the immediately preceding sentence, (i) an Agreement may provide that an 
Award shall be transferable to a Successor in the event of a Participant's 
death and (ii) an Agreement may provide that a Non-Qualified Stock Option 
shall be transferable to any member of a Participant's "immediate family" (as 
such term is defined in Rule 16a-1(e) promulgated under the Exchange Act, or 
any successor rule or regulation) or to one or more trusts whose 
beneficiaries are members of such Participant's "immediate family" or 
partnerships in which such family members are the only partners; provided, 
however, that (1) the Participant receives no consideration for the transfer 
and (2) such transferred Non-Qualified Stock Option shall continue to be 
subject to the same terms and conditions as were applicable to such 
Non-Qualified Stock Option immediately prior to its transfer. 

(f) 
TERMINATION OF EMPLOYMENT. Except as otherwise determined by the Committee or 
provided by the Committee in an applicable Agreement, in case of termination 
of employment, the following provisions shall apply: 

(1) 
OPTIONS AND STOCK APPRECIATION RIGHTS. 

(i) 
DEATH.  If a Participant who has been granted an Option or Stock Appreciation 
Rights shall die before such Option or Stock Appreciation Rights have 
expired, the Option or Stock Appreciation Rights shall become exercisable in 
full, and may be exercised by the Participant's Successor at any time, or 
from time to time, within three years after the date of the Participant's 
death. 

(ii) 
DISABILITY OR RETIREMENT. If a Participant's employment terminates because of 
Disability or Retirement, the Option or Stock Appreciation Rights shall 
become exercisable in full, and the Participant may exercise his or her 
Options or Stock Appreciation Rights at any time, or from time to time, 
within three years after the date of such termination. 

(iii) 
REASONS OTHER THAN DEATH, DISABILITY OR RETIREMENT. If a Participant's 
employment terminates for any reason other than death, Disability or 
Retirement, the unvested or unexercised portion of any Award held by such 
Participant shall terminate at the date of termination of employment. 

(iv) 
EXPIRATION OF TERM. Notwithstanding the foregoing paragraphs (i)-(iii), in no 
event shall an Option or a Stock Appreciation Right be exercisable after 
expiration of the Term of such Award. 

(2) 
PERFORMANCE SHARES. If a Participant's employment with the Company or any of 
its Affiliates terminates during a Performance Period because of death, 
Disability or Retirement, or under other circumstances provided by the 
Committee in its discretion in the applicable Agreement, the Participant 
shall be entitled to a payment of Performance Shares at the end of the 
Performance Period based upon the extent to which achievement of performance 
targets was satisfied at the end of such period (as determined at the end of 
the Performance Period) and prorated for the portion of the Performance 
Period during which the Participant was employed by the Company or any 
Affiliate. Except as provided in this Section 6(f)(2) or in the applicable 
Agreement, if a Participant's employment terminates with the Company or any 
of its Affiliates during a Performance Period, then such Participant shall 
not be entitled to any payment with respect to that Performance Period. 

(3) 
RESTRICTED STOCK. In case of a Participant's death, Disability or Retirement, 
the Participant shall be entitled to receive that number of shares of 
Restricted Stock under outstanding Awards which has been pro rated for the 
portion of the Term of the Awards during which the Participant was employed 
by the Company or any Affiliate, and with respect to such Shares all 
restrictions shall lapse. 

(g) 
RIGHTS AS SHAREHOLDER. A Participant shall have no rights as a shareholder 
with respect to any securities covered by an Award until the date the 
Participant becomes the holder of record. 

7. STOCK OPTIONS. 

(a) 
TERMS OF ALL OPTIONS. Each Option shall be granted pursuant to an Agreement 
as either an Incentive Stock Option or a Non-Qualified Stock Option. Only 
Non-Qualified Stock Options may be granted to Employees who are not employees 
of the Company or an Affiliate. The purchase price of each Share subject to 
an Option shall be determined by the Committee and set forth in the 
Agreement, but shall not be less than 100% of the Fair Market Value of a 
Share as of the date the Option is granted. The purchase price of the Shares 
with respect to which an Option is exercised shall be payable in full at the 
time of exercise, provided that, to the extent permitted by law, Participants 
may simultaneously exercise Options and sell the Shares thereby acquired 
pursuant to a brokerage or similar relationship and use the proceeds from 
such sale to pay the purchase price of such Shares. The purchase price may be 
paid in cash, or through a reduction of the number of Shares delivered to the 
Participant upon exercise of the Option or by delivery to the Company of 
Shares held by such Participant (in each case, such Shares having a Fair 
Market Value as of the date the Option is exercised equal to the purchase 
price of the Shares being purchased pursuant to the Option), or a combination 
thereof, unless otherwise provided in the Agreement. Each Option shall be 
exercisable in whole or in part on the terms provided in the Agreement. In no 
event shall any Option be exercisable at any time after its Term. When an 
Option is no longer exercisable, it shall be deemed to have lapsed or 
terminated. No Participant may receive any combination of Options to purchase 
and Stock Appreciation Rights relating to more than 500,000 Shares in the 
aggregate (which amount includes up to 350,000 Shares pursuant to Awards and 
up to 150,000 Shares received in lieu of cash compensation at the 
Participant's election as permitted by the Compensation Committee) pursuant 
to Awards over a five-year period under this Plan. 

(b) 
INCENTIVE STOCK OPTIONS. In addition to the other terms and conditions 
applicable to all Options: 

(i) 
the aggregate Fair Market Value (determined as of the date the Option is 
granted) of the Shares with respect to which Incentive Stock Options held by 
an individual first become exercisable in any calendar year (under this Plan 
and all other incentive stock option plans of the Company and its Affiliates) 
shall not exceed $100,000 (or such other limit as may be required by the 
Code), if such limitation is necessary to qualify the Option as an Incentive 
Stock Option, and to the extent an Option or Options granted to a Participant 
exceed such limit, such Option or Options shall be treated as a Non-Qualified 
Stock Option; 

(ii) 
an Incentive Stock Option shall not be exercisable and the Term of the Award 
shall not be more than ten years after the date of grant (or such other limit 
as may be required by the Code) if such limitation is necessary to qualify 
the Option as an Incentive Stock Option; 

(iii) 
the Agreement covering an Incentive Stock Option shall contain such other 
terms and provisions which the Committee determines necessary to qualify such 
Option as an Incentive Stock Option; and 

(iv) 
notwithstanding any other provision of this Plan to the contrary, no 
Participant may receive an Incentive Stock Option under this Plan if, at the 
time the Award is granted, the Participant owns (after application of the 
rules contained in Section 424(d) of the Code, or its successor provision) 
Shares possessing more than ten percent of the total combined voting power of 
all classes of stock of the Company or its subsidiaries, unless (A) the 
option price for such Incentive Stock Option is at least 110% of the Fair 
Market Value of the Shares subject to such Incentive Stock Option on the date 
of grant and (B) such Option is not exercisable after the date five years 
from the date such Incentive Stock Option is granted. 

8. STOCK APPRECIATION RIGHTS. An Award of a Stock Appreciation Right shall 
entitle the Participant, subject to terms and conditions determined by the 
Committee, to receive upon exercise of the Stock Appreciation Right all or a 
portion of the excess of (i) the Fair Market Value of a specified number of 
Shares as of the date of exercise of the Stock Appreciation Right over (ii) a 
specified price which shall not be less than 100% of the Fair Market Value of 
such Shares as of the date of grant of the Stock Appreciation Right. A Stock 
Appreciation Right may be granted in connection with a previously or 
contemporaneously granted Option, or independent of any Option. If issued in 
connection with an Option, the Committee may impose a condition that exercise 
of a Stock Appreciation Right cancels the Option with which it is connected 
and exercise of the connected Option cancels the Stock Appreciation Right. 
Each Stock Appreciation Right may be exercisable in whole or in part on the 
terms provided in the Agreement. Notwithstanding anything to the contrary 
stated in this Plan, no Stock Appreciation Right shall be exercisable prior 
to six months from the date of grant except in the event of the death or 
Disability of the Participant. No Stock Appreciation Right shall be 
exercisable at any time after its Term. When a Stock Appreciation Right is no 
longer exercisable, it shall be deemed to have lapsed or terminated. Except 
as otherwise provided in the applicable Agreement, upon exercise of a Stock 
Appreciation Right, payment to the Participant (or to his or her Successor) 
shall be made in the form of cash, Stock or a combination of cash and Stock 
as promptly as practicable after such exercise. The Agreement may provide for 
a limitation upon the amount or percentage of the total appreciation on which 
payment (whether in cash and/or Stock) may be made in the event of the 
exercise of a Stock Appreciation Right. As specified in Section 7(a) hereof, 
no Participant may receive any combination of Options to purchase and Stock 
Appreciation Rights relating to more than 500,000 Shares in the aggregate 
pursuant to Awards over a five-year period under this Plan. 

9. PERFORMANCE SHARES. 

(a) 
INITIAL AWARD. An Award of Performance Shares shall entitle a Participant (or 
a Successor) to future payments based upon the achievement of performance 
targets established in writing by the Committee. Payment shall be made in 
Stock, or a combination of cash and Stock, as determined by the Committee, 
provided that at least 25% of the value of the vested Performance Shares 
shall be distributed in the form of Stock. With respect to those Participants 
who are "covered employees" within the meaning of Section 162(m) of the Code 
and the regulations thereunder, such performance targets shall consist of one 
or any combination of two or more of revenue, revenue per employee, earnings 
before income tax (profit before taxes), earnings before interest and income 
tax, net earnings (profits after tax), earnings per employee, tangible, 
controllable or total asset turnover, earnings per share, operating income, 
total shareholder return, market share, return on equity, before- or 
after-tax return on net assets, distribution expense, inventory turnover, or 
economic value added, and any such targets may relate to one or any 
combination of two or more of corporate, group, unit, division, Affiliate or 
individual performance. The Agreement may establish that a portion of the 
maximum amount of a Participant's Award will be paid for performance which 
exceeds the minimum target but falls below the maximum target applicable to 
such Award. The Agreement shall also provide for the timing of such payment. 
Following the conclusion or acceleration of each Performance Period, the 
Committee shall determine the extent to which (i) performance targets have 
been attained, (ii) any other terms and conditions with respect to an Award 
relating to such Performance Period have been satisfied, and (iii) payment is 
due with respect to a Performance Share Award. No Participant may receive 
Performance Shares relating to more than 85,000 Shares pursuant to Awards 
over a five-year period under this Plan. 

(b) 
ACCELERATION AND ADJUSTMENT. The Agreement may permit an acceleration of the 
Performance Period and an adjustment of performance targets and payments with 
respect to some or all of the Performance Shares awarded to a Participant, 
upon such terms and conditions as shall be set forth in the Agreement, upon 
the occurrence of certain events, which may, but need not, include without 
limitation a Change in Control, a Fundamental Change, the Participant's 
death, Disability or Retirement, a change in accounting practices of the 
Company or its Affiliates, or, with respect to payments in Stock for 
Performance Share Awards, a reclassification, stock dividend, stock split or 
stock combination as provided in Section 14(f) hereof. 

(c) 
VALUATION.  Each Performance Share earned after conclusion of a Performance 
Period shall have a value equal to the average of the Fair Market Values of a 
Share for the 20 consecutive business days ending on and including the last 
day of such Performance Period. 


10. RESTRICTED STOCK. Restricted Stock may be granted in the form of Shares 
registered in the name of the Participant but held by the Company until the 
end of the Term of the Award. Any employment conditions, performance 
conditions and the Term of the Award shall be established by the Committee in 
its discretion and included in the applicable Agreement. The Committee may 
provide in the applicable Agreement for the lapse or waiver of any such 
restriction or condition based on such factors or criteria as the Committee, 
in its sole discretion, may determine. No Award of Restricted Stock may vest 
earlier than one year from the date of grant, except as provided in the 
applicable Agreement. 


11. OTHER STOCK-BASED AWARDS. The Committee may from time to time grant 
Awards of Stock, and other Awards under this Plan (collectively herein 
defined as "Other Stock-Based Awards"), including without limitation those 
Awards pursuant to which Shares may be acquired in the future, such as Awards 
denominated in Stock units, securities convertible into Stock and phantom 
securities. The Committee, in its sole discretion, shall determine the terms 
and conditions of such Awards provided that such Awards shall not be 
inconsistent with the terms and purposes of this Plan. The Committee may, in 
its sole discretion, direct the Company to issue Shares subject to 
restrictive legends and/or stop transfer instructions which are consistent 
with the terms and conditions of the Award to which such Shares relate. 

12. AUTOMATIC GRANTS TO NON-EMPLOYEE DIRECTORS. 

(a) 
INITIAL OPTION GRANTS. Each Non-Employee Director first elected or appointed 
to the Board on or after the date of the 1994 Annual Meeting of Shareholders 
of the Company shall, without any Committee action, automatically be granted, 
on the date such director first becomes a director, a Non-Qualified Stock 
Option to purchase that number of Shares determined by dividing (i) an amount 
equal to $152,000 plus a percentage increase in such $152,000 amount which is 
equal to the percentage increase from the $19,000 Annual Retainer in effect 
at the time of the 1994 Annual Meeting of Shareholders of the Company to the 
Annual Retainer in effect at the date such director first becomes a director 
by (ii) the Fair Market Value of a Share on the date of grant. No increase in 
the Annual Retainer of the Non-Employee Directors after a person becomes a 
Non-Employee Director shall increase the number of Shares for which the 
Non-Qualified Stock Option granted under this Section 12(a) to such 
Non-Employee Director may be exercised. An employee of the Company or an 
Affiliate who terminates such employment and thereafter becomes a 
Non-Employee Director is not entitled to receive a Non-Qualified Stock Option 
under this Section 12(a), but will be entitled to receive Non-Qualified Stock 
Options under Section 12(b) hereof. A Non-Employee Director is not entitled 
to receive more than one Non-Qualified Stock Option under this Section 12(a) 
during his or her lifetime. 

(b) 
ANNUAL OPTION GRANTS. Each year on the date of the Annual Meeting of 
Shareholders of the Company, each Non-Employee Director who is a director of 
the Company immediately following such Annual Meeting shall, without any 
Committee action, automatically be granted a Non-Qualified Stock Option to 
purchase that number of Shares equal to the sum of (i) the Annual Retainer 
for Non-Employee Directors in effect when the grant is made, (ii) the 
aggregate meeting fees in effect when the grant is made for the total number 
of regular Board meetings held in the previous fiscal year and the median 
number of regular Board committee meetings directors were scheduled to attend 
during the previous fiscal year, and (iii) one annual committee chairmanship 
fee in effect when the grant is made, divided by the Fair Market Value of a 
Share on the date of the grant. No increase in the Annual Retainer, Board or 
Board committee meeting fee or committee chairmanship fee for Non-Employee 
Directors of the Company following the annual Non-Qualified Stock Option 
grant shall increase the number of Shares for which such Non-Qualified Stock 
Option may be exercised. 

(c) 
AGREEMENTS. Each such Non-Qualified Stock Option shall be evidenced by and 
subject to the provisions of an agreement setting forth the terms of the 
Non-Qualified Stock Option. It is intended that the provisions of this 
Section 12 shall not cause the Non-Employee Directors to cease to be 
considered Disinterested Persons and, as a result, the provisions of this 
Section 12 shall be interpreted to be consistent with the foregoing intent. 
Non-Employee Directors may not be granted Options under this Plan other than 
pursuant to the provisions of this Section 12. 

(d) 
PURCHASE PRICE; TERM AND EXERCISABILITY OF OPTIONS. The purchase price of 
each Share subject to a Non-Qualified Stock Option granted under this Section 
12 shall be the Fair Market Value of a Share as of the date the Non-Qualified 
Stock Option is granted. Notwithstanding anything to the contrary stated in 
this Plan, for purposes of this Section 12 and the definition of Fair Market 
Value in Section 2(n) hereof, each Non-Qualified Stock Option granted 
pursuant to this Section 12 shall be deemed conclusively to have been granted 
prior to the close of the applicable securities exchange or system on the 
date of grant. Non-Qualified Stock Options granted to a Non-Employee Director 
shall vest and become exercisable in full one year after the date of grant, 
provided, however, that in no event shall a Non-Employee Director initially 
appointed by the Board be entitled to exercise a Non-Qualified Stock Option 
unless, and until such time as, such director shall have been elected to the 
Board by the shareholders of the Company. Notwithstanding the foregoing, 
vesting of a Non-Qualified Stock Option granted to a Non-Employee Director 
who shall have been elected by the shareholders of the Company shall 
accelerate and the Non-Qualified Stock Option shall become immediately 
exercisable in full upon the occurrence of a Change in Control or in the 
event that the Non-Employee Director ceases to serve as a director of the 
Company due to death, Disability or retirement under the policies of the 
Company then in effect providing for retirement of directors from the Board. 
Non-Qualified Stock Options granted to a Non-Employee Director shall expire 
at the earlier of (i) the ten-year anniversary date of the Non-Qualified 
Stock Option's grant, or (ii) the five-year anniversary date of the earlier 
of (A) termination as a director due to such death, Disability or retirement 
or (B) the date the Non-Employee Director otherwise ceases to be a director 
of the Company, provided that the Non-Qualified Stock Option granted to a 
Non-Employee Director initially appointed by the Board shall expire on the 
date such director ceases to be a director of the Company unless such 
director shall have been elected by the shareholders subsequent to the grant 
of the Non-Qualified Stock Option to such director. 

(e) 
PAYMENT OF OPTION PRICE. A Non-Employee Director may exercise a Non-Qualified 
Stock Option granted pursuant to this Section 12 using as payment any form of 
consideration provided for in Section 7(a) hereof, which form of payment 
shall be within the sole discretion of the Non-Employee Director, 
notwithstanding anything stated in Section 7(a) hereof. 

(f) 
LIMITED RIGHTS. 

(i) 
In conjunction with the grant of any Non-Qualified Stock Option pursuant to 
this Section 12 (a "Related Option"), the Non-Employee Director receiving 
such grant shall simultaneously be granted a limited Stock Appreciation Right 
("Limited Rights") with respect to all of the Shares covered by such Related 
Option. Each Limited Right shall be evidenced by a written limited right 
certificate signed by an officer of the Company. 

(ii) 
Limited Rights shall be exercisable at any time within the thirty-day period 
after a Change in Control, whether or not the Related Option is exercisable 
and regardless of whether the Participant is a Non-Employee Director at the 
time of exercise, so long as the holder of the Related Option is a 
Non-Employee Director immediately preceding the Change in Control (provided 
that in no event shall a Non-Employee Director initially appointed by the 
Board be entitled to exercise the Limited Rights granted to such director 
under this Plan unless, and until such time as, such director shall have been 
elected to the Board by the shareholders of the Company). 

(iii) 
Notwithstanding the provisions of paragraph (ii) above, no Limited Right 
shall be exercised within a period of six months after the date of grant of 
the Limited Right. 

(iv) 
If Limited Rights are exercised, the Related Option shall no longer be 
exercisable to the extent of the number of Shares with respect to which the 
Limited Rights were exercised. Upon the exercise or termination of a Related 
Option, Limited Rights granted with respect thereto shall terminate to the 
extent of the number of Shares as to which the Related Option was exercised 
or terminated. 

(v) 
A person entitled to exercise a Limited Right may, subject to its terms and 
conditions and the terms and conditions of this Plan, exercise such Limited 
Right in whole or in part by giving written notice to the Company of an 
election to exercise such Limited Right. The date the Company receives the 
notice is the exercise date. Upon exercise of Limited Rights, the holder 
shall promptly be paid an amount in cash for each Share with respect to which 
the Limited Rights are exercised equal to the difference between the exercise 
price per Share covered by the Related Option and the Fair Market Value per 
Share covered by the Related Option as of the date of exercise of the Limited 
Right. 

(vi) 
A Limited Right may not be assigned and shall be transferable only if and to 
the extent that the Related Option is transferable. 

(g) 
TRANSFERABILITY. During the lifetime of a Non-Employee Director who has been 
granted a Non-Qualified Stock Option pursuant to this Section 12, only the 
Non-Employee Director (or such Non-Employee Director's legal representative 
or, if transfers to members of the Non-Employee Director's "immediate family" 
or to family trusts or partnerships become permitted as hereinafter provided, 
a permitted transferee) may exercise the Non-Qualified Stock Option. No such 
Non-Qualified Stock Option may be sold, assigned, transferred, exchanged, or 
otherwise encumbered, and any attempt to do so shall be of no effect. The 
foregoing sentence notwithstanding, from and after the earlier of (i) the 
time that Exchange Act Rule 16b-3 no longer prohibits such transfers as a 
condition to application of such Rule or (ii) the time that the Non-Employee 
Director retires from the Board and is no longer subject to the reporting 
requirements of Section 16 of the Exchange Act, such Non-Employee Director 
may transfer a Non-Qualified Stock Option granted pursuant to this Section 12 
to any member of such Non-Employee Director's "immediate family" (as such 
term is defined in Rule 16a-1(e) promulgated under the Exchange Act, or any 
successor rule or regulation) or to one or more trusts whose beneficiaries 
are members of such Non-Employee Director's "immediate family" or 
partnerships in which such family members are the only partners; provided, 
however, that (i) the transferor receives no consideration for the transfer 
and (ii) such transferred Non-Qualified Stock Option shall continue to be 
subject to the same terms and conditions as were applicable to such 
Non-Qualified Stock Option immediately prior to its transfer. Unless a 
Non-Qualified Stock Option granted pursuant to this Section 12 shall have 
expired, in the event of a Non-Employee Director's death, a Non-Qualified 
Stock Option granted to such Non-Employee Director pursuant to this Section 
12 shall be transferable to the beneficiary, if any, designated by the 
Non-Employee Director in writing to the Company prior to the Non-Employee 
Director's death and such beneficiary shall succeed to the rights of the 
Non-Employee Director to the extent permitted by law. If no such designation 
of a beneficiary has been made, the Non-Employee Director's legal 
representative shall succeed to such Non-Qualified Stock Option, which shall 
be transferable by will or pursuant to the laws of descent and distribution. 

(h) 
PRIOR PLAN. In the event that this Plan is approved and ratified by the 
shareholders of the Company as provided by Section 14(a) hereof, all 
Non-Employee Director Non-Qualified Stock Options granted from and after such 
approval shall be deemed to have been granted pursuant to this Plan and not 
pursuant to any prior plan of the Company or otherwise. 

13. ELECTIVE GRANTS TO NON-EMPLOYEE DIRECTORS IN LIEU OF COMPENSATION. 

(a) 
ISSUANCE OF RESTRICTED STOCK. Each Non-Employee Director may irrevocably 
elect to receive all or any portion of the Annual Retainer, plus any 
applicable fixed annual chairmanship fee payable to such Non-Employee 
Director, in the form of Restricted Stock to be issued as of the first day of 
the year for which such Annual Retainer is payable (currently October 1) 
(which issuances of Restricted Stock shall be prorated for fractional years 
for those Non-Employee Directors scheduled to retire, in accordance with the 
policies of the Company then in effect, prior to the annual meeting following 
such date). Each irrevocable election shall be made by the Non-Employee 
Director on a form provided by the Company and returned to the officer or 
other employee of the Company designated on such form at least six months 
before the date the Restricted Stock will be issued (currently April 1). In 
the event of such an election, a number of shares of Restricted Stock equal 
to the portion of the Annual Retainer and such chairmanship fees as to which 
the election is made, divided by the Fair Market Value of a Share as of the 
first business day of the month in which the Restricted Stock is issued, 
shall be issued in the name of the Non-Employee Director as of such date. The 
remainder of the Annual Retainer and such chairmanship fees shall be paid in 
cash to the Non-Employee Director at such time or times as payments thereof 
are customarily made by the Company to Non-Employee Directors who receive 
such payments in cash, except that each such payment shall be prorated based 
upon the total percentage of the Annual Retainer and such chairmanship fees 
with respect to which the Non-Employee Director has not elected to receive 
Restricted Stock. 


(b) 
LAPSE OF RESTRICTIONS. The Shares of Restricted Stock issued under this 
Section 13 may not be assigned, sold, pledged, hypothecated or otherwise 
transferred or disposed of (including, without limitation, transfer by gift 
or donation) except that such restrictions shall lapse upon the first to 
occur of the following events: 

(i) 
death, or resignation or removal of the Non-Employee Director from the Board 
as a result of the Disability of the Non-Employee Director; 

(ii) 
retirement of the Non-Employee Director from the Board in accordance with the 
policies of the Company then in effect providing for retirement of 
Non-Employee Directors; 

(iii) 
acceptance by the Board of the offer of the Non-Employee Director to resign 
from the Board in accordance with the policies of the Company then in effect 
after a material change in such Non-Employee Director's full-time position or 
responsibilities; 

(iv) 
termination of service as a director with the consent of a majority of the 
members of the Board other than the terminating Non-Employee Director; or 

(v) 
a Change in Control. 

The Shares of Restricted Stock shall be held by the Company until the lapse 
of the restrictions pursuant to this Section 13 (at which time they shall be 
delivered to the Non-Employee Director without any legend on the Share 
certificates referencing this Plan); provided, however, that unless and until 
the Shares of Restricted Stock are forfeited pursuant to the last sentence of 
this paragraph, the Non-Employee Director shall be entitled to all voting, 
dividend and distribution rights with respect to such Shares (except that 
dividends in Stock and Shares issued upon stock splits shall be deemed to 
constitute additional Restricted Stock to be held by the Company pursuant to 
this Plan). If the Non-Employee Director ceases to be a director of the 
Company before the restrictions on the Restricted Stock lapse pursuant to 
this Section 13, the Restricted Stock issued to the Non-Employee Director 
shall be forfeited and revert to the Company. 

(c) 
PRIOR PLAN. In the event that this Plan is approved and ratified by the 
shareholders of the Company as provided by Section 14(a) hereof, all Shares 
of Restricted Stock granted to Non-Employee Directors from and after such 
approval shall be deemed to have been granted pursuant to this Plan and not 
pursuant to any prior plan of the Company or otherwise. 

14. GENERAL PROVISIONS. 

(a) 
EFFECTIVE DATE OF THIS PLAN. This Plan shall become effective as of April 29, 
1994, provided that this Plan is approved and ratified by the affirmative 
vote of the holders of a majority of the outstanding Shares of Stock present 
or represented and entitled to vote in person or by proxy at a meeting of the 
shareholders of the Company no later than August 31, 1994. 

(b) 
DURATION OF THIS PLAN. This Plan shall remain in effect until all Stock 
subject to it shall be distributed or all Awards have expired or lapsed, 
whichever is latest to occur, or this Plan is terminated pursuant to Section 
14(e) hereof. No Award of an Incentive Stock Option shall be made more than 
ten years after the effective date provided in Section 14(a) hereof (or such 
other limit as may be required by the Code) if such limitation is necessary 
to qualify the Option as an Incentive Stock Option. Except with respect to 
Awards granted pursuant to Sections 12 and 13 hereof, the date and time of 
approval by the Committee of the granting of an Award shall be considered the 
date and time at which such Award is made or granted, notwithstanding the 
date of any Agreement with respect to such Award; provided, however, that the 
Committee may grant Awards other than Incentive Stock Options to be effective 
and deemed to be granted on the occurrence of certain specified 
contingencies. 

(c) 
RIGHT TO TERMINATE EMPLOYMENT. Nothing in this Plan or in any Agreement shall 
confer upon any Participant who is an Employee the right to continue in the 
employment of the Company or any Affiliate or affect any right which the 
Company or any Affiliate may have to terminate or modify the employment of 
the Participant with or without cause. 

(d) 
TAX WITHHOLDING. The Company may withhold from any payment of cash or Stock 
to a Participant or other person under this Plan an amount sufficient to 
cover any required withholding taxes, including the Participant's social 
security and medicare taxes (FICA) and federal, state and local income tax 
with respect to income arising from payment of the Award. The Company shall 
have the right to require the payment of any such taxes before issuing any 
Stock pursuant to the Award. In lieu of all or any part of a cash payment 
from a person receiving Stock under this Plan, the individual may elect to 
cover all or any part of the required withholdings, and to cover any 
additional withholdings up to the amount needed to cover the individual's 
full FICA and federal, state and local income tax with respect to income 
arising from payment of the Award, through a reduction of the number of 
Shares delivered to such individual or a subsequent return to the Company of 
Shares held by the Participant or other person, in each case valued in the 
same manner as used in computing the withholding taxes under the applicable 
laws; provided, however, that if at any time withholding shall be required 
with respect to Non-Employee Directors, the Committee is required to permit a 
Non-Employee Director to make such an election, subject to the limitations of 
the following sentence. Such elections are subject to the following 
limitations if, and to the extent, such limitations are necessary to comply 
with Exchange Act Rule 16b-3 or any successor provision: 

(1) 
Except as set forth in clause (iii) below, any such election by a Participant 
who is then subject to the reporting requirements of Section 16 of the 
Exchange Act or any successor provision ("Section 16") or a Successor of such 
a Participant may be made only if the conditions set forth in clauses (i) and 
(ii) below are satisfied: 

(i) (A) the election may be made during the period beginning on the third 
business day following the date of public release of the Company's quarterly 
or annual summary statements of sales and earnings and ending on the twelfth 
business day following such date, or (B) the election may be made at least 
six months prior to the date the Award is paid to the Participant; 

(ii) 
an election may not be made within six months of the date of grant of the 
Award to which the payment relates; provided, however, that such restriction 
does not apply in the event death or Disability of the Participant occurs 
prior to such election and during that six-month period; 

(iii) 
notwithstanding the foregoing, a Participant who tenders previously owned 
Shares to the Company in payment of the purchase price of Shares in 
connection with exercise of an Option may also tender previously owned Shares 
to the Company in satisfaction of any tax withholding obligations in 
connection with such Option exercise without regard to the time periods set 
forth in clauses (i) and (ii) above. 

The foregoing restrictions do not apply to any Participant who is not subject 
to the reporting requirements of Section 16 at the time of the election. 

(2) 
Any such election by a Participant who is subject to the reporting 
requirements of Section 16 at the time is irrevocable and is subject to 
approval by the Committee. The Committee's approval may be granted in advance 
but is subject to revocation by the Committee at any time. 

(e) 
AMENDMENT, MODIFICATION AND TERMINATION OF THIS PLAN. Except as provided in 
this Section 14(e), the Board may at any time amend, modify, terminate or 
suspend this Plan. Except as provided in this Section 14(e), the Committee 
may at any time alter or amend any or all Agreements under this Plan to the 
extent permitted by law. Amendments are subject to approval of the 
shareholders of the Company only if such approval is necessary to maintain 
this Plan in compliance with the requirements of Exchange Act Rule 16b-3, 
Section 422 of the Code, their successor provisions, or any other applicable 
law or regulation. Without the approval of the shareholders of the Company, 
no amendment, modification, termination or suspension of this Plan may alter 
the provisions of this Plan so as to change the terms, conditions or 
eligibility requirements of Awards granted or, subject to the right of the 
Board to discontinue this Plan, to be granted to Non-Employee Directors 
pursuant to Section 12 or 13 hereof. In no event shall the provisions of this 
Plan as they relate to Options, Limited Rights or Shares of Restricted Stock 
granted pursuant to Section 12 or 13 hereof be amended more than once every 
six months other than to comply with changes in the Code. No termination, 
suspension or modification of this Plan may materially and adversely affect 
any right acquired by any Participant (or a Participant's legal 
representative) or any Successor under an Award granted before the date of 
termination, suspension or modification, unless otherwise agreed by the 
Participant in the Agreement or otherwise or required as a matter of law. It 
is conclusively presumed that any adjustment for changes in capitalization 
provided for in Section 9(b) or 14(f) hereof does not adversely affect any 
right of a Participant under an Award. 

(f) 
ADJUSTMENT FOR CHANGES IN CAPITALIZATION. Appropriate adjustments in the 
aggregate number and type of Shares available for Awards under this Plan, in 
the limitations on the number and type of Shares that may be issued to an 
individual Participant, in the number and type of Shares and amount of cash 
subject to Awards then outstanding, in the Option exercise price as to any 
outstanding Options and, subject to Section 9(b) hereof, in outstanding 
Performance Shares and payments with respect to outstanding Performance 
Shares may be made by the Committee in its sole discretion to give effect to 
adjustments made in the number or type of Shares through a Fundamental Change 
(subject to Section 14(g) hereof), recapitalization, reclassification, stock 
dividend, stock split, stock combination, or other relevant change, provided 
that fractional Shares shall be rounded to the nearest whole Share. 


(g) 
FUNDAMENTAL CHANGE. In the event of a proposed Fundamental Change: (a) 
involving a merger, consolidation or statutory share exchange, unless 
appropriate provision shall be made (which the Committee may, but shall not 
be obligated to, make) for the protection of the outstanding Options and 
Stock Appreciation Rights by the substitution of options, stock appreciation 
rights and appropriate voting common stock of the corporation surviving any 
such merger or consolidation or, if appropriate, the parent corporation of 
the Company or such surviving corporation, to be issuable upon the exercise 
of options or used to calculate payments upon the exercise of stock 
appreciation rights in lieu of Options, Stock Appreciation Rights and capital 
stock of the Company, or (b) involving the dissolution or liquidation of the 
Company, the Committee may, but shall not be obligated to, declare, at least 
twenty days prior to the occurrence of the Fundamental Change, and provide 
written notice to each holder of an Option or Stock Appreciation Right of the 
declaration, that each outstanding Option and Stock Appreciation Right, 
whether or not then exercisable, shall be cancelled at the time of, or 
immediately prior to the occurrence of, the Fundamental Change in exchange 
for payment to each holder of an Option or Stock Appreciation Right, within 
20 days after the Fundamental Change, of cash equal to (i) for each Share 
covered by the cancelled Option, the amount, if any, by which the Fair Market 
Value (as defined in this Section 14(g)) per Share exceeds the exercise price 
per Share covered by such Option or (ii) for each Stock Appreciation Right, 
the price determined pursuant to Section 8 hereof, except that Fair Market 
Value of the Shares as of the date of exercise of the Stock Appreciation 
Right, as used in clause (i) of Section 8, shall be deemed to mean Fair 
Market Value for each Share with respect to which the Stock Appreciation 
Right is calculated determined in the manner hereinafter referred to in this 
Section 14(g). At the time of the declaration provided for in the immediately 
preceding sentence, each Stock Appreciation Right that has been outstanding 
for at least six months and each Option shall immediately become exercisable 
in full and each person holding an Option or a Stock Appreciation Right shall 
have the right, during the period preceding the time of cancellation of the 
Option or Stock Appreciation Right, to exercise the Option as to all or any 
part of the Shares covered thereby or the Stock Appreciation Right in whole 
or in part, as the case may be. In the event of a declaration pursuant to 
this Section 14(g), each outstanding Option and Stock Appreciation Right that 
shall not have been exercised prior to the Fundamental Change shall be 
cancelled at the time of, or immediately prior to, the Fundamental Change, as 
provided in the declaration. Notwithstanding the foregoing, no person holding 
an Option or Stock Appreciation Right shall be entitled to the payment 
provided for in this Section 14(g) if such Option or Stock Appreciation Right 
shall have expired pursuant to an Agreement. For purposes of this Section 
14(g) only, "Fair Market Value" per Share means the cash plus the fair market 
value, as determined in good faith by the Committee, of the non-cash 
consideration to be received per Share by the shareholders of the Company 
upon the occurrence of the Fundamental Change, notwithstanding anything to 
the contrary provided in this Plan. 

(h) 
OTHER BENEFIT AND COMPENSATION PROGRAMS. Payments and other benefits received 
by a Participant under an Award shall not be deemed a part of a Participant's 
regular, recurring compensation for purposes of any termination, indemnity or 
severance pay laws and shall not be included in, nor have any effect on, the 
determination of benefits under any other employee benefit plan, contract or 
similar arrangement provided by the Company or an Affiliate, unless expressly 
so provided by such other plan, contract or arrangement or the Committee 
determines that an Award or portion of an Award should be included to reflect 
competitive compensation practices or to recognize that an Award has been 
made in lieu of a portion of competitive cash compensation. 

(i) 
BENEFICIARY UPON PARTICIPANT'S DEATH. To the extent that the transfer of a 
Participant's Award at death is permitted by this Plan or under an Agreement, 
(i) a Participant's Award shall be transferable to the beneficiary, if any, 
designated on forms prescribed by and filed with the Committee and (ii) upon 
the death of the Participant, such beneficiary shall succeed to the rights of 
the Participant to the extent permitted by law and this Plan. If no such 
designation of a beneficiary has been made, the Participant's legal 
representative shall succeed to the Awards, which shall be transferable by 
will or pursuant to laws of descent and distribution to the extent permitted 
by this Plan or under an Agreement. 

(j) 
FORFEITURES. In the event an Employee has received or been entitled to 
payment of cash, delivery of Stock or a combination thereof pursuant to an 
Award within six months prior to the Employee's termination of employment 
with the Company and its Affiliates, the Committee, in its sole discretion, 
may require the Employee to return or forfeit the cash and/or Stock received 
with respect to the Award (or its economic value as of (i) the date of the 
exercise of Options or Stock Appreciation Rights, (ii) the date of, and 
immediately following, the lapse of restrictions on Restricted Stock or the 
receipt of Stock without restrictions, or (iii) the date on which the right 
of the Employee to payment with respect to Performance Shares vests, as the 
case may be) in the event of any of the following occurrences: competition 
with the Company or any Affiliate, unauthorized disclosure of material 
proprietary information of the Company or any Affiliate, a violation of 
applicable business ethics policies or business policies of the Company or 
any Affiliate, or any other occurrence specified in the related Agreement. 
The Committee's right to require forfeiture must be exercised within 90 days 
after discovery of such an occurrence but in no event later than 15 months 
after the Employee's termination of employment with the Company and its 
Affiliates. 

(k) 
UNFUNDED PLAN. This Plan shall be unfunded and the Company shall not be 
required to segregate any assets that may at any time be represented by 
Awards under this Plan. Neither the Company, its Affiliates, the Committee, 
nor the Board shall be deemed to be a trustee of any amounts to be paid under 
this Plan nor shall anything contained in this Plan or any action taken 
pursuant to its provisions create or be construed to create a fiduciary 
relationship between the Company and/or its Affiliates, and a Participant or 
Successor. To the extent any person acquires a right to receive an Award 
under this Plan, such right shall be no greater than the right of an 
unsecured general creditor of the Company. 

(l) 
LIMITS OF LIABILITY. 

(i) 
Any liability of the Company to any Participant with respect to an Award 
shall be based solely upon contractual obligations created by this Plan and 
the Agreement. 

(ii) 
Except as may be required by law, neither the Company nor any member or 
former member of the Board or of the Committee, nor any other person 
participating (including participation pursuant to a delegation of authority 
under Section 3(b) hereof) in any determination of any question under this 
Plan, or in the interpretation, administration or application of this Plan, 
shall have any liability to any party for any action taken, or not taken, in 
good faith under this Plan. 

(m) 
COMPLIANCE WITH APPLICABLE LEGAL REQUIREMENTS. No certificate for Shares 
distributable pursuant to this Plan shall be issued and delivered unless the 
issuance of such certificate complies with all applicable legal requirements 
including, without limitation, compliance with the provisions of applicable 
state securities laws, the Securities Act of 1933, as amended and in effect 
from time to time or any successor statute, the Exchange Act and the 
requirements of the exchanges on which the Company's Shares may, at the time, 
be listed. 

(n) 
DEFERRALS AND SETTLEMENTS. The Committee may require or permit Participants 
to elect to defer the issuance of Shares or the settlement of Awards in cash 
under such rules and procedures as it may establish under this Plan. It may 
also provide that deferred settlements include the payment or crediting of 
interest on the deferral amounts. Participants who are eligible to 
participate in the Medtronic, Inc. Capital Accumulation Plan Deferral Program 
("CAP") shall be entitled to defer some or all of the cash portion of any 
Performance Shares granted to them hereunder in accordance with the terms of 
the CAP. 


15. GOVERNING LAW. To the extent that federal laws do not otherwise control, 
this Plan and all determinations made and actions taken pursuant to this Plan 
shall be governed by the laws of Minnesota and construed accordingly. 

16. SEVERABILITY. In the event any provision of this Plan shall be held 
illegal or invalid for any reason, the illegality or invalidity shall not 
affect the remaining parts of this Plan, and this Plan shall be construed and 
enforced as if the illegal or invalid provision had not been included. 

17. TERMINATION OF PRIOR PLANS. Effective upon the approval of this Plan by 
the Company's shareholders as provided by Section 14(a) hereof, no further 
grants of options, performance shares or restricted stock or any other awards 
shall be made under the Company's 1979 Restricted Stock and Performance Share 
Award Plan, 1979 Nonqualified Stock Option Plan, 1989 Phantom Stock Award 
Plan or 1991 Restricted Stock Plan for Non-Employee Directors (the "Prior 
Plans"). Thereafter, all grants and awards made under the Prior Plans prior 
to such approval by the shareholders shall continue in accordance with the 
terms of the Prior Plans. 
                                                                    APPENDIX B 

                               MEDTRONIC, INC. 
                          MANAGEMENT INCENTIVE PLAN 
                      (AMENDED EFFECTIVE APRIL 29, 1994) 

                                 I. PURPOSES 

This Medtronic, Inc. Management Incentive Plan is effective as of April 29, 
1994 (the "Plan") and amends and restates in its entirety the existing 
Restated Medtronic, Inc. Management Incentive Plan originally adopted May 1, 
1977 and most recently restated June 27, 1991. The Plan is designed to 
motivate officers and other key employees to achieve the Company's operating 
goals by providing the opportunity for incentive compensation in addition to 
annual salaries. The Plan is also designed to promote the accomplishment of 
management's primary annual objectives as reflected in the Company's annual 
operating plan, in the various business unit annual operating plans, and in 
the objectives established by management for employees, and to recognize the 
achievement of management's objectives through the payment of incentive 
compensation. 

It is not the purpose of this Plan to reward employees for consistent 
performance of primary job responsibilities, nor to assure the payment of 
fixed salaries comparable in amount to those paid by similar companies, nor 
to recognize achievements related to successful daily performance on the job, 
all of which are intended to be identified, recognized, and rewarded through 
the Company's ongoing administration of base salaries. 

The Company intends that all amounts paid to Covered Employees under this 
Plan should qualify as deductible "performance-based compensation" under 
Section 162(m) of the Code, and the Plan shall be interpreted in accordance 
with this intent. 

                               II. DEFINITIONS 

2.01 DEFINITIONS. As used in the Plan: 

(a) 
"Affiliate" shall mean any corporation that is a "parent corporation" or 
"subsidiary corporation" of the Company, as those terms are defined in 
Sections 424(e) and (f) of the Code, or any successor provision, and any 
joint venture in which the Company or any such "parent corporation" or 
"subsidiary corporation" owns an equity interest. 

(b) 
"Board of Directors" or "Board" shall mean the Board of Directors of the 
Company. 

(c) 
"Chief Executive Officer" shall mean the person duly elected by the Board to 
the office of Chief Executive Officer of the Company. 

(d) 
"Code" shall mean the Internal Revenue Code of 1986, as amended and in effect 
from time to time, or any successor statute. 

(e) 
"Committee" shall mean the Compensation Committee of the Board of Directors, 
which shall consist of members of the Board who are not employees and who are 
not eligible for participation in this Plan. 

(f) 
"Company" shall mean Medtronic, Inc., its Affiliates and their successors and 
assigns. 

(g) 
"Covered Employee" shall mean any Employee who is a "covered employee" as 
defined in section 162(m) of the Code. 

(h) 
"Employee" shall mean any employee of the Company, whether or not an officer 
or member of the Board, but excluding any temporary employee and any person 
serving the Company only in the capacity of a member of the Board. 

(i) 
"Participant" shall mean an Employee who has been selected in accordance with 
the Plan's terms by the Committee or the Chief Executive Officer for 
participation in this Plan. 

(j) 
"Participation Categories" shall mean those categories which specify the 
range of plan awards, one of which categories will be assigned to each Plan 
Participant. The Participation Categories may be redesignated or revised 
(such as by establishing more or fewer categories or by changing the 
percentages of salary ranges applicable to a category) from time to time at 
or prior to the commencement of an applicable Plan Year by the Committee or, 
except as otherwise provided in Sections 3.02 and 3.03, by the Chief 
Executive Officer if such administrative responsibility has been delegated to 
such officer by the Committee. 

(k) 
"Performance Categories" shall mean those financial and management 
objective-based categories for performance measurement specified in Section 
4.05 hereof. 

(l) 
"Plan Year" shall mean the applicable fiscal year of the Company. 

(m) 
"Salary" shall mean the direct gross (as opposed to taxable) compensation 
earned by a Participant as base salary during the Plan Year, excluding any 
and all commissions, bonuses, incentive payments for the current Plan Year or 
prior Plan Years and other similar payments. 

(n) 
"Subsidiary" means a "subsidiary corporation," as that term is defined in 
Section 424(f) of the Code, or any successor provision. 

Certain other terms used in the Plan shall have the meanings ascribed to such 
terms in the text of the Plan. 

                       III. ADMINISTRATION OF THE PLAN 

3.01 COMMITTEE OVERSIGHT. The Committee will administer the Plan by majority 
vote. The Committee may establish such rules and regulations as it deems 
necessary for the Plan and its interpretation. In addition, the Committee may 
make such determinations and take such actions in connection with the Plan as 
it deems necessary. Each determination made by the Committee in accordance 
with the provisions of the Plan will be final, binding and conclusive. The 
Committee may rely on the financial statements certified by the Company's 
independent public accountants. 

3.02 CHIEF EXECUTIVE OFFICER'S OVERSIGHT. Except as provided in Section 3.03, 
the Committee may delegate some or all of its administrative powers and 
responsibilities under the Plan to the Chief Executive Officer for Employees 
other than any Covered Employee. The Chief Executive Officer may make such 
determinations and take such actions within the scope of such delegation and 
as otherwise provided in the Plan as he deems necessary. Each such 
determination made by the Chief Executive Officer will be final, binding and 
conclusive. The Chief Executive Officer may rely on the financial statements 
certified by the Company's independent public accountants. Unless the 
Committee determines otherwise, the Committee shall be treated as delegating 
its authority to the Chief Executive Officer to the full extent permitted 
hereunder. 


3.03 FURTHER APPROVAL NECESSARY. The Committee in its sole discretion may 
modify, suspend, terminate or reinstate the Plan; provided, however, that the 
Committee must receive prior approval of the Board of Directors (a) to render 
nonemployees, whether or not members of the Board of Directors, eligible to 
participate in the Plan, or (b) to increase the maximum awards (expressed as 
a percentage of salary) for a Participation Category beyond the maximum award 
which has been previously approved by the Board for such Participation 
Category. 



                      IV. ELIGIBILITY AND PARTICIPATION 

4.01 CERTAIN PARTICIPANTS SELECTED BY COMMITTEE. At the beginning of each 
Plan Year (or at such other time as is consistent with the requirements under 
Section 162(m) of the Code), the Committee will assign each Covered Employee 
to a Participation Category. 

4.02 OTHER PARTICIPANTS. Employees eligible to participate in the Plan shall 
include executives, heads of key staff functions, heads of operating business 
units and other major contributors to business unit or corporate results. At 
the beginning of each Plan Year, the Chief Executive Officer will select 
Participants in the Plan (other than those Participants who are to be 
assigned to Participation Categories by the Committee pursuant to Section 
4.01 hereof) from among such eligible employees. In addition, the Chief 
Executive Officer may select other employees (other than Covered Employees) 
to participate in the Plan when the Chief Executive Officer, in his sole 
discretion, deems such participation appropriate. 

4.03 FUTURE PARTICIPATION. Participation in the Plan during one Plan Year 
does not guarantee participation during any other Plan Year. 

4.04 PARTICIPATION CATEGORY. The Chief Executive Officer shall designate for 
each Participant in the Plan (other than Covered Employees) a Participation 
Category for purposes of determining the Participant's award. The 
Participation Categories and relative awards for such category for each Plan 
Year shall be set forth in writing. The range of potential awards to 
Participants under the Plan is stated for each Participation Category as 
percentages of each Participant's Salary and, if minimum performance 
objectives are met or exceeded, actual awards will fall within a scale 
ranging from designated minimum awards to designated target awards to 
designated maximum awards. The designated target award for each respective 
Participation Category is sometimes referred to herein as the "Target Award 
Percentage." Notwithstanding any contrary provisions of this Plan, the final 
award granted to any Participant under this Plan shall not be permitted to 
exceed the maximum award as a percentage of Salary for such Participant's 
Participation Category. 

4.05 PERFORMANCE CATEGORY. Each Participant's entitlement to an award under 
the Plan will be based on one or more of the weighted combinations of the 
performance of the Participant individually, as part of a team or as a member 
of management ("Management" performance), the Participant's division or other 
business unit ("Unit Financial" performance) and the Company as a whole 
("Corporate Financial" performance). The Chief Executive Officer shall 
designate for each Participant in the Plan (except for Covered Employees) a 
Performance Category for purposes of establishing such weighted combination 
from the Participant's Performance Categories. The Committee shall designate 
Performance Categories for all Covered Employees; provided however, that for 
Covered Employees such Performance Categories shall be based solely on one or 
any combination of two or more of revenue, revenue per employee, earnings 
before income tax (profit before taxes), earnings before interest and income 
tax, net earnings (profit after taxes), earnings per employee, tangible, 
controllable or total asset turnover, earnings per share, operating income, 
total shareholder return, market share, return on equity, before- or 
after-tax return on net assets, distribution expense, inventory turnover, or 
economic value added. For Covered Employees, such targets may relate to one 
or any combination of two or more of corporate, group, unit, division, 
Affiliate, or individual performance, and such designated targets will be 
treated as Corporate Financial objectives, Unit Financial objectives, or 
Management objectives as appropriate. 

                          V. PERFORMANCE OBJECTIVES 

5.01 CORPORATE FINANCIAL OBJECTIVES. Subject to Section 4.05 hereof, at the 
beginning of each Plan Year, or, with respect to Covered Employees, at such 
other time as is consistent with the requirements under Section 162(m) of the 
Code, the Committee will establish the Corporate Financial objectives by 
which the Company's financial performance during the Plan Year will be 
measured. Each Corporate Financial objective shall have a stated performance 
target. In the event that more than one Corporate Financial objective is 
used, the multiple Corporate Financial objectives shall be appropriately 
weighted by percentage in accordance with their importance (with the 
aggregate weighted objectives totalling 100%) at the time the objectives are 
established. At the end of each Plan Year the degree of achievement of each 
stated Corporate Financial objective shall be expressed as a percentage of 
the Corporate Financial performance target for each such objective. When one 
objective is used, such percentage shall constitute the "Corporate Financial 
Score" as such term is used herein. (When more than one objective is used, 
the determined percentage achievement of each objective's target must be 
multiplied by the percentage weight (out of 100%) assigned to each such 
specific objective, and the resulting percentages for the various objectives 
must then be added and such sum shall constitute the Corporate Financial 
Score.) The relationship between Corporate Financial performance and awards 
hereunder will be distributed to all Participants at the beginning of each 
Plan Year. 

5.02 OVERRIDING MINIMUM THRESHOLD. At the beginning of each Plan Year (or at 
such other time as is consistent with the requirements under Section 162(m) 
of the Code), the Committee will designate a minimum threshold level of 
Corporate Financial performance objective(s) which the Company must achieve 
for there to be any award made under the Plan. If such minimum threshold is 
not met or exceeded, no awards will be paid to Participants regardless of 
whether other Corporate Financial objectives, Unit Financial objectives or 
Management objectives have been met. 

5.03 UNIT FINANCIAL OBJECTIVES. Subject to Section 4.05 hereof, at the 
beginning of each Plan Year (or at such other time as is consistent with the 
requirements under Section 162(m) of the Code), the Vice President or other 
unit head responsible for each business unit of the Company will recommend 
and the Chief Executive Officer will adopt the Unit Financial objectives by 
which the business Unit's Financial performance will be measured. The Unit 
Financial objective(s) will be based on financial goals reflected in the 
respective business unit's fiscal year operating plan. Each Unit Financial 
objective shall have a stated performance target. In the event that more than 
one Unit Financial objective is used, the multiple Unit Financial objectives 
shall be appropriately weighted in accordance with their importance (with the 
aggregate weighted objectives totalling 100%). At the end of each Plan Year 
the degree of achievement of each stated Unit Financial objective shall be 
expressed as a percentage of the Unit Financial performance target for each 
objective. When one objective is used, such percentage shall constitute the 
"Unit Financial Score" as such term is used herein. When more than one 
objective is used, the determined percentage achievement of each objective's 
target must be multiplied by the percentage weight (out of 100%) assigned to 
each such specific objective, and the resulting percentages for the various 
objectives must then be added and such sum shall constitute the Unit 
Financial Score. The relationship between Unit Financial performance and 
awards hereunder shall be distributed at the beginning of each Plan Year to 
all Participants to which it applies. For all Participants other than Covered 
Employees, at the beginning of each Plan Year each business unit Vice 
President or other unit head may recommend and the Chief Executive Officer 
may adopt, in the Chief Executive Officer's sole discretion, a minimum 
threshold level of the business unit's most significant financial objective 
which the business unit must achieve for there to be any award based on such 
business unit's financial and management performance. If such minimum is 
established for any Participant (other than a Covered Employee) and is not 
met or exceeded, no award will be paid for one or both of the Unit Financial 
and Management portions, as determined by the Chief Executive Officer, under 
the Performance Category of each Participant in the business unit. The 
Committee shall determine whether a minimum threshold level shall apply in 
the case of a Covered Employee and the consequences of the failure to attain 
such minimum threshold level. 

5.04 MANAGEMENT OBJECTIVES. Subject to Section 4.05 hereof, at the beginning 
of each Plan Year (or, with respect to Covered Employees, at such other time 
as is consistent with the requirements under Section 162(m) of the Code), the 
manager of each Participant will recommend and the Chief Executive Officer 
will adopt the Management objectives by which the individual Participant's 
performance will be measured. Management objectives shall relate to 
objectives in the business unit's annual operating plan and/or long-range 
plan. Each Management objective shall have a stated performance target. In 
the event that more than one Management objective is used, the multiple 
Management objectives shall be appropriately weighted by percentage, at the 
time they are established, in accordance with their importance (with the 
aggregate weighted objectives totalling 100%). At the end of each Plan Year 
the degree of achievement of each stated Management objective shall be 
expressed as a percentage of the Management performance target for each such 
objective. When one objective is used, such percentage shall constitute the 
"Management Score" as such term is used herein. When more than one objective 
is used, the determined percentage achievement of each objective's target 
must be multiplied by the percentage weight (out of 100%) assigned to each 
such specific objective, and the resulting percentages for the various 
objectives must then be added and such sum shall constitute the Management 
Score. The relationship between individual performance and awards hereunder 
will be distributed at the beginning of each Plan Year to all Participants to 
which it applies. 

5.05 FINAL AWARD FUNDING. At the end of each Plan Year, the Chief Executive 
Officer will submit to the Committee a statement of the proposed final award 
to be granted to each Participant (including Covered Employees) under the 
terms of the Plan. The Committee shall determine and certify that the 
performance goals were satisfied and shall make the final award for each such 
Participant; provided that no Covered Employee may receive an award under 
this Plan in excess of $2 million during any Plan Year. The Chief Executive 
Officer shall make the final award for each Participant, other than Covered 
Employees, subject, however, to having first received the Committee's 
approval of the aggregate amount of the awards to be paid to all of such 
Participants. 

                    VI. CALCULATION AND PAYMENT OF AWARDS 

6.01 CALCULATION OF AWARDS. Each Participant's final award shall be equal to 
the sum of the following: 

(a) 
CORPORATE FINANCIAL PORTION. The Corporate Financial portion of each 
Participant's award will be the product of (i) the Participant's Salary, (ii) 
the Target Award Percentage for the Participant's applicable Participation 
Category, (iii) the Corporate Financial percentage under the Participant's 
Performance Category and (iv) the Corporate Performance Score; 

(b) 
UNIT FINANCIAL PORTION. The Unit Financial portion of each Participant's 
award will be the product of (i) the Participant's Salary, (ii) the Target 
Award Percentage for the Participant's applicable Participation Category, 
(iii) the Unit Financial percentage under the Participant's Performance 
Category and (iv) the Unit Financial Score; and 

(c) 
MANAGEMENT PORTION. The Management portion of each Participant's award will 
be the product of (i) the Participant's Salary, (ii) the Target Award 
Percentage for the Participant's applicable Participation Category, (iii) the 
Management percentage under the Participant's Performance Category and (iv) 
the individual's Management Score; 

provided, however, that for Covered Employees subsection (i) of (a), (b) and 
(c) above shall be equal to such Participant's annual Salary in effect on the 
first day of the Plan Year, if required to comply with Section 162(m) of the 
Code. 


6.02 PAYMENT OF AWARDS. Final awards shall be paid to each Participant in 
cash within 90 days after the end of the Plan Year. Notwithstanding the 
preceding sentence: (1) a Participant who is eligible to participate in the 
Medtronic, Inc. Capital Accumulation Plan Deferral Program ("CAP") shall be 
entitled to defer any part or all of the award granted to him or her 
hereunder in accordance with the terms of the CAP, and (2) if the Committee 
in its discretion permits, a Participant may elect to receive stock options 
granted under the Company's 1994 Stock Award Plan in lieu of any part or all 
of the cash award to which the Participant would otherwise be entitled 
hereunder, in accordance with rules established by the Committee for such 
purpose. 



                          VII. EMPLOYMENT PROVISIONS 

7.01 PROMOTIONS AND NEW EMPLOYEES. Except as to Covered Employees (as to whom 
such determinations must be made by the Committee), Employees who are newly 
hired or promoted into positions eligible for participation in the Plan will 
participate in the degree deemed appropriate, if at all, by the Chief 
Executive Officer and at the sole discretion of the Chief Executive Officer. 

7.02 TERMINATION OF EMPLOYMENT. 

(a) 
DEATH, DISABILITY OR RETIREMENT. Following termination of employment (which 
shall be deemed to occur on the date on which the Participant ceases working 
for the Company) during a Plan Year by reason of death, disability or normal 
or early retirement, a Participant will be eligible to receive a pro rata 
award equal to the portion of the final award, otherwise determined in 
accordance with Section 6.01, represented by the percentage equal to the 
number of full months of employment during the Plan Year divided by 12. Such 
pro rata award will be paid in accordance with Section 6.02. 

(b) 
OTHER TERMINATION. Following a termination of employment (which shall be 
deemed to occur on the date on which the Participant ceases working for the 
Company) during a Plan Year for any reason other than death, disability or 
normal or early retirement, a Participant's eligibility to receive an award 
for that Plan Year will be determined solely at the discretion of the Chief 
Executive Officer, or, in the case of a Covered Employee, solely at the 
discretion of the Committee. No such award may exceed a pro rata portion of 
the amount that normally would be available under the Plan, with such pro 
rata portion to be determined as in Section 7.02(a). 

If a Participant's employment is terminated for "Cause," the time at which 
such employee ceases to be an employee for purposes of this subparagraph 
shall mean the time at which such employee is instructed or notified to cease 
performing his or her job responsibilities for the Company or any Affiliate, 
whether or not for other reasons such as payroll, benefits or compliance with 
legal procedures or requirements that he or she may still have other 
attributes of an employee. For purposes of this subparagraph, "Cause" shall 
mean (i) failure to comply with any material policies and procedures of the 
Company, (ii) conduct reflecting dishonesty or disloyalty to the Company, or 
which may have a negative impact on the reputation of the Company, (iii) 
commission of a felony, theft or fraud, or violations of law involving moral 
turpitude or (iv) failure to perform the material duties of his or her 
employment. 

7.03 NO EMPLOYMENT CONTRACT. Nothing contained in the Plan shall create any 
right in any employee to continued employment or otherwise affect his or her 
status as an employee-at-will. 

                        VIII. MISCELLANEOUS PROVISIONS 

8.01 NONASSIGNABILITY OF BENEFITS. No Participant, nor his or her legal 
representative, shall have any right to assign, transfer, appropriate, 
encumber or anticipate any interest in the Plan or any payments hereunder. 
Participants have only the right to receive payments under this Plan if, as 
and when such payments are due and payable under the terms and conditions of 
the Plan. 

8.02 WITHHOLDING TAXES. The Company will deduct from all payments under the 
Plan any taxes required to be withheld by the federal or any state or local 
government and will pay over such taxes to such government for the account of 
such Participant. 

8.03 EXPENSES OF THE PLAN. The Company will bear all of the expenses of 
administering the Plan and will not charge such expenses against amounts 
payable hereunder. 

8.04 APPLICABLE LAW. This Plan, all determinations made hereunder, and all 
actions taken pursuant hereto will be governed by the laws of the state of 
Minnesota. 

                            IX. CHANGE IN CONTROL 

9.01 CALCULATION OF AWARDS. Notwithstanding any other provisions of this 
Plan, including without limitation the minimum threshold requirements of 
Sections 5.02 and 5.03 and the provisions of Section 7.02(b) which shall not 
apply, Participants shall be entitled to a final award calculated in 
accordance with Section 6.01 of the Plan during any Plan Year in which there 
is a Change in Control, as defined in Section 9.03 hereof; provided, however, 
that for purposes hereof the amount of the final award shall be the product 
of (i) the amount of the Participant's Salary that the Participant would have 
earned if paid through the end of the Plan Year at the Participant's base 
salary in effect at the time of the Change in Control and (ii) the greater of 
(A) the target award as a percentage of salary for the Participant's 
Participation Category or (B) if the Change in Control occurs after the first 
quarter of a Plan Year, the award as a percentage of salary that the 
Participant would have received if (1) no Change in Control had occurred 
during such Plan Year, (2) Participant's employment did not terminate during 
such Plan Year and (3) the applicable Management performance, Unit Financial 
performance and Corporate Financial performance (or if less than all such 
performance categories are to be taken into consideration in determining the 
achievement of performance objectives of the Participant, such categories as 
are to be taken into consideration in determining the achievement of such 
performance objectives) had equalled the performance most recently projected 
by the Company prior to the Change in Control with respect to such 
performance categories for such Plan Year (adjusted to exclude (a) all legal, 
accounting, investment banking and other costs and expenses incurred or 
projected by the Company in connection with, or in opposition to, the events 
resulting in the Change in Control and (b) the projected effect of the Change 
in Control upon Management performance, Unit Financial performance and 
Corporate Financial performance). The Company shall compute such projections 
for the Plan Year at or about the end of each quarter, except the last 
quarter, of each Plan Year. 


9.02 PAYMENT OF AWARDS. Final awards shall be paid under this Article IX 
within 90 days following the occurrence of the earliest Change in Control 
described in Section 9.03. Notwithstanding the preceding sentence, a 
Participant who is eligible to participate in the CAP shall be entitled to 
defer any part or all of the award granted to him or her hereunder in 
accordance with the terms of the CAP. 

9.03 CHANGE IN CONTROL. For purposes of this Article IX, a "Change in 
Control" shall mean: 

(i) 
the acquisition by any individual, entity or group (within the meaning of 
Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as 
amended (the "Exchange Act")) of beneficial ownership (within the meaning of 
Rule 13d-3 promulgated under the Exchange Act) of 30% or more of either (A) 
the then outstanding shares of common stock of the Company (the "Outstanding 
Company Common Stock") or (B) the combined voting power of the then 
outstanding voting securities of the Company entitled to vote generally in 
the election of directors (the "Outstanding Company Voting Securities"); 
provided, however, that the following acquisitions shall not constitute a 
Change of Control: (A) any acquisition directly from the Company, (B) any 
acquisition by the Company or any Subsidiary, (C) any acquisition by any 
employee benefit plan (or related trust) sponsored or maintained by the 
Company or any Subsidiary or (D) any acquisition by any corporation with 
respect to which, following such acquisition, more than 55% of, respectively, 
the then outstanding shares of common stock of such corporation and the 
combined voting power of the then outstanding voting securities of such 
corporation entitled to vote generally in the election of directors is then 
beneficially owned, directly or indirectly, by all or substantially all of 
the individuals and entities who were the beneficial owners, respectively, of 
the Outstanding Company Common Stock and Outstanding Company Voting 
Securities immediately prior to such acquisition in substantially the same 
proportions as their ownership, immediately prior to such acquisition, of the 
Outstanding Company Common Stock and Outstanding Company Voting Securities, 
as the case may be; or 

(ii) 
individuals who, as of the effective date of this Plan, constitute the Board 
(the "Incumbent Board") cease for any reason to constitute at least a 
majority of the Board; provided, however, that any individual becoming a 
director subsequent to the date hereof whose election, or nomination for 
election by the Company's shareholders, was approved by a vote of at least a 
majority of the directors then comprising the Incumbent Board shall be 
considered as though such individual were a member of the Incumbent Board, 
but excluding, for this purpose, any such individual whose initial assumption 
of office occurs as a result of either an actual or threatened election 
contest (as such terms are used in Rule 14a-11 of Regulation 14A promulgated 
under the Exchange Act) or other actual or threatened solicitation of proxies 
or consents; or 

(iii) 
approval by the shareholders of the Company of a reorganization, merger, 
consolidation or statutory exchange of Outstanding Company Voting Securities, 
in each case, with respect to which all or substantially all of the 
individuals and entities who were the beneficial owners, respectively, of the 
Outstanding Company Common Stock and Outstanding Company Voting Securities 
immediately prior to such reorganization, merger, consolidation or exchange 
do not, following such reorganization, merger, consolidation or exchange, 
beneficially own, directly or indirectly, more than 55% of, respectively, the 
then outstanding shares of common stock and the combined voting power of the 
then outstanding voting securities entitled to vote generally in the election 
of directors, as the case may be, of the corporation resulting from such 
reorganization, merger, consolidation or exchange in substantially the same 
proportions as their ownership, immediately prior to such reorganization, 
merger, consolidation or exchange of the Outstanding Company Common Stock and 
Outstanding Company Voting Securities, as the case may be; or 

(iv) 
approval by the shareholders of the Company of (A) a complete liquidation or 
dissolution of the Company or (B) the sale or other disposition of all or 
substantially all of the assets of the Company, other than to a corporation 
with respect to which, following such sale or other disposition, more than 
55% of, respectively, the then outstanding shares of common stock of such 
corporation and the combined voting power of the then outstanding voting 
securities of such corporation entitled to vote generally in the election of 
directors is then beneficially owned, directly or indirectly, by all or 
substantially all of the individuals and entities who were the beneficial 
owners, respectively, of the Outstanding Company Common Stock and Outstanding 
Company Voting Securities immediately prior to such sale or other disposition 
in substantially the same proportion as their ownership, immediately prior to 
such sale or other disposition, of the Outstanding Company Common Stock and 
Outstanding Company Voting Securities, as the case may be. 

Notwithstanding the foregoing provisions of this definition, a Change of 
Control shall not be deemed to occur with respect to a Participant if the 
acquisition of the 30% or greater interest referred to in subparagraph (i) of 
this definition is by a group, acting in concert, that includes the 
Participant or if at least 40% of the then outstanding common stock or 
combined voting power of the then outstanding voting securities (or voting 
equity interests) of the surviving corporation or of any corporation (or 
other entity) acquiring all or substantially all of the assets of the Company 
shall be beneficially owned, directly or indirectly, immediately after a 
reorganization, merger, consolidation, statutory share exchange or 
disposition of assets referred to in subparagraph (iii) or (iv) of this 
definition by a group, acting in concert, that includes that Participant. 



                             MEDTRONIC, INC. 
                                                                         PROXY 
                      ANNUAL MEETING -- AUGUST 31, 1994 
  The undersigned appoints WINSTON R. WALLIN and RONALD E. LUND, and each of 
them, as Proxies, each with the power to appoint his substitute, to represent 
   and vote, as designated below, all shares of the undersigned at the 1994 
   Annual Meeting of Shareholders of Medtronic, Inc. at the Medtronic, Inc. 
    Corporate Center at its Rice Creek facility, 7000 Central Avenue N.E., 
  Minneapolis (Fridley), Minnesota, at 10:00 a.m., Central Daylight Time, on 
         Wednesday, August 31, 1994, and at any adjournment thereof. 
                 The Board of Directors recommends votes FOR: 
1. ELECT CLASS II DIRECTORS FOR THREE-YEAR TERMS: 
  Nominees: William W. George, Bernadine P. Healy, M.D., Richard L. Schall, 
Gordon M. Sprenger, and Richard A. Swalin, Ph.D. 
[ ] FOR all nominees listed above (except those whose names have been written 
on the line below) 
[ ] WITHHOLD AUTHORITY to vote for all nominees listed above 
    (To withhold authority to vote for any nominee, write that nominee's name 
on the line below.) 
           (Continued and to be signed and dated on the other side) 
2. Approve adoption of the 1994 Stock Award Plan. 
                                           [ ] FOR   [ ] AGAINST   [ ] ABSTAIN 
3. Approve adoption of the Management Incentive Plan. 
                                           [ ] FOR   [ ] AGAINST   [ ] ABSTAIN 
4. Approve appointment of Price Waterhouse as independent auditors. 
                                           [ ] FOR   [ ] AGAINST   [ ] ABSTAIN 
   In their discretion, the Proxies are authorized to vote upon such other 
business as may properly come before the Meeting or any adjournment thereof. 
 Date: , 1994PLEASE DATE AND SIGN ABOVE exactly as name appears, indicating, 
  if appropriate, official position or representative capacity. If stock is 
             held in joint tenancy, each joint owner should sign. 
    THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED AS DIRECTED OR, IF NO 
 DIRECTION IS GIVEN, WILL BE VOTED FOR EACH PROPOSAL. THIS PROXY IS SOLICITED 
ON BEHALF OF THE BOARD OF DIRECTORS. 


                               MEDTRONIC, INC. 
                                                                         PROXY 
                      ANNUAL MEETING -- AUGUST 31, 1994 
  The undersigned appoints WINSTON R. WALLIN and RONALD E. LUND, and each of 
them, as Proxies, each with the power to appoint his substitute, to represent 
   and vote, as designated below, all shares of the undersigned at the 1994 
   Annual Meeting of Shareholders of Medtronic, Inc. at the Medtronic, Inc. 
    Corporate Center at its Rice Creek facility, 7000 Central Avenue N.E., 
  Minneapolis (Fridley), Minnesota, at 10:00 a.m., Central Daylight Time, on 
         Wednesday, August 31, 1994, and at any adjournment thereof. 
                 The Board of Directors recommends votes FOR: 
1. ELECT CLASS II DIRECTORS FOR THREE-YEAR TERMS: 
  Nominees: William W. George, Bernadine P. Healy, M.D., Richard L. Schall, 
Gordon M. Sprenger, and Richard A. Swalin, Ph.D. 
[ ] FOR all nominees listed above (except those whose names have been written 
on the line below) 
[ ] WITHHOLD AUTHORITY to vote for all nominees listed above 
    (To withhold authority to vote for any nominee, write that nominee's name 
on the line below.) 
           (Continued and to be signed and dated on the other side) 
2. Approve adoption of the 1994 Stock Award Plan. 
                                           [ ] FOR   [ ] AGAINST   [ ] ABSTAIN 
3. Approve adoption of the Management Incentive Plan. 
                                           [ ] FOR   [ ] AGAINST   [ ] ABSTAIN 
4. Approve appointment of Price Waterhouse as independent auditors. 
                                           [ ] FOR   [ ] AGAINST   [ ] ABSTAIN 
   In their discretion, the Proxies are authorized to vote upon such other 
business as may properly come before the Meeting or any adjournment thereof. 
    THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED AS DIRECTED OR, IF NO 
 DIRECTION IS GIVEN, WILL BE VOTED FOR EACH PROPOSAL. THIS PROXY IS SOLICITED 
ON BEHALF OF THE BOARD OF DIRECTORS. 
Benefit Plan Shares 
ESOP Shares 
Restricted Shares 
Registered Shares 
                                 Date: , 1994 
      PLEASE DATE AND SIGN ABOVE exactly as name appears, indicating, if 
 appropriate, official position or representative capacity. If stock is held 
               in joint tenancy, each joint owner should sign. 







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission